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ABSTRACT 
 
 
TARGETED LIPIDOMICS: 
 
ANALYTICAL STRATEGIES FOR FATTY AMIDES 
 
 
 
 
 
 
 
By 
 
Kristin Marie Kroniser 
 
May 2010 
 
 
 
Dissertation supervised by Mitchell E. Johnson, Ph.D. 
 
 
 There are many significant compounds whose resting levels in biological systems 
are at nanomolar concentrations or below.  In order to more effectively study these 
compounds work is being done to develop a completely automated system on a 
microchip.  Several steps will be taken to start setting up this system because, at these 
low concentrations, detection is problematic for many current methods of analysis.  First, 
develop a high performance liquid chromatography with mass spectrometry detection 
(HPLC/MS) method using atmospheric pressure chemical ionization (APCI) to detect 
primary fatty acid amides (PFAMs), one of the lipid classes of interest.  Additives such as 
formic acid will be added to the mobile phase in an HPLC/MS method in order to 
increase the analyte signal and lower detection limits.  Second, develop a LC method to 
replace the solid phase extraction (SPE) method that uses a gradient elution instead of the 
 v 
step elution currently done.  The LC method would allow for analysis with electrospray 
mass spectrometry (ESI-MS) in order monitor the separation between the “polar” neutral 
lipid classes.  Third, develop a method using capillary electrochromatography (CEC) to 
separate the fatty amines that have been derivatized for fluorescence detection on a 
microchip packed with a C18 chromatographic stationary phase.   
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Chapter 1  
 
 
Methods of Separating and Detecting “Polar” Neutral 
Lipids 
 
 
1.1 Abstract 
 
Lipids are a class of compounds that vary widely in polarity and function.  Some 
lipids form the structural component of living cells, while others are involved with 
intercellular communication and energy storage.  This review will focus on the neutral 
lipid classes – more specifically the more polar of the neutral lipids (free fatty acids, 
primary fatty acid amides, monoacylglycerol, diacylglycerol, and N-acylglycines, N-
acylethanolamines and N-acylamino acids).  These lipid classes are biologically active, 
but because they are found at trace levels in the cells, the analysis can be tedious and in 
some cases has not been studied extensively.  This review will focus mainly on the 
analytical techniques that have been developed for separating and analyzing the “polar” 
neutral lipids – GC/MS, LC/MS, MALDI/MS, SPE and TLC.   
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1.2  Background and Significance 
 
Lipids vary greatly in structure and functionality among the different lipid classes.  
One of the few similarities among all the classes of lipids is that they are insoluble in 
water.  Lipidomics is the study of lipids focused on fingerprinting the entire cellular 
lipidome in order to be able to understand lipid metabolism and lipid-mediated 
signaling [2].  The goals of lipidomics include quantifying each molecule, identifying the 
sub-structures of the cell formed by lipids, and determining the mechanisms with which 
the lipids interact with each other [2].  The motivation of these projects is to be able to 
gain new insights into health and disease.  Preliminary lipid studies of the lipidome have 
already shown that phosphatidylethanolamine (PtdEtn) is the main storage deposit for 
arachidonic acid (AA) in resting platelets, that there are different effects from saturated 
and unsaturated acyl functional groups in cellular metabolism, and that there are different 
lipid concentrations in the postmortem gray and white matter found in the brain samples 
from subjects with varying levels of Alzheimer’s disease [2].  The example list of 
diseases influenced by lipid production includes rheumatoid arthritis, sepsis, asthma, 
cancer and stroke [3, 4].  Because sample size can be limited and often the lipids are 
found at trace levels, methods need to be developed to allow for quantitation of the lipids 
at these low levels.  Some work is being done to study the normal levels of a one lipid.  
For example, while looking for improved clinical and biochemical techniques to quantify 
the cholesterol levels in human skin fibroblast samples, Liebisch et al. developed an 
ESI-MS/MS method [5].  The goal of this method was to quantify the free cholesterol and 
cholesteryl ester levels by derivatizing the lipids with acetyl chloride before infusing into 
the MS.  A few reviews summarize the different experimental approaches to lipidomics 
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research [4, 6-12].  With current technology, it is impossible to analyze the total lipid 
profile of a complex tissue sample at one time.  One column is not able to separate the 
various polarities, chain lengths, and varying bond positions completely.  Two 
dimensional or even multiple dimensional separations are being developed to allow for 
the analysis of more types of lipids in one sample, but this analysis is still limited to a few 
classes of lipids.  A more common approach is to focus on one or two lipid classes to 
study in detail [13-15].   
Lipids can be divided into classes based on polarity, structure or function.  A 
naming system for lipids, described by Fahy et al. [16], has been adopted.  This system 
breaks the lipids down into eight classes based on structure and function:  fatty acyls 
(FA), glycerolipids (GL), glycerophospholipids (GP), sphingolipids (SP), sterol lipids 
(ST), prenol lipids (PR), saccharolipids (SL), and polyketides (PK).  Using this 
classification of lipids the “polar” neutral lipids are in the following subclasses:  fatty 
acyls (FA), and glycerolipids (GL), shown in Table 1-1.  The free fatty acids (FFAs), the 
primary fatty acid amides (PFAMs), the N-acyl ethanolamines (NAEs), and the N-acyl 
amino acids (NAAs) are part of the FA lipid class.  The N-acyl glycines (NAGs) are 
included as part of the NAA subclass.  FAs are hydrophobic in nature because of the long 
carbon chains, which can be saturated or contain double or triple bonds.  For these studies 
(see Chapters 2-6) only the straight chain FAs were included, but lipids in this class can 
contain rings or branches.  The monoacylglycerols (MAGs) and the diacylglycerols 
(DAGs) are part of the GL lipid class.  The GL class contains all the glycerol-containing 
lipids that can be mono-, di-, or tri-substituted, except for the GPs which form their own 
class.  GLs are used as metabolic fuels and signal molecules.   
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Class Name 
(abbreviation) 
Example 
Name (subclass) 
Fatty Acyls (FA) 
 
 
oleic acid (free fatty acid – FFA) 
 
lauramide (primary fatty acid amide - PFAM) 
 
anandamide (N-acyl ethanolamines - NAE) 
 
N-arachidonoyl glycine (N-acyl amino acids - NAAs) 
Glycerolipids (GL) 
 
1-monooleoyl-rac-glycerol (monoacylglycerol - MAG) 
 
1,3-dipalmitoyl-rac-glycerol (diacylglycerol - DAG) 
 
Table 1- 1 Example lipids for each subclass of interest grouping them by lipid class.  
 
 
1.3  Separation and Analysis Methods  
 
When developing analysis methods for a particular class of lipids, the presence of 
the other classes of lipids needs to be considered.  Usually the unwanted lipid classes are 
removed during sample preparation (i.e. solid phase extraction, thin layer 
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chromatography or liquid-liquid extraction) [17-20].  If the unwanted lipids are not 
removed they can interfere with the analysis either by blocking the transfer lines or 
increasing background noise.  Solubility is also an issue as the total mass of lipids is 
increased.   
 
 
1.3.1  Free Fatty Acids (FFAs) 
 
The free fatty acids are part of the fatty acyl class of lipids.  A few reviews have 
been written summarizing the different instruments that have been used in FFA studies 
[7, 21-23].  GC/MS analysis is popular for analyzing the FFAs because of their low 
molecular weight [20, 24-29].  The analysis conditions vary depending on the number of 
FFAs included and the required detection limits.  Several reviews have been published 
summarizing the FFA GC/MS analysis methods.  The analysis parameters for the 
different GC separation of the longer FFA have been summarized by Rezanka and 
Votruba [30].  In these cases, the FFA had been derivatized before separation.  The 
method of detection was included but the detection limits were not included.  A few 
books have chapters dedicated to the separation of FFAs.  Kramer et al. compared the 
separations of C18:2 isomers on different columns [31].  This summary includes the 
extraction method, but does not note how much the percent recovery changed from one 
method to the next.  Tevini and Steinmueller reviewed the separations of saturated FFA 
and a few with some degrees of unsaturation [32] while Sébédio and Ratnayake reviewed 
the separations focusing on the trans C18:1 isomers [33].  Christie wrote a review 
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showing the fragmentation patterns of different fatty acid derivatives [34].  A variety of 
analysis methods have been developed to focus on either saturated or a series of 
unsaturated FFAs.   
Most of the LC/MS analysis of FFA has been done on derivatized fatty acids [18, 
19, 28, 35-40], but separations have been developed for un-derivatized fatty acids [20].  
The different types of derivatization agents to enhance sensitivity for UV and 
fluorescence have been summarized by Smith [41], Rosenfeld [38], and Brondz [42].  
When several FFA are present, the analysis can be lengthy.  In one example, the total 
analysis was over two hours long between the derivatization and separation of the fatty 
acids [18] (See Figure 1-1).  The HPLC separations have mostly been done on reverse 
phase columns (RP-C4 [37], RP-C8 and, RP-C18), but other stationary phases have been 
used including silver ion columns and monolithic columns [20, 26, 31, 40, 43-46].  The 
use of RP-C8 and RP-C18 columns has been summarized by Lima et al. [47], but there 
have been a few methods developed recently [18, 48].  Silver ion columns are usually 
used for separating a series of FFA with the same chain length but the double bonds in 
different locations.  Additionally the FFA will elute in three groups, FFA with all trans 
double bonds, FFA with a mixture of cis and trans double bonds, and FFA with all cis 
double bonds [26, 45].  Dobson et al. have summarized the FFA separations done with 
silver ion chromatography [49].   
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Figure 1- 1  Chromatogram of standard fatty acid derivatives (corresponding injected amount 
35.7 pmol).  The fatty acids were derivatized with acridone-9-ethyl-p-toluenesulfonate before 
separating.  Chromatographic conditions:  column temperature at 30 
o
C; excitation wavelength 
404 nm, emission wavelength 440 nm; Eclipse XDB-C8 column (4.6 x 150 mm, 5 mm); flow rate = 
1.0 mL/min.  1.  formic acid; 2. acetic acid; 3.  propionic acid; 4. butyric acid; 5. valeric acid; 6. 
hexanoic acid; 7. heptonic acid; 8. octoic acid; 9. pelargoic acid; 10. decoic acid; 11. undecanoic 
acid; 12. dodecanoic acid; 13. tridecanoic acid; 14. tetradecanoic acid; 15. petadecanoic acid; 16. 
hexadecanoic acid; 17. heptadecanoic acid; 18. octadecanoic acid; 19. nonadecanoic acid; A. 
acridone-9-ethanol; B. actidone; C. reagent peak.  Reprinted from reference [18].   
 
The total analysis time varies on the gradient and the number of analytes being 
studied.  For the most part, the published separations only include a few FFA or they do 
not completely separate between two FFA positional isomers.  There are some published 
chromatographic conditions that have been optimized to separate a partial series of FFA 
with the same chain length and degree of un-saturation [19, 35, 36, 46, 50-52].  A 
summary of the different liquid chromatography (LC) mobile phases and detection 
methods that have been used in FFA analysis have been complied by Rezanka and 
Votruba [30] and Lima et al. [47].   
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Because FFA are often found at trace levels (FFA were reported at less than 1 % 
of the total lipids found in green-lipped mussel [53], for example) in the sample matrix, 
detection limits need to be considered.  Detection limits for the LC separations vary 
depending on the detector being used.  For example Mehta et al. found the UV detection 
limit to be in the nmol range for the six phenacyl bromide FFA derivatives [36], while 
Czauderna and Kowalczyk found the UV detection limits to be in the pmol range for the 
dibromacetophenone FFA derivatives [51].  The detection limits for MS depend on the 
type of source being used.  Sanches-Silva et al. report detection limits around 130 pmol 
for C18:1, C18:2 and C18:3 using atmospheric pressure chemical ionization-mass 
spectrometry (APCI-MS) for detection [20].  Li et al. found the atmospheric pressure 
chemical ionization-multidimensional mass spectrometry (APCI-MS/MS) detection 
limits to be between 12 and 44 fmol for 19 different FFA when monitoring the fragment 
ion m/z 195.8 SRM mode [18], while Yang et al. found the electrospray ionization mass 
spectrometry (ESI-MS) detection limits to be between 40 and 160 fmol injected onto the 
column for derivatized FFA between C10 and C24 when monitoring for the [M-H]
-
 peak 
[37].  Detection of fluorescent derivatives allows for the lowest detection limits.  For 
example, Prados et al. reported detection limits between 4-7 fmol in the LC separation of 
FFA labeled with 4-N,N-dimethylaminosulfonyl-7-N-(2-aminoethyl)amino-2,1,3-
benzoxadiazole (DBD-ED) [54].   
In general, the FFAs are separated with either a C8 or C18 LC column (5 μm 
particles).  The column is equilibrated with a high percentage of water (~70 %) and then 
ramped to 100 % of either methanol or acetonitrile.  Although APCI-MS/MS allows for 
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detection limits in the tens of femtomoles, derivatization and fluoresce detection allows 
for detection limits less than 10 fmol.   
Capillary electrophoresis (CE) has also been used to separate a series of FFA [55-
58].  Gallaher and Johnson showed that a series of derivatized FFA could be separated by 
CE [56, 57].  The FFA were labeled with a polymethine cyanine near-infrared 
fluorophore so that laser induced fluorescence could be used for detection [57] (See 
Figure 1-2).  Heinig et al. showed that by using indirect detection the FFA did not need to 
be derivatized before analysis [55].  This method was compared to HPLC methods where 
the FFA (even chains C12:0 through C24:0, C17:0, C19:0, C23:0, C18:1
9
, C18:1
trans 9
, 
and C18:2
9,12
) were derivatized before analysis.  These experiments showed that HPLC 
method had a better separation, but the CE analysis was completed in a third of the time.   
 
Figure 1- 2  CE separation of C18 saturated (E) and unsaturated (A-D) FFA homologues in 
methanol/tetraethylammonium chloride with 25 kV applied voltage.  A, γ-linolenic (C18:3
9,12,15
); B, 
linoleic (C18:2
9,12
); C, petroselenic (C18:1
6
); D, oleic (C18:1
9
); E, stearic (C18:0).  Reprinted from 
reference [56] with permission from the American Chemical Society.   
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1.3.2  Primary Fatty Acid Amides (PFAMs) 
 
The separations of the PFAMs followed the same patterns as the separations of 
FFAs under similar conditions.  On a reverse phase column, the saturated PFAMs will 
elute by chain length with the smallest PFAM eluting first.  When a double bond is 
present in the compound, the retention would be approximately the same as a saturated 
PFAM with two carbons less in the chain.  In general, the analysis methods for the 
PFAMs have not been explored as extensively as the FFA analysis.  Therefore, it is 
common to use the analysis of FFAs as a starting point when developing PFAM analysis 
methods.  They both have a long carbon chain, but different polar head groups.  They can 
be found in the fatty acids and conjugated sub-class of the fatty acyls lipid class.  
However, the two vary enough in polarity that when separating them by TLC [17, 59] or 
by normal phase LC (Chapter 5), the two groups separate.  The FFA class will elute first 
from the normal phase LC column because the FFAs have a less polar head group.  Like 
the FFA analysis, GC/MS [17, 59-64] and LC/MS [60, 65-68] (Chapter 4) are the most 
common methods for further separating the sub-class.   
Derivatizing the PFAMs is common before GC analysis.  Gee et al. explored 
several different derivative methods to improve the detection of PFAMs with GC/MS 
analysis [61, 62].  From these studies, it was determined that derivatizing the PFAMs 
with bis-trimethylsilyltrifluoroacetamide (BSTFA) in toluene produced the highest 
signal-to-noise ratios.  Using selected ion monitoring (SIM) mode in the ion trap GC/MS, 
the detection limits were in the low pmol range.  Sultana and Johnson further developed 
this method in order to separate a series of six derivatized C18:1 PFAMs [17] (See 
Figure 1-3).  Unfortunately, further studies show that the derivatizing method is not 
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efficient at low concentrations.  Analysis can be done on underivatized PFAMs.  For 
example, Sultana and Johnson separated a series of PFAMs (even chains C12:0 – C22:0) 
on a HP-5MS column [17, 59].  This method was limited to separating the PFAMs by 
chain length and degree of unsaturation.  This method cannot separate by bond position, 
so all of the C18:1 PFAMs co-eluted.  The non-polar column does not have enough 
selectivity.  Additionally, using GC/CI-MS instead of GC/EI-MS with un-derivatized 
PFAMs improved the analysis so that the detection limits are in the high fmol range 
(Chapter 4).  The GC methods have been summarized in Table 1-2.   
Derivatizing the PFAMs before analysis has been done to improve detection 
limits among positional isomers.  The largest series of positional isomers separated was 
derivatized before injecting onto a polar GC column [17].  Although, the separation of 
cis/trans isomers can be done without derivatization [64].  The PFAMs can be easily 
separated by chain length using GC, but the separation of positional isomers cannot be 
done on non-polar columns.   
 
Figure 1- 3  Separation of derivatized unsaturated C18 amides on a BPX70 column.  The relative 
intensities of m/z 67, 81, 122, 124, 136, and 138 are plotted against retention time.  Average 
linear velocity of He was 30 cm/s.  Reprinted from reference [17] with permission from Elsevier.   
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GC Column Dimensions Derivative (Reagent) PFAMs Reference 
BP1 25 m x 0.32 mm; 
1 μm film 
No C18:0  
C18:1
9
 
C22:1
13
 
[69] 
BP20 25 m x 0.22 mm; 
0.25 μm film 
No C18:0 
C18:1
9 
[70] 
BPX70 60 m x 0.25 mm; 
0.25 μm film 
Trimethylsilyl derivatives 
(Bis-trimethylsilyl 
trifluoroacetamide) 
C18:1
trans 6
 
C18:1
trans 9
 
C18:1
6
  
C18:1
9
 
C18:1
trans 11
 
C18:1
13
 
C18:2
trans 9,12
 
C18:2
9,12
  
[17] 
CP-Sil 10 m x 0.53 mm No 
 
C18:1
9
 
C20:1
11
 
C22:1
13 
[71] 
CP-Sil 25 m x 0.32 mm No C18:1
9
 
C20:1
11
 
C22:1
13
 
[71] 
CP-Sil 5 CB 
 
25 m x 0.32 mm; 
1.2 μm film 
No C18:0 
C18:1
9
 
C22:1
13
  
[69] 
Dexil 300 GC 3 m x 2 mm No C16:0  
C18:0 
C18:1
9 
[63] 
HP 5MS 30 m x 0.25 mm; 
1 um film 
No C16:0 
 C18:1
9
 
 C18:0  
[66] 
HP-5MS 30 m x 0.25 mm; 
0.25 μm film 
No C12:0 – 
C20:0 (even) 
C13:0  
C18:1
9
 
C22:1
13
  
[17] 
HT5 12 m x 0.32 mm; 
0.1 μm film 
No C18:0  
C18:1
9
 
C22:1
13
 
[69] 
Methyl silicon 
film 
15 m x 0.261 mm; 
0.25 μm film 
Trimethylsilyl derivatives 
(N-methyl, N-trimethylsilyl 
trifluoroacetamide) 
C16:0  
C16:1  
C18:1
9
 
C18:1
trans 9
 
C18:2
9,12
   
 [72] 
Permabond 
CW 
30 m x 0.2 mm; 
0.25 μm film 
No C18:0  
C18:1
9
 
C22:1
13 
[60] 
Simplicity-5 30 m x 0.25 mm; 
0.25 μm film 
 
Trimethylsilyl derivatives 
(N-methyl, N-trimethylsilyl 
trifluoroacetamide) 
C7:0 - C9:0, 
C12:0 - C18:0 
(even) 
[73] 
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GC Column Dimensions Derivative (Reagent) PFAMs Reference 
Simplicity-5 30 m x 0.25 mm; 
0.25 μm film 
Trimethylsilyl derivatives 
(N-methyl, N-trimethylsilyl 
trifluoroacetamide) 
C12:0 - C20:0 
(even)  
C16:1
9 
C18:1
9
  
[61, 62] 
Simplicity-5 30 m x 0.25 mm; 
0.25 μm film 
Trimethylsilyl derivatives 
(N-methyl, N-trimethylsilyl 
trifluoroacetamide) 
C18:1
6
  
C18:1
9
 
C18:1
11
 
C18:2
9,12
 
C18:3
9,12,15
 
C18:1
9,12-OH 
[61, 62] 
SP-2330 30 m x 0.32 mm; 
0.2 μm film 
No C14:0 – 
C22:0 (even), 
C16:1
9
 
C16:1
trans 9
 
C18:1
9
 
C18:1
trans 9
 
C18:2
9,12
 
C18:3
9,12,15
 
C22:1
13
   
[64] 
Table 1- 2  Summary of GC separations of PFAMs on both polar and nonpolar columns.   
 
Predominantly the PFAM separations have been done on nonpolar columns (BP1, 
CP-Sil, Dexsil 300, HP-5MS, HT5, or Simplicity-5) to separate by chain length.  When 
the mixture includes a complex series (i.e. mixture included cis/trans isomers), then a 
polar column (BPX70 or SP-2330) is needed.  If the PFAMs are derivatized before 
separating, N-methyl, N-trimethylsilyl trifluoroacetamide is used as the derivatizing 
reagent.  The best detection limits are in the tens of femtomoles using EI-MS for 
detection. 
The HPLC separations of PFAMs have mainly been done on C18 reverse phase 
columns [60, 65, 66, 68, 74, 75] (Chapter 4).  Acetonitrile, methanol, and water are 
common solvents in the reverse phase gradients [60, 65, 66, 68, 75], but dichloromethane 
and tetrahydrofuran have also been used [74].  A normal phase column has also been 
used for the separation [67].  In this case, hexane and chloroform were part of the mobile 
phase [67].  Additives such as formic acid and acetic acid have been added to the mobile 
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phase to increase the ionization efficiency for APCI-MS detection [66, 67] (Chapter 4).  
Overall, the methods depended on the number of PFAMs of interest for the study and 
variation in degree of unsaturation.  The LC PFAM separations have mainly been done 
on C18 reverse phase columns with 4-5 μm particles.  The length of the columns was 
either 150 or 250 mm and the diameter of the columns was either 3.9 or 4.6 mm.  The 
best gradients start at approximately 30 % water and ramp to 100 % organic (methanol or 
acetonitrile).  In order to improve detection limits for APCI-MS methods, formic acid 
was added to the mobile phase.  These separations show that a series of saturated PFAMs 
can be separated by chain length.  The difficulties in separating positional isomers are 
discussed in Chapter 4.  Overall, more studies need to be done to test the limits of the 
separation on smaller columns (both dimensions and particle size) so that the position of 
the double bond can be determined by retention time.  Knowing the exact structure will 
be important for profiling the PFAM content of biological tissues.   
 
LC Column Dimensions Solvents PFAMs  Reference 
Waters XTerra 
RPC18 
150 x 3.9 mm; 
5 μm particles 
acetonitrile and water C12:0 – C22:0  
(even) 
[65] 
Alltech 
Associates 
Nucleosil 100  
250 x 4.6 mm; 
5 μm particles 
hexane, chloroform and 
acetic acid 
C18:1
9
, C12:0 – 
C12:0 (even), 
C8:0, and C8:1
9 
[67] 
Waters Nova 
Pack C18  
150 x 3.9 mm; 
4 μm particles 
methanol and water C18:1
9
 and 
C22:1
13
  
[68] 
Cosmosil 5C18   250 x 4.6 mm; 
5 μm particles 
methanol, 
dichloromethane and 
tetrahydrofuran 
C16-C30 (even) [74] 
Waters C18 
Nova Pack  
150 x 3.9 mm; 
5 μm particles 
acetonitrile and 
methanol 
C18:0, C18:1
9
 
and C22:1
13
  
[60] 
Zorbax Eclipse 
XDB C18 
150 x 4.6 mm; 
5 μm particles 
acetonitrile, methanol, 
water, and formic acid 
C14:0, C16:0, 
C17:0, C18:1
9
, 
C18:0
 
[66] 
Zorbax ODS 250 x 4.6 mm methanol C1:0, C3:1
2 
[75] 
Waters XTerra 
RPC18 
150 x 3.9 mm; 
5 μm particles 
methanol, water, and 
formic acid 
C12:0 – C22:0 
(even), C18:1, 
C22:1
13 
Chapter 4 
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LC Column Dimensions Solvents PFAMs  Reference 
Waters XTerra 
RPC18 
150 x 3.9 mm; 
5 μm particles 
methanol, water, and 
formic acid 
C18:1 series
 
Chapter 4 
Table 1- 3  Summary of HPLC separations of PFAMs.   
 
Detection limits are similar to the reported FFA detection limits and vary 
depending on the detector and experimental conditions.  Carpenter et al. found the UV 
detection limits for underivatized C18:0 to be 1 nmol injected [65].  Madl and Mittelbach 
found the detection limit of PFAMs to be around 20 fmol when using APCI-MS for 
detection [66] (Chapter 4).  Single ion monitoring was needed to achieve these detection 
limits.  Table 1-4 summarizes the MS detection limits for the different methods of 
ionization.  The detection limits are in the tens of femtomoles for each of the different 
MS interfaces:  LC/MS, GC/MS, and MALDI-TOF-MS.  In cases where positional 
isomers are studied, a separation prior to the MS was needed to differentiate between the 
PFAM isomers.  Because the injection volume for an LC separation is larger than the 
injection volume for a GC separation, the sample has to be more concentrated when 
injecting on to a GC column versus a LC to get the same mass load detection limit.  It is 
difficult to compare MALDI-TOF-MS detection limits, because they depend on the 
percentage of the spot ablated during analysis and whether the spot was homogeneous.   
 
Mass Load PFAMs Detector Reference 
40 fmol C16-C30 (even) APCI-MS 
 
[74] 
20 fmol C14:0, C16:0, C17:0, 
C18:1
9
, C18:0 
APCI-MS [66] 
360 pmol  C18:1
9
 and C22:1
13
 APCI-MS/MS [68] 
1 – 100 nmol Derivatized C7:0 – C9:0, 
C12:0 - C18:0 (even) 
CI-MS [73] 
17 nmol C1:0, C3:1
2 
EI-MS [75] 
1 nmol C18:1
9
 EI-MS [76] 
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Mass Load PFAMs Detector Reference 
6 fmol – 90 fmol Derivatized C16:0, C16:1, 
C18:1
9
, C18:1
trans 9
, 
C18:2
9,12
   
EI-MS [72] 
30 – 1500 fmol C22:1
13 
EI-MS [77] 
4 – 40 pmol Derivatized C18:1
9
 EI-MS [78] 
20 - 6000 fmol C12:0 – C20:0 (even), 
C13:0, C18:1
9
, C22:1
13
 
EI-MS [17] 
0.001 – 10 nmol Derivatized C12:0 – C20:0 
(even), C16:1
9
, C18:1
9
, 
C18:1
6
, C18:1
11
, C18:2
9,12
, 
C18:3
9,12,15
, C18:1
9,12-OH
 
EI-MS [61, 62] 
0.1 – 5 nmol C18:1
9
 EI-MS [76] 
35 nM– 350 mM C18:1
9 
ESI MS/MS [78] 
 C18:1
9
 ESI-MS
3 
[79] 
90 fmol C18:1
9
 MALDI-TOF-MS [80] 
Table 1- 4  Summary of MS detection methods for PFAMs.  The mass load is either the mass of 
each PFAM loaded onto the column/plate or the concentration injected into the MS depending on 
the technique.   
 
 
1.3.3  N-acylethanolamines (NAEs) 
 
NAEs are defined by a long carbon chain with a head polar group similar to the 
PFAM head group, but containing two extra carbons and a hydroxyl group.  NAEs 
separations have not been extensively studied, but have been studied more than PFAMs.  
GC/MS and LC/MS have both been used for analysis NAEs samples.  
N-Arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, 
is the most commonly studied NAE, so most of the LC methods focus on separating 
anandamide from the other NAEs in order to purify the sample.  Hansen et al. and Yang 
et al. have summarized results to show that effective detection methods would have to be 
able to analyze pmol of NAE per gram of tissue to low nmol of NAE per gram of tissue 
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depending on the tissue being examined [81, 82].  However, Muccioli and Stella have 
reported that detection limits may not need to be as low as originally reported [83].   
When comparing results, it is important to note the time of obtaining a sample to the 
analysis time because there can be postmortem changes in endocannabinoid levels [84]. 
Most of the published NAE separation methods only include a few NAEs.  The 
GC/MS methods have been summarized in Table 1-5.  In each case, the NAEs were 
derivatized prior to injection with one of four derivatization reagents (derivative):  
pyridine (O-acetyl-NAE), bis-trimethylsilyltrifluoroacetamide (BSTFA) 
(trimethylsilylether), tert-butyldimethylchlorosilane/ imidazole reagent (tert-
butyldimethylsilyl) or dimethyl isopropylsilyl imidazole (dimethyl isopropylsilyl ether).  
When the column dimensions were described, the separation was done on a column 30 m 
x 0.25 mm.  Fontana et al. published the chromatogram including the most NAEs 
(Figure 1-4).  The shortest NAE elutes first.  Most of the published separation methods 
have been developed on a HP-5 MS column (5 % phenyl).  These separations include 
both saturated and unsaturated carbon chain lengths, but none of the published methods 
have included a series of positional isomers to test the limits of the separation.   
Detection limits vary on detector and derivatizing agent.  Detection limits for 
O-acetyl derivatives are between 0.05 and 0.1 nmol when using a flame ionization 
detector [85], while the detection limit for BSTFA derivatized oleylethanolamide is 
0.1 pmol using MS in SIM mode for detection [86].  Detection limits for the dimethyl 
isopropylsilyl (DMiPSi) ether derivatized anandamide is 10 pg (~30 fmol) using SIM 
mode [87].  The NAEs have also been derivatized with tert-butyldimethylsilyl (t-BDMS) 
before GC analysis and the detection limits are approximately 2.9 pmol for anandamide 
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[88].  Because all of the published methods do not include detection limits, the 
derivatization reagents cannot be directly compared to determine which is the most 
effective for lowering detection limits.   
GC Column Dimensions Derivative (Reagent) NAEs Reference 
CP-Sil8 CB 30 m Trimethylsilylether 
(BSTFA) 
C16:0 
C17:0  
C18:1
9
  
C18:0 
C20:4
6
  
C20:0 
[83] 
OP-15  O-acetyl-NAE (pyridine) C12:0 – 
C24:0 (even) 
C20:4
6
  
C20:1 
C18:1 
C18:2
9
 
[85] 
HP-5 MS 30 m x 0.25 mm tert-butyldimethylsilyl (tert-
butyldimethylchlorosilane/ 
imidazole reagent) 
C18:0 
C16:0  
C18:1
9
  
C18:1
7
  
C20:4
6 
[89] 
HP-5 MS 30 m x 0.25 mm Trimethylsilylether 
(BSTFA) 
C16:0  
C18:0  
C18:1
9
  
C20:4
6 
[90] 
DB-17 30 m x 0.25 mm;  
0.25 μm thickness 
tert-butyldimethylsilyl (tert-
butyldimethylchlorosilane/ 
imidazole reagent) 
C16:0  
C18:0 
C18:1
7
  
C18:1
9
  
C18:2
6
  
C20:4
6
  
C22:5
6 
[91] 
HP-5 MS 30 m tert-butyldimethylsilyl (tert-
butyldimethylchlorosilane/ 
imidazole reagent) 
C16:0  
C17:0  
C18:0  
C18:1
9
  
C18:2
9
  
C20:4
6 
[88] 
HP-5 MS 30 m x 0.25 mm Trimethylsilylether 
(BSTFA) 
C16:0  
C18:1
9
  
C20:4
6 
[86] 
HP-5 MS 30 m tert-butyldimethylsilyl (tert-
butyldimethylchlorosilane/ 
imidazole reagent) 
C16:0  
C18:0  
C18:1
9
  
C18:1
7
  
C18:2
6
  
C20:4
6 
[92] 
DB-1 30 m x 0.317 mm; 
0.1 μm film 
Dimethyl isopropylsilyl 
ether (dimethyl 
isopropylsilyl imidazole) 
C20:4
6
  
2-AG 
[87] 
Table 1- 5  Summary of NAE analysis by GC/MS. 
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Figure 1- 4  Typical GC elution profile of a mixture of synthetic acetylated NAEs.  Reprinted from 
reference [85] with permission from Elsevier.   
 
Reverse phase [85, 93-98], normal phase [99-101], and silver ion [102] HPLC 
methods have also been explored to separate and/or purify NAEs (See Table 1-6).  The 
reverse phase method has been developed to include more NAEs in the separation [85, 
95].   Fontana et al. have compared a few columns showing that a free fatty acid HP 
column allows for a better separation between N-γ-linoleoyl-ethanolamine and 
anandamide than a Nova-Pak column [85].  Williams et al. found that working with a 
cyano column rather than typical reverse phase columns improved the resolution between 
the analytes [98].  Additives such as silver acetate [102], sodium acetate [97], ammonium 
acetate [96, 98] and formic acid [96] have been added, depending on the ionization 
source, to the mobile phase to improve detection limits.  Sugiura et al. published the 
separation of the most diverse mixture of NAEs [95] (Figure 1-5).  The reverse-phase 
separation included 18 different NAEs, but baseline separation was not reported for all 
NAEs in the mixture especially ones with the same carbon chain length and degree of 
un-saturation.  Similar problems are also seen in FFA and PFAM separations.   
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The majority of the NAE separations have been done on reverse phase columns 
(C18) 4.6 x 250 mm (5 μm particles).  Isocratic conditions were used with the mobile 
phase containing water (less than 35 %) and organic (acetonitrile, methanol, and/or 
2-propanol).  These conditions separate by chain length.  Currently, the published 
methods have not explored the conditions needed to separate positional isomers.  Since 
anandamide and deuterated anandamide are separated on a UPLC column (1.7 μm 
particles) future studied should develop methods on column with smaller the particle 
sizes.    
LC Column Dimensions Solvents NAEs Reference 
Waters Free 
Fatty Acid  
4.6 x 150 mm; 
5 μm particles 
acetonitrile, 
tetrahydrofuran and 
water 
C18:3, C18:2,  
C16:0, C20:4, 
C18:1, C22:4, 
C18:0, C20:1 
[85] 
Waters 
Resolve silica 
3.9 x 150 mm; 
5 μm particles 
2-propanol and 
n-hexane 
C16:0, C18:0, 
C18:1
9
, C20:4
6 
[90] 
Shiseido 
Capcell Pack 
C18 
4.6 x 250 mm acetonitrile, 2-propanol, 
and water 
C16:0,C 18:0, 
C18:1
7
, C18:1
9
, 
C18:2
6
, C20:4
6
, 
C22:4
6
, C22:5
6 
[93] 
HP C18 
Hypersil  
4.6 x 100 mm; 
5 μm particles 
methanol and water C16:0, C18:1
9
, 
C20:4
6 
[94] 
Shiseido 
Capcell Pack 
C18 
4.6 x 250 mm acetonitrile, 2-propanol, 
and water 
C14:0, C16:0, 
C16:1
7
, C18:0, 
C18:1
7
, C18:1
9
, 
C18:2
6
, C20:4
6
, 
C22:6
3 
[95] 
Thermo 
Electron 
Hypersil BDS 
C18 
2.1 x 100 mm; 
3 μm particles 
aqueous silver acetate 
solution and methanolic 
silver acetate solution 
C16:0, C18:1
9
, 
C20:4
6 
[102] 
Waters Acquity 
UPLC BEH 
C18 
2.1 x 50 mm; 
1.7 μm 
particles 
ammonium acetate, 
formic acid and 
acetonitrile 
C20:4
6
 and 
deuterated 
C20:4
6 
[96] 
Beckman 
ultrasphere 
ODS 
4.6 x 250 mm; 
5 μm particles 
methanol and sodium 
acetate 
C14:0, C16:0, 
C18:0, C18:1
9
, 
C20:4
6 
[97] 
Agilent 
Technologies 
Zorbax SB-CN 
2.1 x 50 mm; 
5 μm particles 
ammonium acetate and 
methanol 
C16:0, C18:1
9
, 
C20:1
12
, C20:4
6
, 
C20:5
5
,  C22:6
4 
[98] 
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LC Column Dimensions Solvents NAEs Reference 
Tosoh TSKgel 
ODS[103] 
4.6 x 150 mm; 
5 μm particles 
hexane, 2-propanol and 
methanol 
C16:0, C18:1
9
, 
C20:3
8
, C20:4
6
, 
C22:4
7 
[103] 
Normal phase 
Whatman 
4.6 x 250 mm; 
5 μm particles 
2-propanol and 
n-hexane 
C12:0, C14:0, 
C16:0, C18:2, 
C18:1, C18:0 
[101] 
Waters XTerra 
MS C8 
2.1 x 10 mm + 
2.1 x 150 mm; 
3.5 μm 
particles 
ammonium acetate, 
formic acid, methanol, 
acetonitrile, and water 
C16:0, C18:0, 
C18:1, C20:4, 
C22:4 
[104] 
Table 1- 6  Summary of NAE analysis by LC. 
 
Figure 1- 5  Separation of 1-anthroylderivatives of various types of N-acylethanolamines by 
reverse phase HPLC.  Copyright 1996.  Reprinted from reference [95] with permission from 
Blackwell Publishing.   
 
Unless MS is used for detection, the analytes need to be derivatized in order to get 
trace detection limits.  Fontana et al. found UV detection limits to be between 4 nmol and 
200 nmol depending on NAE [85].  Qin et al. found the detection limits of derivatized 
ethanolamines with o-phthaldialdehyde to be 1.0 pmol using a UV detector [97].  Sugiura 
et al. reported a detection limit of 0.3 pmol for the 1-anthroyl derivative of anandamide 
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using a fluorescence detector [95].  The method was further developed by Arai et al. by 
switching to derivatizing with 4-N-chloroformylmethyl-N-methylamino-7-N,N-
dimethylaminosulfonyl-2,1,3-benzoxadiazole (DBD-COCl) improving the detection 
limits be approximately 10 fmol for anandamide [105].  Schreiber et al. have shown that, 
when using ESI-MS/MS for the analysis of anandamide and palmitoylethanolamide, the 
detection limits are between 25 fmol and 100 fmol [102].  In this case, silver acetate was 
added to the mobile phase and the [M+Ag]
+
 ion was monitored.  Williams et al. used an 
APCI source on a triple quadrupole MS to detect approximately 10 pg (~30 fmol) NAEs 
found in bovine serum albumin (BSA) [98].  Lam et al. reported the best detection limits 
for anandamide using UPLC-MS/MS [96].  Using an ESI source in positive MRM mode 
the transition signals were 348.3 to 62.3.  The limit of quantification was 0.22 fmol 
(signal to nose ratio > 10) loaded onto the column, while the detection limit was 
0.055 fmol (signal to noise ratio = 3) loaded onto the column.   
 
 
1.3.4  N-Acyl Amino Acids (NAAs) 
 
NAAs have been postulated as being part of the biological cycle where 
peptidylglycine α-amidating enzyme (α-AE) will convert the N-acyl glycine (NAG) to 
the corresponding PFAM  [106], but only a few studies have been done to improve the 
detection of this sub-class of lipids.  The NAA sub-class co-elutes with the NAE 
sub-class when the TLC separation developed by Sultana and Johnson was used [17, 59], 
but the classes were separated when doing normal phase chromatography (Chapter 6).  
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The published NAA separations include a wide variety of compounds.  Direct 
comparison between the methods is difficult because of the variation in head groups or 
only a few NAAs were included in the separation.     
The GC separations have been summarized in Table 1-7.  These separations were 
not done on commercially available columns.  Costa et al. developed a separation 
(Figure 1-6) between glycine conjugates using a GC with a CI-MS detector in negative 
mode [1].  The limits of detection for this method ranged from 0.2 nmol of 
2-methylbutyrylglycine per liter of urine to 3 nmol of suberylglycine per liter of urine.  In 
general, published results for NAAs’ separations have not shown the detection limits nor 
explored the limits of the separation between a series of NAAs.  Rinaldo et al. used 
ammonia chemical ionization to detect NAAs derivitized with diazomethane [107].  
Detection limits were not reported for this method, but the lowest calibration point was 
0.0167 μg/mL (approximately 10 fmol when 1 μL was injected (in split mode 1:20) onto 
the column).  However, the authors of the published separations have taken different 
approaches in developing their method.   
 
GC Column Dimensions Derivative (Reagent) NAA Reference 
 100 x 0.3 cm;  
0.16-0.2 mm 
particles 
N-acylated amino acids 
(diazomethane) 
C16:1 (Gly), 
C18:0 (Gly), 
C18:1 (Gly) 
[108] 
CP-sil 19 25 m x 
0.25 mm; 
0.4 μm film 
3,5-
bis(trifluoromethyl)benzyl 
ester derivatives (3,5-
bis(trifluoromethyl)benzyl 
bromide) 
 
HG, PPG, SG, 
BG, IVG 
[1] 
Phenyl 
methylsilicone 
gum 
25 m x 0.2 mm; 
0.33 μm film 
N-acylated amino acids 
(diazomethane) 
HG, PPG, SG [107] 
3 % Dexsil 300 180 cm x 3 mm N-O-bis-(trimethylsilyl)-N-
acylglycine (BSTFA) 
PG, IVG, BG, 
MBG, HG, 
MAG, CG, MCg, 
TG, 2-HG 
[109] 
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GC Column Dimensions Derivative (Reagent) NAA Reference 
3 % OV-17 180 cm x 3 mm N-O-bis-(trimethylsilyl)-N-
acylglycine (BSTFA) 
PG, IVG, BG, 
MBG, HG, 
MAG, CG, MCg, 
TG, 2-HG 
[109] 
Table 1- 7  GC methods for separating derivatized NAAs.  Abbreviations:  N-palmitoyl-D,L-
alanine (C16:1Gly), N-stearoylglycine (C18:0 Gly), N-stearoyl-D,L-alanine (C18:1 Gly), 
hexanoylglycine (HG), phenylpropinylglycine (PPG), suberylglycine (SG), butyrylglycine (BG), 
isobutyrylglycine (IVG), propionylglycine (PG), methylbutyrylglycine (MBG), methylacrylglycine 
(MAG), crotonylglycine (CG), methylcrotonylglycine (MCG), and tiglyglycine (TG).   
 
 
Figure 1- 6  Ion current trace for negative mode CI-MS at m/z (M-BTFMB) from a pool urine 
spiked with a mixture of glycine conjugates.  (A) isobutyryglycine, (B) butyrylglycine, (C) 
2-methylbutyrylglycine, (D) isovalerylglycine, (E) hexanoylglycine, (F) phenylpropionylglycine, and 
(G) suberylglycine.  Reprinted from reference [1] with permission from Elsevier.   
 
A few HPLC separations have been developed with NAAs.  The separations have 
been summarized in Table 1-8.  Most of the separations only include a few NAAs and 
none include a complete series of positional isomers to test the limits of the separation.  
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All of the published separations, except the ones done on the CSP2 column [110, 111],  
have been done on reverse phase columns.  Carpenter et al. separated seven NAAs 
(C2-C12, saturated NAAs) using sodium phosphate and acetonitrile as the mobile phase 
on a C8 reverse phase column [65] (See Figure 1-7).  Using UV for detection, the limits 
of detection were around 1 nmol.  The authors also showed that if three C18 analogs 
(NAA, FFA, and PFAM) are combined in the same separation, the NAA analog will elute 
first from the C8 column.  Goddard and Felsted developed an HPLC method using a 
reverse phase column to separate five azlactone derivatized NAAs [112].  For this 
method, water and acetonitrile made up the mobile phase.  The detection limits were 
between 5 and 10 pmol using UV absorbance at 350 nm.  Both positive mode [104, 113] 
and negative mode [114, 115] MS/MS have been used to detect the NAA depending the 
additives in the mobile phase.  The best detection limits reported for positive mode are in 
the tens of picomoles when the fragment corresponding to the loss of ethanolamine is 
monitored [104].  The detection limits are two orders of magnitude lower (approximately 
100 fmol) when negative mode API is used in MRM mode to monitor 338 and 74 m/z for 
the detection of N-oleoylglycine [115].   
The separations that included the most NAAs in the mixture were done on either a 
C8 or C18 column (depending on the average chain length of NAAs in the mixture) 4.6 x 
250 mm (5 μm particles).  The gradients ramped from almost 100 % water to 100 % 
organic (acetonitrile).  The separations were based on chain length and none of the 
published methods included a series of positional isomers.   
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LC Column Dimensions Solvents NAA Reference 
ODP50 250 x 10 mm acetonitrile, water, 
and triethylamine 
N-acyl-L-tyrosines with 
acyl side chains C8 – 
C18 
[116] 
CSP2 250 x 4.6 mm; 
5 μm particles 
2-propanol and 
hexane 
Carbon chains C1-C7 
with various amino acid 
head groups 
[110, 111] 
Vydac C-18 
protein/peptide 
250 x 4.6 mm; 
5 μm particles  
acetonitrile and 
water 
C10:0 Gly, C12:0 Gly, 
C14:0 Gly, C16:0 Gly 
[112] 
Phenomenex 
Luna C8 
250 x 4.6 mm; 
5 μm particles 
50 mM sodium 
phosphate and 
acetonitrile 
C2:0 Gly, C3:0 Gly, C4:0 
Gly, C6:0 Gly, C8:0 Gly, 
C10:0 Gly, C12:0 Gly 
[65] 
Zorbax Eclipse 
C18 
50 x 2.1 mm acetonitrile and 
10 mM 
ammonium 
acetate 
N-arachidonyl glycine [117] 
Phenomenex 
Luna C8 
4.6 x 250 mm; 
5 μm particles 
acetonitrile, water 
and trifluoroacetic 
acid 
oleoylglycine [113] 
In house 
packed with 
Microm 
Bioresources’s 
Magic C18 
9 cm x 7 μm; 
3 μm particles 
acetonitrile, water 
and formic acid 
C18:0 Gly, C16:0 Gly, 
C18:1 Gly 
[114] 
Waters XTerra 
MS C8 
2.1 x 10 mm + 
2.1 x 150 mm; 
3.5 μm particles 
ammonium 
acetate, formic 
acid, methanol, 
acetonitrile, and 
water 
N-arachidonyl glycine [104] 
Table 1- 8  LC separation conditions for NAAs.  Abbreviations:  decanoylglycine (C10:0 Gly), 
lauroylglycine (C12:0 Gly), myristoylglycine (C14:0 Gly), palmitoylglycine (C16:0 Gly), 
stearoylglycine (C18:0 Gly), oleoylglycine (C18:1 Gly).  The number in the other abbreviations 
refers to the number of carbons in the acyl chain.   
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Figure 1- 7  Separation of short chain N-acylglycines.  Peaks are identified according to the 
number of carbons in the saturated acyl chain.  The gradient on the C8 column is shown 
graphically; the other mobile phase component is 50 mM aqueous phosphate buffer.  Reprinted 
from reference [65] with permission from Elsevier.   
 
 
1.4  Steps towards 2D/LC 
 
In order to profile different mammalian tissues, it would be useful to have a 
comprehensive LC method where one dimension separated the neutral lipids by class and 
the second dimension could be varied to further separate the lipids in the class by chain 
length, double bond position, and cis/trans orientation.  Such a method is currently being 
developed.  Experiments from this lab have shown that a normal phase PVA-Sil column 
can separate the “polar” neutral lipid classes (data shown in Chapter 5).  Further analysis 
on the PFAMs can be done by collecting the PFAM fraction and loading it onto a C18 
reverse phase column to separate by chain length and degree of unsaturation (Chapter 6).  
This is just one approach to developing a comprehensive method.  Other research groups 
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have taken different approaches and focused on different sub-classes of lipids [10, 101, 
105, 118, 119].   
Brydwell has started to develop a parallel LC method [10].  For this method, the 
polar and the non-polar lipids were analyzed separately for two different sample tissues:  
bovine brain and sand bream filet.  The polar lipids were separated using normal phase 
LC with an ion trap MS for detection.  The non-polar lipids, which eluted in the dwell 
volume were diverted to a reverse phase column to be separated and then detected with a 
triple quadrupole MS for detection.  These two gradients were run in parallel and 
monitored by two different MS instruments to reduce analysis time.  The LC gradients 
are able to separate the classes of lipids, but this method relies on the MS to separate the 
lipids further.  The drawback of this method is that isobaric lipids cannot be positively 
identified.   
A 2D-LC method, combining a silver ion column and a reverse phase column, has 
been developed for the characterization of TAGs [120, 121].  The first dimension used a 
HotSep
TM
 microbore column (150 x 1 mm; 5 μm particles) flushed with a silver nitrate 
aqueous solution.  The second dimension used a Chromolith
TM
 Performance RP-18 guard 
column (5 x 4.6 mm) and column (100 x 4.6 mm).  Using this method, the authors were 
able to identify 57 different TAGs in donkey milk fat.  The total analysis time of this 
method was 155 min.  The authors noted that the concentration injected onto the first 
dimension is critical.  If the concentration is too high, the column could be overloaded, 
but if the concentration is too low, the TAGs present at trace levels could be diluted to a 
concentration below the detection limit of the APCI-MS.     
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2D analysis systems have been developed where fractions are collected from a 
HPLC separation and then analyzed on the GC/MS.  For example, Chapman et al. 
purified NAEs from seeds using normal phase HPLC, then further analysis was done 
using a GC/MS after the NAE fraction was derivatized with bis(tri-
methylsilyl)trifluoroacetamide [101].  This method did not explore collecting additional 
fractions to analyze the TAGs also found in the seeds.   
Arai et al. developed a method using a phenyl column and an octadecylsilica 
column to separate derivitzed ananamide from other compounds found in rat brain [105].  
The sample was loaded onto the phenyl column, where the dervitized anandamide 
fraction was collected onto a trapping column (an octadecylsilica column).  Then, the 
sample was loaded onto the second column (an octadecylsilica column) for further 
purification.  This method allows for the detection of anandamide down to 10 fmol, but 
does not track other NAEs though the separation.   
Sommer et al. has developed a heart cutting method 2D/LC analysis [118].  The 
heart cutting approach to 2D/LC focuses on a few fractions where the lipids of interested 
are expected to elute instead of continuous fraction collection.  Fractions were collected 
from the first dimension, a normal phase column, where the 
glycerolphosphoethanolamine and the glycerophosphocholine classes were purified.  
Further separations within the classes were done by analyzing the two fractions 
separately on a reverse phase column followed by nanospray MS/MS detection by 
monitoring neutral loss scans in both positive and negative mode.   
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1.5  Summary 
 
Out of the FA lipid class, the FFAs have been studied the most.  Several GC and 
LC methods have been published and the best detection limits are using LC and 
fluorescent detection to detect down to 4 fmol.  CE separations have been developed to 
reduce the analysis time.  Methods still need to be developed in order to determine bond 
position.  Even though the PFAMs have not been studied as extensively, the PFAMs are 
similar enough that the FFA separation methods can be easily adapted to analyze a series 
of PFAMs instead.  When using APCI-MS for detection, the detection limit is 
approximately 20 fmol.  Most of the NAEs analysis has been focused on purifying and 
detecting anandamide.  The detection limits on both the GC/MS and LC/MS are usually 
in the low femtomole range, but one method shows that hundreds of attomole detection is 
possible with ESI-MS/MS.  The NAAs have mostly been studied on the GC/MS.  UV 
detection has mostly been used for LC methods.  The detection limits are lower using 
GC/MS, but the LC detection limits could be improved if MS detection methods were 
developed.   
When using a reverse phase LC column (i.e. C18) or a nonpolar GC column (i.e. 
5 % phenyl), the saturated forms of the lipids in the classes described above (FFA, 
PFAM, NAE, and NAA), elute with increasing chain order.  When a double bond is 
present in the compound, the retention would be approximately the same as a saturated 
form with two carbons less in the chain.  It has been demonstrated that when three C18 
analogs (NAA, FFA, and PFAM) are combined in the same separation on a C8 column, 
the NAA analog will elute first followed by the PFAM analog [65].  The FFA analog 
eluted last.  Therefore, the retention times cannot be compared across class in order to 
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determine structural information.  The GC methods tend to be more complex because the 
methods require derivatization prior to separations, but more GC methods have been 
developed to separate a series of positional isomers than LC methods.  This is partially 
the result of the GC methods being studied more than the LC methods.   
For each of the lipid classes, femtomole detection is possible.  The best detection 
limits reported are for the NAE lipid class when ESI-MS/MS is used for detection.  The 
head group for the lipid class determines whether positive mode or negative mode MS 
ionization is more effective for detection.  The FFAs and NAAs have the best detection 
limits in negative mode, while PFAMs and NAEs have the best detection limits in 
positive mode.  Ammonium acetate is commonly added to the mobile phase to improve 
negative mode detection, while formic acid is used for improving positive mode detection 
limits.  The detection limits between SIM mode on both GC/MS and LC/MS with a 
single stage quadruple MS are approximately the same when comparing the moles loaded 
onto the column.  However, because the LC methods allow for a larger injection volume, 
the detection limit for LC/MS is lower when comparing the concentration of the solution 
injected onto the column.  MRM mode MS/MS methods usually have lower detection 
limits than SIM mode MS methods.   
There are a few problems that need to be addressed before the 2D/LC method can 
be fully developed.  When developing the analysis methods for the different lipid classes, 
pure standards are not commercially available in a variety of carbon chain lengths and 
varying bond positions.  Synthesis methods that convert between the different sub-classes 
do always produce a pure standard of the final lipid.  Out of the lipid classes described, 
the FFAs are the easiest to commercially obtain.  Secondly, the overall goal is to develop 
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a 2D/LC method, but since extensive research has not been done on each of the sub-
classes, the separations within the sub-class need to be explored before the 2D/LC 
method can be fully developed.  Because each of the lipids have the long carbon chains, it 
is possible that the second method will only need minor modifications to be able to 
analyze a different lipid sub-class.   
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Chapter 2    
 
 
Microchip Reactions Followed by Capillary 
Electrochromatography and Laser-Induced Fluorescence 
for Detecting Fluorescent Fatty Amine Derivatives 
 
 
2.1  Abstract 
 
Published research on PFAMs has hypothesized that being able to analysis the 
levels of PFAMs present in biological samples could aid in medical diagnosis.  
Unfortunately, current analysis methods to do provide the accuracy and detection limits 
required.  One approach to lowering the detection limits of primary fatty acid amide 
(PFAM) analysis is to convert the PFAM into the corresponding fatty amine and then 
derivatize the fatty amine with a fluorescent dye.  The fatty amines can be derivatized 
with several different fluorescent dyes including 5-fluorescein isothiocyanate (FITC), a 
common dye used for laser-induced fluorescence (LIF) detection.  The Johnson lab has 
been exploring several different analytical techniques to improve the detection.  Two 
different techniques are presented in this chapter:  (1) show that a microchip platform 
containing a C18 column can be used to reduce the reaction time between FITC and the 
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fatty amines and (2) show that a capillary electrochromatography (CEC) method can be 
used to separate the derivatives.  For the reaction experiments, HPLC with fluorescent 
detection was used to monitor the derivatization reaction.  For the second set of 
experiments, LIF detection monitored the separation of the derivatives.  The purpose of 
these experiments was to explore separation and detection methods for analyzing the 
PFAMs found at trace levels in biological matrixes.   
 
 
2.2  Introduction 
 
The use of microchip interfaces has become a popular method for analytical 
development in recent years.  There are many advantages in using the microchip over 
conventional methods.  These include reducing the reagent consumption by a factor of 
~10
4
, reducing the size of instrumentation, allowing for reactions that are problematic on 
a larger scale, and reducing total analysis time [1, 2].  These advantages are important 
when analyzing certain biological molecules, because they are found at nanomolar or 
lower concentrations in the biological system.  Current methods for separating and/or 
derivatizing are often lengthy and inefficient.  Scaling principles applied to 
microchannels show that the initial sample size, mass or volume, can be significantly 
reduced over traditional methods.  Depending on the design of the microchip and the 
form of the analytes, a variety of different functions can be performed including: 
derivatization, purification, polymerase chain reaction (PCR) amplification, and 
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separation.  The analytes and reagents can be loaded and moved around the microchip 
either by using pressure driven flow or electroosmotic flow.   
Although the microchips provide a good platform for manipulating trace amounts 
of analytes, they are limited by the detection methods.  The detectors have to be able to 
detect the small amounts of analytes loaded onto the microchip.  Manufacturers have chip 
interfaces that introduce the sample into a mass spectrometer; however, laser-induced 
fluorescence (LIF) can be the best choice if sensitivity is the most important issue 
because, if the conditions are right, LIF is able to detect single molecules [3-5].  It is 
important to note that single molecule detection is also dependent on the single 
molecule’s probability of being in the window of detection.   
For this project fatty amines were chosen as the test analytes.  Amines are related 
to the primary fatty acid amides (PFAMs).  Common examples of biologically occurring 
PFAMs are oleamide and erucamide [6, 7].  PFAMs are a class of neutral lipids that can 
be converted to their corresponding amines via a Hofmann rearrangement [8].  Because 
of the variation and number of lipids that can be present in a sample, most methods 
would require three steps in order to isolate each of the PFAMs from a tissue sample or 
cell.  The first step would be a liquid-liquid extraction to collect the neutral lipids from 
the tissue.  The second step would be to purify the lipid class of interest either by solid 
phase extraction (SPE) or by normal phase liquid chromatography (LC).  Details about 
this step are discussed in Chapter 5.  Once the PFAM fraction is purified, they can be 
converted into their corresponding amines and derivatized with a fluorescent tag such as 
5-fluorescein isothiocyanate (FITC) [8].   
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The derivatized analytes could then be analyzed with capillary 
electrochromatography (CEC) or capillary electrophoresis (CE).  The estimated detection 
limit for this method when using LIF detection is sub-zmol, significantly lower than any 
of the other current detection methods [9].  However, if the amines will be derivatized, 
the reaction efficiency needs to be considered.  The rate of reaction is reduced as the 
concentration of the solution is lowered.  In order to be able to work with tens of 
nanomoles of amines, the sample could be pre-concentrated on a microchip packed with a 
C18 stationary phase before reacting with the fluorescent tag on the stationary phase.  In 
an attempt to develop a trace analytical method for the detection of fatty amines, the 
analytes were derivatized on a microchip and analyzed using HPLC with fluorescence 
detection.  The CEC/LIF detection method was developed using a series of purified 
derivatized amines.   
Unlike HPLC, there is not a variety of pumps, detectors, and consumables 
commercially available for CEC analysis in part because the limited number of research 
groups currently working with the technique.  Although, the technique is becoming more 
popular, there are still only a few commercially available CEC columns (summarized by 
Dittman [10]).  Currently the columns do not have a wide variety of diameters and 
stationary phases.  Therefore, CEC column needed for this analysis had to be packed by 
hand.  In order to try different stationary phases in the CEC column, the sol-gel reaction 
would have to be modified to create variations of the CEC column.  The advantage of 
CEC methods is that they are not limited by pressure, allowing for the use of smaller 
particles in the stationary phase.  CEC methods can be completed in a third of the time it 
takes for a HPLC separation [11].   
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CEC would be easier to integrate onto a microchip interface.  In order to put an 
HPLC column on a microchip interface, the fittings would have to withstand the pressure 
from the mobile phase being pushed through the column.  Secondly, a simpler design for 
the microchip would involve the use of a sol-gel for the stationary phase.  The sol-gel 
would hold the stationary phase in place eliminating the need for weirs (see Figure 2-1) 
that are required to hold the stationary phase in place for an HPLC column.   
 
Figure 2- 1  Diagram of the straight design microchip.  This microchip design was used for 
previous experiments.  This microchip was packed with Phenomenex’s Luna C18 bulk packing 
(100 Å pore size, 15 μm diameter) and baked overnight at 115 
o
C. 
 
Derivatization on a microchip platform and CEC separations are just two of many 
analytical techniques explored by the Johnson group in order to develop a method that 
extracts a class of neutral lipids and then further separated the lipids in the class so that 
each lipid could be positively identified and quantified.  The advantage of a microchip 
platform would be that it could incorporate both the reaction and separation on the same 
devise.  The analytes would be able to be loaded onto the first column to be 
preconcentrated and reacted with a derivatizing agent.  This is demonstrated in 
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section 2.3.  After reacting the analytes could be moved directly onto a second column 
used for separation.  The separation parameters are demonstrated in section 2.4.  This 
design could reduce sample loss by reducing the dead volume zones.  Contamination 
from handling the sample would also be reduced.   
 
 
2.3  Fluorescence Derivatization on a Microchip 
2.3.1  Microchip Background 
 
Carpenter was able to derivatize nanomoles of phenylalkylamines on a 
2.1 x 10 mm guard column containing C18 as the stationary phase [12].  This procedure 
improved the detection limit and decreased total analysis time.  For these experiments, 
the samples were analyzed with HPLC for separation and UV-vis for detection.  
Experiments were done to determine the effectiveness of preconcentration on the phase 
by pumping a 200 nM solution for 2.5 hours to load 2.5 nmol of each of the 
phenylalkylamines onto the column.  Build up of back pressure prevented the use of 
lower solution concentrations.  Also, an excessive load time makes it impractical with 
that set-up.  It was recommended that a fluorescence detector be used to achieve lower 
detection limits [2].   
There have been several different types of reactions done on microchips, 
suggesting that the reaction can be scaled down even further.  Fluri et al. achieved post 
column reactions on a microchip following capillary electrophoresis separation [13].  The 
microchip was used to mix the amino acids with o-phthaldialdehyde.  This technique was 
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monitored with a fluorescence detector which allowed for detection limits of about 2 μM.  
It has been estimated that 1-3% of the amino acids are derivatized on the column from the 
time they are mixed to the time they reach the detector, making this an on-column 
reaction.   
Harrison’s group, with the use of fluorescent dyes, has been able to detect sub-pM 
concentrations of peptides and amino acids using a 300 pL, 200 μm long SPE bed [14].  
The high surface area of the octadecylsilane (ODS) beads allows for preconcentration 
factors as high as 500.  Efficient preconcentration is necessary when analyzing many of 
the biological compounds which are found at nanomolar concentrations in the system.  
Although beads have been used in various applications to improve reactions because of 
their high surface area, it is not until recently that they have been integrated into chips 
with etched channels.  The addition of a side channel perpendicular to the main channel 
was used to control the packing and unpacking the column.  This design has been used 
for selective preconcentration and solid-phase extraction.  [15] 
Another method of preconcentration on a microchip involves electrokinetics and a 
silicate membrane [16].  If the right pore size is chosen, the silicate membrane will 
collect the large molecules while supporting an electrical current.  One of the advantages 
of this type of packing is that is has low flow resistance, allowing flow rates up to 
10 μL/min.  In this case it was more effective to use lower flow rates when 
preconcentrating the Phe-Gly-Phe-Gly peptide.   
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2.3.2  Reagents 
 
Five different fatty amines were used:  n-decylamine, 95 % (Sigma, St. Louis, 
MO), 1-dodecylamine, 98 % (Acros Organics, Morris Plains, NJ), 1-tetradecylamine, 
96 % (Aldrich, Milwaukee, WI), 1-hexadecylamine, 99 % (Aldrich), and octadecylamine, 
97 % (Aldrich).  Fluorescein (laser grade) was from Kodak (Rochester, NY).  Sodium 
bicarbonate (reagent grade), 5-fluorescein isothiocyanate (isomer 1, 90 %) and 
chlorotrimethylsilane (98 %), were from Acros Organics.  Acetronitrile (HPLC grade), 
methanol (HPLC grade), toluene (ACS grade), sodium phosphate monobasic, sodium 
phosphate dibasic, hydrochloric acid and sodium hydroxide were from Thermo Fisher 
Scientific (Pittsburgh, PA).  The solutions were filtered with 0.22 μm nylon membrane 
filters from Whatman (Maidstone, England) before use.  The microchip bulk stationary 
phase, C18(2) 100 Å, was from Phenomenex (Torrance, CA).  The 100 μm i.d. capillary 
was from Polymicro Technologies (Phoenix, Az).  The nitrogen used for drying was from 
Air Gas (Pittsburgh, PA).  Distilled water was deionized with a Barnstead (Dubuque, IA) 
Nanopure water system.   
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2.3.3  Microchips 
 
Chips were manufactured by Dr. Mitchell Johnson at the University of Virginia 
according to published procedures [17] with a few modifications.  The chip substrate was 
borofloat glass (Nanofilm, Westlake Village, CA, 0.040" thick or Telic, Valencia, CA, 
1.1 mm thick) precoated with chromium and AZ 1518 negative photoresist (5300 Å 
thick).  The image for the desired chip features was created by emulsion printing on 
mylar film (Pixels, Charlottesville, VA) from a postscript file created in AutoCAD LT 
(Autodesk).  The chip features were clear on the photomask.  A "sandwich" of clear 
glass, photomask, and substrate was exposed under UV radiation, transferring the pattern 
to the photoresist. The resist/substrate was baked at 110 
o
C for 30-60 min to polymerize 
the unexposed portion of the resist, and the exposed resist and the chromium under it 
were removed with solvent.  Thus, the underlying glass was exposed only where desired 
chip features (such as channels) were present in the original film photomask.  The 
exposed glass was etched with hydrofluoric acid: nitric acid: water 50:14:36 for about 
45 min to etch channels approximately 90 μm deep and 300 μm wide.  The remaining 
resist and chromium were removed and the plates were washed thoroughly.  Top and 
bottom chips were exposed and etched at the same time.  Individual chips were scored 
and cut, drilled (for inlet and outlet capillary connections), cleaned again, assembled, and 
baked at 110 
o
C for 30 min, 550 
o
C for 1 hr, and finally at 680 
o
C for 8 hr.  The weir 
structures were created by leaving a gap in the channels in the photomask which was 
etched only part way through.  The isotropic etching process thus created a sloping 
bottom in the channel with a very small open portion at the top.  When bonded to a top 
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channel, the net result was a channel with a double trapezoidal structure, 300 μm wide in 
the middle, 120 μm wide at top and bottom, with an elliptical weir that was about 
10-15 μm wide at the widest (top to bottom).     
Before packing the microchip, it was conditioned by pumping about 200 μL each 
of the following solutions through the microchip:  1 M sodium hydroxide, deionized 
water, and methanol.  A slurry was made of the stationary phase and methanol and this 
mixture was loaded through the inlet side of the microchip for the straight microchip 
design.  The microchip was packed with Phenomenex’s Luna C18 bulk packing (100 Å 
pore size, 15 μm diameter).  The stationary phase was packed up against the weir by 
pulling a vacuum on the outlet side, then flushed with methanol and deionized water.  In 
order to hold the stationary phase in place in the straight microchip design, the 
microchips are baked overnight at 115 
o
C in a Pro-Set II Stabil Therm Electric Oven 
(Blue Island, IL).  Solutions were pushed through the column using a syringe pump.  The 
straight microchip design is shown in Figure 2-1.   
There are a few known problems with the straight design microchip.  The 
reservoirs create a dead volume zone that retains the analytes/reagent instead of loading 
these onto the microchip.  The length of the column varies slightly from one microchip to 
another because of the packing method.  The baking process needed to hold the stationary 
phase in place degrades the packing.  The T-chip design, described in Chapter 5, will 
eliminate some of these problems, but the T-chip design microchips are more prone to 
clogging relative to the straight chip design microchips because of the extra weir.   
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2.3.4  Reaction Set Up  
 
The set-up used for the reaction is shown in Figure 2-2.  For this set up the 
syringe pump (Harvard Compact Infusion Pump model 975) was connected to a series of 
valves and then the microchip.  The first valve was a six port valve (Rheodyne 7000) that 
switched the flow from loading buffer (95 % phosphate buffer:  5 % method) to elution 
solvent (100 % methanol).  The second valve was an injector valve (Rheodyne 7725) 
with a 2 μL sample loop for loading the FITC solution and the amine mix.  The final 
valve was a four port valve that was able to divert the flow during the reaction.  A fused 
silica capillary (75 μm i.d.) was used to connect the valves after the injection port while 
PEEK tubing (0.005 ID) was used to connect the plastic syringes (BD 5 mL) to the first 
valve.  The flow rate was set to 5 μL/min, but the flow varied depending on the condition 
of the microchip column, because the syringe pump does not have a back pressure 
regulator.  The microchip was placed in a water bath in order to control the reaction 
temperature.  Finger tight fittings were used to keep a tight seal on the inlet and outlet 
channels to keep the water out of the system.   
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Figure 2- 2  Diagram of the reaction set up.  The dark lines are 0.005 ID PEEK tubing and the 
light lines are 75 μm ID silica tubing. 
  
  
2.3.5  Silanization 
 
Because the amines, at low concentrations, tend to adsorb to glass, all the 
collection vials and capillary tubing need to be silanized.  First clean vials were soaked in 
1 M sodium hydroxide for 20 min.  These vials were then rinsed with deionized water 
and distilled acetone before being dried completely.  Each vial was rinsed with toluene 
and filled with a solution 10% chlorotrimethylsilane: 90% toluene by volume under 
nitrogen.  The next day the solution was removed and the vials were rinsed with toluene 
before putting in the oven to dry.  Before use, the vial was rinsed with methanol to 
remove any residue.  The capillaries were also conditioned in a similar matter.  Each 
solution was pumped at 10 μL/min through the capillary for 15 min:  1 M hydrochloric 
acid, deionized water, 1 M sodium hydroxide, deionized water, distilled acetone, toluene, 
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and 10% chlorotrimethylsilane: 90% toluene.  The chlorotrimethylsilane: toluene solution 
was left in the capillary overnight.  End caps were put on the capillary to prevent drying.  
The next day, toluene and then methanol were pumped through the capillary each at 
10 µl/min for 15 min.  The capillary was then reconnected to the microchip.   
 
 
2.3.6  Chromatographic Conditions 
 
Separation and analysis were done on a Waters 600 HPLC with a Waters XTerra 
column (RP18 5μm, 3.9 x 150 mm).  A Waters 600 pump equipped with both a Waters 
2487 UV-vis absorbance detector (monitoring at 480 nm) and a Waters 470 fluorescence 
detector (monitoring with excitation 490 nm and emission 520 nm) was used for analysis.  
The following linear gradient developed by Carpenter was used for analysis of the 
derivatives: 70% A, 30% B, to 40% A, 60% B over 5 min, hold at 40% A, 60 % B for 
4 min before returning to 70% A, 30% B over 5 min, and hold for 2 min to equilibrate for 
the next injection at 0.8 mL/min where A was 10 mM carbonate buffer adjusted to pH 9.6 
and B was acetonitrile [12].  All solutions were filtered with 0.22 μm nylon membrane 
filter.  The injection volume was 5 µL.  Millenium software (Waters Corporations) was 
used for analyzing the chromatograms.   
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2.3.7  Results and Discussion 
 
The amines and FITC are not soluble in 100 % phosphate buffer, so for these 
experiments methanol was added to each of the solutions.  A 50 μM mix of each of the 
five different fatty amines was made from the following fatty amines:  n-decylamine 
(C10), 1-dodecylamine (C12), 1-tetradecylamine (C14), 1-hexadecylamine (C16), and 
octadecylamine (C18).  The solution was made in 35 % methanol: 65 % 10 mM phosphate 
buffer (pH 7.5).  The solution for loading was 150 µM FITC in 5 % methanol: 95 % 
10 mM phosphate buffer.  These are the lowest percentages of methanol that allowed the 
analytes to stay in solution.  Each of these solutions was filtered before reacting using a 
0.22 μm nylon membrane.  Figure 2-3 is a diagram showing the three main steps 
involved in doing the reaction on a microchip.   
 
Figure 2- 3  Block diagram showing the three main steps in doing a reaction on a microchip:  load 
amines, load FITC, and elution followed by HPLC separation and fluorescence detection. 
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For each reaction, the amines and FITC were first preconcentrated on the 
stationary phase.  An overlap of the analyte and reagent zones would have to occur for 
the reaction to take place.  Then the derivative was eluted off the stationary phase with 
methanol and injected onto the C18 HPLC column followed by fluorescence detection.  
The reaction time was optimized by varying the reaction time between 15 min and 
60 min finding no significant increase in amount of derivatives formed.  Because the chip 
was in a water bath, the reaction temperature could be controlled.  Increasing the 
temperature of the water bath from 30 
o
C to 40 
o
C doubled the amount of derivatives 
formed, but the packing degraded faster at the elevated temperatures so no further 
temperature studies were done.  Additional changes in the flow rate due to increased 
temperature were not studied.   
The optimized method allowed the column to equilibrate with 95 % phosphate 
buffer and 5 % methanol for 15 min.  The amines were loaded in a 2 μL sample loop and 
pushed towards the column with 95 % phosphate buffer and 5 % methanol for 9 min.  
FITC was loaded in the 2 μL sample loop and pushed towards the column with 95 % 
phosphate buffer and 5 % methanol for 9 min.  The flow was stopped to the microchip 
allowing the reaction to occur for 15 min.  During this time the lines going from the first 
value, through the injection port towards the third valve were flushed with 100 % 
methanol.  After the reaction was done, the derivatives were eluted from the column with 
100 % methanol for 15 min.  Throughout the entire method, the syringe pump was set to 
4.9 μL/min (actual flow rate was around 1 μL/min) and the water bath was set to 30 oC.  
The eluant was dried down and reconstituted in 30 μL of methanol in order to do three 
injections on the HPLC with fluorescence detection.  The resultant chromatogram is 
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shown in Figure 2-4.  This reaction worked the best when 25 pmol of each amine and 
300 pmol of FITC were loaded onto the column.  It would take 3-4 hours doing an offline 
reaction (25 nmol of each amine and 300 nmol of FITC in 3 mL of 65 % methanol and 
35 % buffer) with the same 2:1 reaction ratio to get a similar percentage of derivatization.  
More details about this reaction can be found in Carpenter’s thesis [12].   
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Figure 2- 4  Fluorescent chromatogram from reacting either 25 pmol or 15 pmol of each amine 
with 300 pmol of FITC for 15 min on the microchip column. 
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2.3.8  Reaction Conclusions 
 
There are several problems limiting this method.  Primarily, this method was 
limited by the fluorescence detector on the HPLC.  The lower detection limit was around 
5 nM, which limits the mass of the analytes used in the reaction on the microchip.  If less 
than 10 pmol of each amine were loaded onto the microchip, the amount of derivative 
formed was below the detection limit on the detector.  The syringe pump used for loading 
the solutions onto the chip did not have pressure regulation.  As pressure increased, the 
flow rate going through the microchip decreased causing a variation in the amount of the 
analytes/reagents that were loaded onto the stationary phase.  The baking processes 
needed to hold the stationary phase in place as well as higher temperature experiments 
caused the stationary phase to degrade.  This caused variation in the efficiency of the 
reaction occurring from one microchip to another microchip.  Overall by reducing the 
total volume of the solution, the reaction occurred faster.  There are still some 
reproducibility issues stopping this reaction set-up from being used regularly, but using 
this reaction set-up does derivatize the amines faster than a bench top reaction.   
Even though this reaction method does not allow for much variation in the 
amount of amines loaded onto the column, the percentage of derivatives formed was 
increased.  On a bench top reaction where 50 nmol of each amine was reacted with 
500 nmol of FITC approximately 2 % of derivative was formed in 15 min.  On the 
microchip 25 pmol (2,000 fold difference in mass) of each amine was reacted with 
300 pmol of FITC approximately 10 % of derivative was formed in 15 min.  
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Future directions in this project might include switching to laser induced 
fluorescent (LIF) detection to lower the detection limits.  Varying the length of the 
column on the microchip or varying the percentage of methanol used in the elution buffer 
might allow for separation between the derivatives allowing for the eluent to go directly 
into the LIF set-up for analysis.  These changes would be dependent on using a pump that 
can withstand the changes in back pressure caused by switching the mobile phase from 
phosphate buffer to methanol.   
 
 
2.4  CEC/LIF Separation and Detection 
2.4.1  CEC Background 
 
Capillary electrochromatography (CEC) is a combination between capillary 
electrophoresis (CE) and HPLC, because the capillary is packed with a stationary phase, 
but the flow rate is controlled by an applied voltage.  The advantage of CEC is high 
efficiency, high resolution microscale separations with minimal solvent consumption 
[18].  CEC uses an electric field resulting in a flat flow profile going though the column, 
while HPLC uses pressure resulting in a parabolic flow profile [18].  (Figure 2-5) 
 
  
63 
cathode
+
Anode
-
High 
pressure
Low
pressure
Hydrodynamic velocity profile
Electroosmotic velocity profile  
Figure 2- 5  Pressure driven flow is parabolic while EOF is flat. 
 
The pressure range on the pump limits the size of the capillary and the flow rate 
of the mobile phase that can be used for the HPLC separation.  The parabolic profile is 
caused by friction between the solvent and the capillary wall.  This friction slows down 
the molecules moving near the capillary wall causing peak broadening.  This effect does 
not show in electroosmotic flow (EOF) because the flow is driven by the double layer 
occurring along the walls.  The double layer is created by the negatively charged silica 
groups in the capillary wall and the anions in the buffer solution which are attracted to the 
capillary walls as well as the cathode.  Figure 2-6 shows a representation of the double 
layers that occur along the capillary wall and also on the stationary phase.   
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Figure 2- 6  This diagram, looking down through the capillary, shows the double layer occurring 
on both the surface of the capillary and the stationary phase.   
 
A voltage, usually less than 30 kV [19], across the capillary creates an EOF which 
moves the mobile phase to either the cathode or the anode depending on the charge of the 
stationary phase.  In this case, the positive charges are attracted to the negative charge 
from the cathode.  This effect cancels the effect of friction and, therefore, allows for a flat 
profile.  The double layer thickness is directly proportional to temperature and inversely 
proportional to the ionic strength of the mobile phase.  Typical double layer thicknesses 
are between 1 and 10 nm for silica surfaces in aqueous buffers about pH 5 [19].  If the 
diameter of the capillary or the space between particles is not large enough, the double 
layers overlap reducing the flow velocity [19].  The EOF is also influenced by the 
permittivity in vacuum (εo), the relative permittivity (εr), the zeta potential (ζ), and the 
solvent viscosity (η).  The EOF can be described by Equation 2-1 [20].   
η
ςεε ro
EOF 
      (2-1) 
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In theory, CEC is not dependent on particle size, column length, or maximum 
pressure available [21].  The diameter of the CEC capillary is limited to the same small 
diameter (100 μm or less) as CE in order to minimize the generation of heat and avoid 
peak spreading [19].  Increasing temperature affects the resolution of the peaks, often 
making them broader.  Some commercial systems have a cooling system to 
reduce/prevent the temperature of the capillary from increasing.  By multiplying the EOF 
by the electric field strength (E), as shown in equation 2-2, the linear velocity can be 
determined.  
Eu EOFEOF      (2-2) 
 
The same stationary phases used in HPLC columns can be used in CEC columns, 
but some are unable to create a stable EOF.  It is important for the stationary phase to 
have surface silanol groups to stabilize the EOF [10].  New stationary phases are being 
developed with larger surface areas and increased silanol activity to help generate a 
higher EOF, which allows for a better separation [20].  CEC has already been used to 
separate a variety of analytes including lipids [22, 23], amino acids [24, 25], and proteins 
[26].  In order to do the separation, there are two major classes of CEC columns from 
which to choose:  open-tubular (OT) columns, and packed columns (PC).  In OT columns 
the stationary phase is bonded to the capillary wall.  In PC the capillary is filled 
completely with a bead-based or monolithic stationary phase.  The problem with most of 
these stationary phases in PC is that they need to be held in place by on-column frits, and 
the methods used for creating the frits cause a weak spot in the column which causes 
peak broadening, bubbles, and limit the flow [21, 27].  There is a third class of CEC 
columns called monolithic columns, where a porous, continuous separation bed is made.  
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The monolithic packing can be either organic polymer-based or bonded silica-based, but 
both are chemically bonded to the inner walls of the capillary, eliminating the need for 
end frits.  The advantage of monolithic columns is their pH stability, but the draw back of 
these columns is that they swell or shrink depending on the solvents used in the mobile 
phase.  By combining silica based stationary phase with a monolith creates a column that 
is held in place by the monolithic matrix, but no longer swells or shrinks.  This type of 
monolith is known as a sol-gel [28].  Sol-gels combine organic and inorganic stationary 
phases allowing for a more selective separation.  Figure 2-7 shows diagrams of the 
different types of columns. 
Packed Column
Open-tubular Column
Monolithic Column
Silica coating
Capillary wall Stationary particles
Frits
Capillary wall
Silica coating
Capillary wall
Silica coating
Monolithic packing
Stationary phase coating
 
Figure 2- 7  Diagram showing the view when looking along the side of the three different types of 
CEC columns:  packed column, open tubular and monolithic.   
 
Abidi et al. have been able to separate fatty acids found in vegetable oils and 
plants with PC-CEC followed by analysis with a photodiode array detector system [18].  
The samples had to be purified before separation.  The authors tried a few different 
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stationary phases, but were only able to get complete separation with 
pentafluorophenylsilica (PFPS) packing on a column that was 25 cm long with 75 μm i.d.  
For the CEC separation 25 mM Tris buffer in a 92:8 mixture of methanol: water was used 
as the mobile phase.  The injections were done at 10 kV for 2 s and the applied voltage 
was 20 kV to separate.  Increasing the percentage of water in the mobile phase increased 
the resolution of the peaks, but this also increased the run times.  The CEC separations 
resembled the elution patterns from reversed-phase HPLC, using a PFPS packed column, 
but had better resolution.   
Jemere et al. integrated a CEC column onto a glass microchip.  The column was 
packed with ODS coated silica beads [29].  The column length varied between 1 and 
5 mm and the packing was held in place by two weirs in the main channel and a polymer 
seal in the bead introduction channel.  By applying a voltage across the microchip, the 
samples could first be injected and then separated.  Only 2 kV was applied during 
separation.  A laser induced confocal epifluorescence detection system with an Ar-ion 
laser was used for detection.  The fluorescent dye used was BODIPY (4,4,-difluro-
1,3,5,7,8-penta methyl-4-bora-3a, 4a-diaza-s-indacene).  In these experiments, the 
detection limit was 10 μM for the two amino acids, arginine and leucine, which is three 
times lower than the detection limit for CE on a microchip, but still poor relative to 
typical laser dye experiments.   
Dermaux et al. used fused silica columns 50 cm in length, 100 μm i.d., and 
packed with C18 particles [22].  Ammonium hydroxide (50 mM) was dissolved in a 
57:38:5 mixture of acetonitrile: 2-propanol: n-hexane to make the mobile phase for the 
CEC runs that separated the eleven triglycerides found in argan oil.  The sample (5 mg) 
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was dissolved in 1 mL of 2-propanol and injected at 10 kV for 3 s.  During analysis the 
voltage was turned up to 30 kV creating a mobile phase velocity of 0.42 mm/s.  This 
method allowed for baseline separation between peaks that normally coeluted in LC.   
 
 
2.4.2  Reagents 
 
Five different fatty amines:  n-decylamine, 95 % (Sigma, St. Louis, MO), 
1-dodecylamine, 98 % (Acros Organics, Morris Plains, NJ), 1-tetradecylamine, 96 % 
(Aldrich, Milwaukee, WI), 1-hexadecylamine, 99 % (Aldrich), and octadecylamine, 97 % 
(Aldrich) derivatized with 5-fluorescein isothiocyanate (FITC) and purified by 
Dr. Carpenter was used.  Fluorescein (laser grade) was from Kodak.  FITC (isomer 1, 
90 %), methyltrimethoxysilane (C1-TMOS), and diethylamine were from Acros 
Organics.  Sodium phosphate monobasic, sodium phosphate dibasic, sulfuric acid, 
sodium hydroxide, ammonium hydroxide, acetic acid and polyethylene glycol 8000 were 
from Thermo Fisher Scientific (Pittsburgh, PA).  Ethyl alcohol 200 proof (Pharmco, 
Brookefield, CT) was distilled before use in CEC to increase purity.  All other solvents 
were HPLC grade from Thermo Fisher Scientific.  All solutions were filtered with 
0.22 μm nylon membrane filters from Whatman before use.  The 100 μm i.d. capillary 
was from Polymicro Technologies (Phoenix, Az) and the premium plain glass 
microscope slides were from Thermo Fisher Scientific.  The epoxy was 5 min set from 
the local hardware store.   
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2.4.3  Standards  
 
The amine derivative standards were made by Carpenter doing an off-line bench 
top reaction overnight to form the derivatives [12].  The derivatives were separated and 
purified using a Waters Prep LC 4000.  They were then extracted from the mobile phase, 
dried down, and then reconstituted in methanol.  These samples were used as standards 
when developing the CEC separation method.   
 
 
2.4.4  Preparing the Capillary 
 
The C1 sol-gel used for packing the capillaries was developed by Dr. Braden 
Giordano (Naval Research Laboratory).  In order to prepare the capillary for packing, a 
60 cm length of 100 µm i.d. fused silica capillary was flushed separately with 3 mL of 
1 M sodium hydroxide, 3 mL of deionized water, and 3 mL of distilled ethanol before 
drying with nitrogen.  To make the gel, 1 mL of the aqueous phase, 558 μL 
methyltrimethoxysilane (C1-TMOS), and 390 μL of ethanol were mixed for 2 hrs at room 
temperature.  The aqueous phase was made up of 100 mM acetic acid with 0.2 g/mL 
polyethylene glycol (8000 molecular weight).  Before pumping the mixture into the 
capillary, 40 μL of 1:1 mixture of diethylamine and acetonitrile was added to induce 
gelation.  Once the capillary was completely filled the ends are capped with septa and the 
column was baked at 60 
o
C for 1 hr.   
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At the desired detection point, a window was created by removing the coating on 
the capillary, by dripping hot concentrated sulfuric acid over the capillary to dissolve the 
coating.  The window was cleaned with clean methanol and lens cleaning tissue to 
remove any residue.  The window was then centered on a microscope slide and held in 
place with a drop of epoxy on each side of the window.  This mounting method was 
necessary because the capillary was brittle without its coating, and it allowed the 
capillary to be clamped down during analysis.  The capillary was flushed with distilled 
ethanol to wet all the packing.  This usually took about a day.  Then the capillary was 
flushed with 0.1 mM ammonium hydroxide for about two days to remove the gel 
precursor used in making the sol-gel.  Any remaining gel precursor could affect the 
double layer and possibly reverse the direction of the flow.  The capillary was then 
flushed with ethanol for several hours before switching to the mobile phase.  A low flow 
rate had to be used because excessive pressure will unpack the capillary.  A capillary 
washer was set-up to flush the capillary column so that the pressure did not exceed 
30 psi.   
 
 
2.4.5  CEC/LIF Set up 
 
The basic CEC set-up is shown in Figure 2-8.  The power supply (Spellman 
1000R; Plainview, NY, USA) is adjustable so that the number of volts applied across the 
capillary can be controlled.  The ground and voltage probes were put into vials containing 
the mobile phase.  These created the anode and cathode.  A capillary containing the sol-
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gel connected the anode to the cathode.  When a voltage was applied, flow went from the 
anode to the cathode, because of the negatively charged silica in the stationary phase.  
The window was aligned with the laser in order to excite the amine derivatives causing a 
fluorescent emission.  In this case the LIF detector was an argon-ion laser (American 
Laser, Salt Lake City, UT USA), operating at 488.0 nm.  The photons were filtered with a 
filter (for FITC, 525DF40, 525 ± 20 nm; Omega) set at a 90
o
 angle to the laser beam.  An 
avalanche photodiode (APD) (EG&G Optoelectronics, Vandrueil, Canada), a photon 
counting detector, used to convert the photons into digital pulses that was measured by a 
multichannel scaler card.  In order to monitor the current through the column, a 100 μΩ 
resistor was added in series with the circuit and a voltmeter was placed over the resistor.  
The voltage profile was saved by the computer using the Logger Pro program 
version 1.0.7 by Vernier Software (Beaverton, OR). 
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Figure 2- 8  Diagram of the CEC set up showing the C1 sol-gel packed capillary connecting the 
inlet and the outlet vials containing the running buffer.  The argon laser was aligned with the 
capillary to allow for detection of the derivatives.  A 100 μΩ resistor was placed between the 
anode and the ground in series for measurement purposes.   
 
 
2.4.6  Sample Loading 
 
Electrokinetic injection is done by applying a voltage across the capillary creating 
an electric field.  According to Harris [30], the moles of each ion loaded onto the 
capillary can be calculated using the following equation:   
 
(2-3) 
In this technique, the number of moles injected is dependent on the apparent 
mobility, described in equation 2-4, the applied electric field (E in V/m), the capillary 
Crt
s
b 2
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radius (r), the sample concentration (C in mol/m
3
), and the ratio of conductivities 
between the buffer and sample (κb/κs), which is one in this case because the sample was 
dissolved in the running buffer [30].  The apparent mobility (equation 2-4) is affected by 
the length of the column from injection to the detector (Ld), the migration time of a 
neutral solute added to the sample (t), the applied volts (V) and total length of the column 
from end to end (Lt).   
 
(2-4) 
 
The maximum injection volume is dependent on the fraction of allowable peak 
broadening (θ2, usually 5%) as shown in equation 2-5 [31].   
 
 
(2-5) 
 
The volume of an OT column assumes that the volume is equal to the volume of a 
cylinder with the same dimensions.  The volume of a sol-gel column would be equal to 
the dead volume in the capillary, which would be less than the calculated value.  So a 
proper injection may need to be smaller than the calculated injection size.  The number of 
theoretical plates is determined using equation 2-6, where tr is the time of elution and w1/2 
is the width of that peak at its half height [32].   
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2.4.7  Results and Discussion 
 
Before exploring the possibility of using CEC to separate the five different 
fluorescent derivatized fatty amines several preliminary experiments were done.  First an 
Ohm’s plot was made to show the stability range of the column.  As shown in Figure 2-9, 
the stability range changes depending on the concentration of buffer being used.  The 
results of two different running buffers are shown:  40% methanol in 1 mM phosphate 
buffer and 40 % methanol in 10 mM phosphate buffer.  The pH of the buffer stock 
solution was 7.5.  Increasing the concentration of the ions in solutions, increased the 
current going through the column, which increased the amount of heat created by the 
system.  The EOF broke down when the double layers overlap or when bubbles formed 
on the column from the solvent heating.  This experiment shows that the conductivity is 
directly proportional to the concentration of the buffer.  In this case, the slope using the 
1 mM buffer is 0.324 μA/kV, while the slope using the 10 mM buffer is 2.45 μA/kV.   
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Figure 2- 9  Ohms plot for the C1 sol-gel column approximately 30 cm long.  The results of two 
different running buffers are shown:  40% methanol in 1 mM phosphate buffer (pH 7.5) and 40 % 
methanol in 10 mM phosphate buffer. 
 
One method of controlling the separation is varying the applied voltage, so an 
experiment was done to show the affects of increasing voltage on elution.  In this 
experiment the mobile phase was 40 % methanol in 2 mM phosphate buffer.  A C1 
sol-gel column approximately 30 cm in length was used.  All injections were 1 min at 
15 kV of 25 nM fluorescein in 40 % methanol in 2 mM phosphate buffer.  Figure 2-10 
shows the results of three different applied voltages:  15 kV, 20 kV, and 25 kV.  As the 
voltage increased, the run times were decreased.  The trends were the same as CE done 
under the same conditions except with an unpacked capillary.  The voltage is indirectly 
proportional to the elution time (see equation 2-4); therefore, the elution time decreases 
as higher voltages are applied to the capillary.  This showed that the highest stable current 
would shorten the analysis time.   
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Figure 2- 10  25 nM fluorescein injections done for 1 min at 15 kV, but the running voltage was 
varied:  15 kV, 20 kV, and 25 kV to show the effects on elution time. 
 
In order to test the reproducibility of the injections, three fluorescein injections 
were then performed on the packed capillary (results shown in Figure 2-11).  The 
capillary was conditioned with 40 % methanol in 2 mM phosphate for an hour before 
starting and then 30 min in between each injection.  Both end vials contained 40 % 
methanol in 2 mM phosphate during running and the injection vial had 100 nM 
fluorescein in 40 % methanol in 1 mM phosphate buffer.  Injections were 20 sec long at 
10 kV and ran at 10 kV.  Even though the current increased throughout the runs because 
of joule heating, the eluting fluorescein peaks from each injection overlapped.  Flushing 
for about 20 min with the buffer solution between injections returned the current to the 
same starting value each time.  For this experiment higher voltages broke down the EOF 
before the analyte was detected.   
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Figure 2- 11  Three 20 sec injections of 100 nM fluorescein on a 100 μm C1 sol-gel packed 
capillary ran with 10 kV applied voltage.  The left axis shows the LIF detector intensity, while the 
right axis shows the actual current across a 100 kΩ resistor in series with the capillary.   
 
In order to study the effects of the buffer concentration (i.e. ionic strength) on 
both the current and the elution time of fluorescein, a series of running buffers were tried:  
40 % methanol in 1 mM phosphate buffer, 40 % methanol in 2 mM phosphate buffer, and 
40 % methanol in 3 mM phosphate buffer (results shown in Figure 2-12).  Each of the 
injections was done with 25 nM fluorescein in 40 % methanol and 1 mM phosphate 
buffer for 20 sec at 10 kV.  The running voltage was held constant at 10 kV.  The 
capillary was flushed at 5 μL/min with the new running buffer for 30 min before doing 
the next set of injections.  These experiments showed that the running buffer with 2 mM 
phosphate buffer concentration had the most stable current.  Although the 3 mM 
phosphate buffer concentration was also stable, the lower concentration of phosphate in 
the running buffer was chosen because of solubility limitations of phosphate in methanol 
at higher concentrations.  It was possible that solubility issues caused the fluorescein in 
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the 2 mM and the 3 mM runs to have similar retention times, due to 3 mM phosphate not 
being completely dissolved.   
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Figure 2- 12  Three 20 sec injection of 25 nM fluorescein on a 100 μm i.d. x 30 cm C1 sol-gel 
packed capillary ran with 10 kV applied voltage.  The concentration of the phosphate in the 
running buffer was varied between 1-3 mM in 40 % methanol.  The left axis shows the LIF 
detector intensity, while the right axis shows the actual current across a 100 kΩ resistor in series 
with the capillary.   
 
A series of injections were then compared where the phosphate buffer was held 
constant at 2 mM, but the percentage of methanol varied (results shown in Figure 2-13).  
For each of these solutions, the pH of the phosphate buffer was 7 before adding the 
methanol.  Each of the three injections were 20 sec long at 10 kV with fluorescein 
(25 nM for 40 % methanol and 100 nM for both 50 % and 60 % methanol) on a 
100 μm i.d. x 30 cm C1 sol-gel packed capillary ran with 10 kV applied voltage.  The 
concentration of the phosphate in the running buffer was held constant at 2 mM while the 
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percentage of methanol was varied from 40-60 %.  These injections were run on three 
separate days.  It was expected that increasing the methanol concentration would 
continually speed up the elution of fluorescein from the column, but this was not the case 
as 60 % methanol had a longer elution time than 50 % methanol.  The 60 % methanol 
elution could have been slower because of bubble formation on the column or the 
phosphate buffer not being soluble in the higher concentration of organic solvent.  Either 
way the EOF was not as stable with the higher organic concentration, limiting the solvent 
elution strength.    
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Figure 2- 13  Three 20 sec injection of fluorescein on a 100 μm i.d. x 30 cm C1 sol-gel packed 
capillary ran with 10 kV applied voltage.  The concentration of the phosphate in the running buffer 
was held constant at 2 mM while the percentage of methanol was varied from 40-60 %.   
 
A 10 nM each mixture of the five amine derivatives (C10, C12, C14, C16 and 
C18) in 40 % methanol and 1 mM phosphate buffer was injected on the C1 sol-gel CEC 
column.  The injection was 20 sec long with 10 kV applied during both injection and 
separation.  Results are shown in Figure 2-14.  Because the run time had to be set before 
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injecting, the voltage was only monitored for the first 100 min and the LIF detector run 
for 110 min.  The first peak was assigned to be the FITC, the second peak was assigned 
to be the C10 derivative, the third peak was assigned to be the C12 derivative, and the 
fourth peak was assigned to be the C14 derivative while C16 and C18 did not elute.  
During this experiment, the order of elution was hypothesized and later confirmed during 
a spiking experiment (Figure 2-15). 
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Figure 2- 14  20 sec injection of 10 nM each mixture of the five amine derivatives on a 100 μm i.d 
x 30 cm C1 sol-gel packed capillary run with 10 kV applied voltage.  The left axis shows the LIF 
detector intensity, while the right axis shows the actual current across a 100 kΩ resistor in series 
with the capillary column.   
 
In order to determine the elution order, a series of mixtures were analyzed where 
one derivatized amine was at a higher concentration than the others in solution.  Results 
are shown in Figure 2-15.  For these separations, the mobile phase was a mixture of 
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50 % methanol and 2 mM phosphate buffer.  Each amine derivative was injected at 
50 nM except the amine derivative of interest which was added into the mixture at 
150 nM.  Injections were 10 sec long at 25 kV.  Each injection was run right after the 
previous injection and the current had a flat profile (stable with no joule heating).  
Although there was some variation in elution times, the elution order was confirmed to be 
fluorescein, C10, C12, and the C14.  Some tailing was occurring on the C14 peak.  It was 
determined that this column was too hydrophobic for C16 and C18 analysis.   
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Figure 2- 15  10 sec injection at 25 kV of 50 nM of each amine derivatives with the spike 
concentration at 150 nM on a 100 μm i.d x 30 cm C1 sol-gel packed capillary run with 25 kV 
applied voltage.  Each spike mixture was run twice. 
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2.4.8  Problems 
 
Most of the time was spent on conditioning the columns.  Low flow rates had to 
be used, because at high pressures the capillaries came unpacked.  The ammonium 
hydroxide wash took the longest.  This step was necessary to remove any precursor left 
after making the sol-gel.  The precursor was positively charged, causing the flow to be 
reversed if any remained on the column.  When working with the columns, they needed 
to be kept as straight as possible.  Bending could cause the capillary to break or the 
packing to separate.  Any inconsistency in the packing or capillary causes the voltage to 
arc in that location, decreasing the stability of the current.  If this region was close 
enough to the end of the capillary, this region was cut off.  (Inconsistencies were 
identified using a microscope.)  If this region was close to the capillary window, a new 
column had to be made.  All of the running buffers and the injection solutions had to be 
degassed before using.  Any bubbles in the solution could have been injected onto the 
column, which caused the current to fluctuate until the bubble was eluted.  The bubbles 
could also have formed when the column over heated from Joule heating especially when 
using the higher concentration of organic solvents. 
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2.4.9  CEC/LIF Conclusions 
 
Varying the concentration of methanol and the concentration of the phosphate 
buffer in the running buffer determines the elution time.  The length of the column could 
have also been varied, but due to the problems encountered trying to keep a stable current 
going through the column, the length of the column was never varied.  By lowering the 
concentration of phosphate in the mixture, the ionic strength will also be lowered.  The 
lower the ionic strength, the higher the EOF will be.  Increasing the EOF, which can also 
be done by increasing the applied voltage, allows for shorter run times and higher 
resolution.  The power supply can go up to 30 kV, but, depending on the mobile phase, a 
lower voltage had to be used so that there was a stable current going across the column.  
By doing an Ohm’s plot, it was determined whether the selected voltage was in the stable 
range of the current set-up.  There will be a lower limit on how much the buffer 
concentration can be reduced before a current can no longer be sustained across the 
column.  The running buffer was optimized to contain 2 mM phosphate buffer, since 
experiments show that this concentration produces the most stable current.   
Adding methanol to the running buffer was necessary to increase the elution 
strength of the mobile phase and elute the derivatives off the column.  The methanol also 
needed to be in the loading solution since the amines and the amine derivatives were not 
soluble in water.  The mobile phase cannot be 100 % methanol because phosphate was 
not soluble in methanol and methanol has a lower boiling point making bubble formation 
more likely.  The running buffer was optimized to contain 50 % methanol since the EOF 
was not reproducible with the higher concentration.  Additionally, the fluorescein 
  
84 
actually took longer to elute with the higher concentration of methanol because of 
solubility limitations of phosphate in methanol.   
Unfortunately, under these conditions, the higher chain amine derivatives (C16 
and C18) did not elute from the column.  Future work for this column would include 
optimizing the stationary phase of the column.  The sol-gel procedure would need to be 
examined so that a less hydrophobic stationary phase could be made.  Another approach 
would be to use a buffer salt that is soluble in methanol so that higher concentrations 
could be used during the analysis.   
 
 
2.5  Conclusions 
 
Unfortunately, neither one of the phases was able to be completely developed.  
Both of these analysis methods proved to be very irreproducible in their own way.  The 
microchips often clogged as the stationary phase degraded, making it impossible to 
optimize the reaction.  For the reaction to work on the microchip, the microchip would 
have to be redesigned so that the stationary phase would not have to be baked into 
position in order to prevent degradation of the stationary phase.  Adding some automation 
to the solvent/analyte delivery system would deliver the same amount each time and the 
loading volume would not be dependent on the amount of back pressure.  A possible 
solution would be to use a microchip where the stationary phase is loaded from a side 
channel off the main separation channel that could be sealed off with epoxy (T-chip 
design is described in Chapter 5).  The CEC separation also proved to be very 
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irreproducible due to air bubble formation.  It often took days to flush the bubbles out of 
the capillary.  The best results show that C12-C16 were able to be separated, but C18 
stuck to the stationary phase.  In order for this separation to work for longer chain 
amines, the sol-gel used to pack the CEC column would need to be modified so that it is 
less hydrophobic.  Currently, there are no commercial columns that could be applied to 
this application, so the columns have to be made in-house.  Overall these methods show 
that reducing the reaction volume allows for a more effective reaction between the dye 
and analytes and small volumes of analytes can be analyzed using CEC/LIF. 
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Chapter 3  
 
 
Exploring Amide Detection Methods:  MALDI-MS 
 
 
3.1  Abstract 
 
Primary fatty acid amides (PFAMs) are found in biological systems at nanomolar 
concentrations or below.  Currently the standard method for PFAM analysis in this 
laboratory is a GC/MS method developed by Sultana [1].  Problems with the method 
include poor reproducibility of the derivation reaction needed to make the compound less 
polar for a better separation between isomers with different bond positions.  In this 
chapter, the use of time-of-flight mass spectrometry (TOF-MS) with a matrix-assisted 
laser desorption and ionization (MALDI) source or was explored as a possible alternative 
method.  This analytical technique provides an opportunity to develop a highly selective 
method to detect the lipids at low concentrations.  For this study several different 
matrices (2,5-dihydroxybenzoic acid, α-cyano-4-hyroxycinnamic acid, caffeic acid, 
4-nitroaniline, 2-naphthalene boronic acid, cetrimonium bromide, dithranol, retinoic acid, 
vitamin D, and sinapic acid) and additives (sodium acetate, lithium acetate, potassium 
acetate, ammonium acetate and trifluoroacetic acid) were examined to see which 
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improved the signal of the fatty amides.  Optimization experiments were done with four 
fatty amides:  lauramide, oleamide, palmitamide, and stearamide, in order to test each 
method.   
 
 
3.2  Introduction  
 
The matrix assisted laser desorption ionization (MALDI) process involves short 
laser pulses and the matrix is able to absorb the given wavelength [2-6].  When the laser 
is focused on a spot containing a mixture of the matrix and the analytes, the matrix 
absorbs the energy from the laser and the surface molecules are then ablated.  In the 
resulting plume of both matrix and analyte molecules, the charge is transferred from the 
matrix to the analytes, creating the charged analyte ions needed for analysis by mass 
spectrometry (MS).  MALDI is a soft ionization technique; the analytes are more likely to 
have a single charge or cluster than to fragment.  The benefits of using a MALDI source 
include low detection limits and small sample size.   
According to Pasch and Schrepp, there are three main goals when preparing a 
MALDI sample:  the matrix and sample mix needs to form crystals, the matrix needs to 
absorb the laser radiation in the MALDI source, and the analyte needs to be ionized [2].  
One of the hardest steps is creating homogeneous, uniform crystals.  There are several 
different methods to apply the sample and matrix to the plate:  dried droplet procedure, 
spin coating, formation of thin films, air-spray deposition, electrospray deposition, and 
solventless [2, 7, 8].  The dried droplet procedure is the most common where a solution 
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of the matrix is mixed with the sample solution [2, 7, 8].  Approximately 1-5 μL of the 
final solution is applied to the MALDI plate and allowed to dry.  Spin coating requires 
the samples to be loaded into stainless steel probe tips and then rotated at 300 rpm [2, 9].  
The small crystals could then be crushed by applying pressure with a glass slide.  
Experiments showed a homogeneous mixture of the matrix and analyte.  Thin films have 
been applied by first applying the matrix and then a layer of the analytes [2].  Spraying 
the mix solution on the MALDI plate with an air-spray brush increases the shot-to-shot 
reproducibility [2].  This method eliminates some of the inhomogeneous crystals formed 
with a drop drying.  Electrospray deposition uses a set-up similar to the electrospray MS 
source [2, 7, 8].  This method provides a homogeneous layer, but it is more complicated 
and could produce fragmentation depending on the analyte.  It is estimated that 
approximately 1-2 μL of the solution is applied to a 2.5 cm diameter circle.  The final 
method is similar to KBr pellets where the matrix and analyte powders are finely ground 
and mixed together [2, 10].  This method eliminates any inconsistencies due to solvent 
evaporation.   
Graphite has been added to liquid matrices for MALDI analysis [11].  In these 
experiments, the liquid matrix (glycerol) was diluted in methanol and mixed with 
graphite particulates.  The slurry was applied to the sample holder and the methanol was 
allowed to dry.  If the mixture was able to spread before drying, it created a thin layer of 
graphite/liquid matrix.  The analytes were spotted on top of the graphite/liquid matrix.  
The problem with this technique is that it could contaminate the source.  The advantage 
of this technique is that the graphite acts as an energy transfer medium and allowed for 
fmol detection of medium range molecular weight compounds.  A separate sample 
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preparation method called desorption/ionization on porous silicon mass spectrometry has 
also been used [12].  In this case the analytes are trapped in the porous silicon and 
released when the laser is aimed at a spot.  The advantage of this technique is that small 
molecules can be analyzed without interferences from the matrix.  The disadvantage is 
that the surface will degrade over time and contaminants from the air can also be trapped 
onto the surface.   
Relativity few MALDI experiments have been done on small molecules.  This is 
mostly due to the baseline noise at low mass-to-charge ratios when vacuum MALDI 
sources are used.  There is less baseline noise when atmospheric pressure MALDI 
sources are used, but the matrix signal can still interfere.  Although MALDI is commonly 
used in proteomics, experiments have been done to analyze the different lipid classes.  
For example  phospholipids [13], diacylglycerols [14, 15], cholesterol [16] and fatty acids 
[17] have been detected using a MALDI-MS.  Ayorinde et al. developed a MALDI 
method to qualitatively determine the composition of fatty acids in vegetable oils [17].  
This method used meso-tetrakis(pentafluorophenyl)porphyrin (F20TPP) as the matrix and 
sodium acetate was added as the dopant.  The vegetable oil was saponified before mixing 
with the matrix and dopant solutions.  The final mixture was made in methanol for 
spotting on the MALDI plate.  Each of the acids were detected as the [RCOONa + Na]
+
 
peak.  For this study there was approximately 10 nmol of each acid in one spot.   
Additives have been included in the MALDI spot in order to improve the 
spectrum either by increasing the analyte signal or by reducing the matrix signal.  Hanton 
et al. added alkali cations to the analyte solution [18].  This study found that the analytes 
were more likely to fragment rather than separate from the metal cation.  Guo et al. have 
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shown that additives such as CTAB can be added at low concentrations to the sample 
spot in order to suppress the matrix signal [19].  This technique was used to analyze small 
molecules such as cyclodextrin using alpha-cyano-4-hydroxycinnamic acid (CHCA) as 
the matrix.   
A list of common matrices including common solvents that have been used for 
MALDI-TOF analysis has been compiled elsewhere [2, 20].  Table 3-1 shows the 
matrices examined for the PFAM analysis.   
 
Name Molecular 
Formula/ 
Molecular Mass 
Structure 
3,4-dihydroxycinnamic acid  
(caffeic acid) 
C9H8O4 
180.16 amu 
 
 
Alpha-cyano-4-
hydroxycinnamic acid  
(CHCA) 
C10H6O3N 
189.17 amu 
 
Cetyltrimethyl ammonium 
bromide  
(CTAB) 
C19H42BrN 
364.34 amu  
2,5-dihydroxybenzoic acid 
(DHB) 
C7H6O4 
154.12 amu 
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Name Molecular 
Formula/ 
Molecular Mass 
Structure 
dithranol C14H10O3 
226.23 amu 
 
4-nitroaniline C6H6O2N2 
138.12 amu 
 
Sinapic acid C11H12O5 
224.21 amu 
 
all-trans-retionic acid  
(Vitamin A) 
C20H28O2 
300.44 amu 
 
cholecalciferol 
(Vitamin D3) 
C27H44O 
384.64 amu 
 
2-Naphthaleneboronic acid C10H7B(OH)2 
171.99 amu 
 
 
Table 3- 1  Structures of matrices analyzed in this study for optimizing PFAM (C12:0, C16:0, 
C18:0 and C18:1
9
) detection by MALDI-TOF. 
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MALDI MS is known for being a trace analysis technique, and a few published 
experiments have shown that MALDI MS can be used for quantitative analysis.  Benard 
et al. were able to quantify the amount of diacylglycerols (DAGs) by carefully controlling 
the experimental conditions [14].  The analyte/matrix solutions were dissolved in 
ethylacetate.  It was found that ethylacetate produced a more homogeneous mixture 
between the compounds (DHB and DAGs) than methanol.  Secondly, because alkali 
metal ions commonly found in chemicals and solvents are not readily soluble in 
ethylacetate, the ratio between the sodium adduct and the potassium adduct could be kept 
at an approximate constant.  One of the DAGs was used as an internal standard to reduce 
the differences in intensities from run to run.  By setting the laser power to obtain the 
optimal signal to noise ratio, it was possible to quantify the DAGs in the picomolar to 
nanomolar range.  This method is less sensitive than GC/MS or LC/MS methods, but the 
sample preparation is less extensive and total analysis time is significantly less.   
The two main goals for this project were to test the detection limits for PFAMs 
with TOF-MS using an AP-MALDI source and to determine whether a method can be 
developed in order to accurately quantitative the trace levels of PFAMs found in a 
sample.  Several different compounds were evaluated to determine which matrix would 
increase the analyte signal with minimal baseline interference.   
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3.3  Reagents 
 
2-Naphthaleneboronic acid, 2,5-dihydroxybenzoic acid (DHB), 3,4-
dihydroxycinnamic acid (caffeic Acid, predomintly trans isomer, 99+ % pure) , all-trans-
retionic acid (Vitamin A acid, 97 % pure), cetyltrimethyl ammonium bromide (CTAB) 
and Vitamin D3 crystalline (99+ % pure) were from Acros Organics (Morris Plains, NJ).  
Dithranol (97+ % pure) and α-cyano-4-hyroxycinnamic acid (CHCA, 97 % pure) were 
from Aldrich (Milwaukee, WI).  4-nitroaniline was from Kodak (Rochester , NY).  
Sinapic acid (98 % pure) and oleic acid were from Sigma (St. Louis, MO).  The methanol 
(HPLC grade for solutions and reagent grade for cleaning) and the trifluoroacetic acid 
(TFA) were from Thermo Fisher Scientific (Pittsburgh, PA).  Car wax (paste form by 
Turtle Wax Inc.) was from the local hardware store and was used to condition the 
MALDI plates.  Lauric acid and stearic acid were from Thermo Fisher Scientific.  
Palmitic acid was from ICN Biomedicals Inc. (Aurora, OH).  The primary fatty acid 
amide (PFAM) standards [lauramide (C12:0), palmitamide (C16:0), stearamide (C18:0), 
and oleamide (C18:1
9
)] were synthesized in house from their corresponding fatty acids 
with a greater than 95% purity as verified by GC/MS [21].   
  
  
3.4  Instrument Set Up 
 
For these experiments, an Agilent Technologies (Santa Clara, CA) time-of-flight 
mass spectrometer was used with an AP/MALDI ion source interface.  The instrument 
was calibrated and checked using the ESI source before switching to the MALDI source.  
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For these experiments, the fragmenter was set to 300 V, the skimmer was set to 60 V, the 
Oct RFV was set to 300 V, and the nitrogen gas temperature was 325 
o
C at 5.0 L/min 
unless otherwise noted.  The intensity of the signal was increased when the laser was 
focused on a crystal.  In order to increase crystal formation when drying, the plates were 
waxed, which prevented the sample from spreading over the MALDI plate.  Figure 3-1 
shows the difference in spot sizes between a treated MALDI plate and an untreated 
MALDI plate.  Figure 3-2 shows the differences in mass spectra.  There is some 
additional noise from the presence of the wax, but none of the signal from the wax 
overlaps with the m/z for the analytes.  The signal of the 714 m/z peak is stronger on the 
waxed MALDI plate vs the untreated MALDI plate.  For all the experiments, the waxed 
MALDI plates were used.  The wax was applied as needed when the spots started to 
spread before drying.   
 
 
Figure 3- 1  0.5 µL spots of DHB.  On the left where the plate has been waxed, the spots 
remained condensed and crystals start to form.  On the right where the plate has no treatment, 
the spot spreads out of the block and no crystals form.  The results are better when the laser can 
be aimed at crystals.   
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Figure 3- 2 Comparison of mass spectra between DHB when spotted on a waxed MALDI plate 
(top) and DHB when spotted on an untreated MALDI plate (bottom).   
 
 
3.5  Results and Discussions 
3.5.1  UV-Vis of Matrix 
 
In order to determine possible matrixes, a series of compounds were examined on 
the UV-visible spectrophotometer (Cary 1E from Varian, Palo Alto, CA) from 200 to 
500 nm to determine the absorbance at 337 nm (Figure 3-3).  If the compounds do not 
absorb at 337 nm from the nitrogen laser on the MALDI source, the compound will not 
be effective at lifting the analytes off the plate and into the MS source.  For these 
experiments, the compounds were dissolved in methanol at 10 μM.  Eight different 
compounds were analyzed:  caffeic acid, CHCA, DHB, CTAB, nitroaniline, dithranol, 
retinoic acid, and vitamin D3.   
100 
 
0.4
0.3
0.2
0.1
0.0
in
te
n
s
it
y
500450400350300250200
wavelength (nm)
 Caffeic Acid
 CHCA
 DHB
 CTAB
 Nitroaniline
 Dithranol
 Retinoic Acid
 Vitamin D3
337 nm
 
Figure 3- 3 UV-Vis scans of the possible matrix compounds for MALDI analysis.  Each of the 
compounds was dissolved in methanol at 10 μM for analysis.   
 
Any of the compounds except CTAB and Vitamin D3 will work as a matrix for 
MALDI detection.  The attenuation of laser on the MALDI source had to be adjusted for 
each matrix to optimize absorption.   
 
 
3.5.2  Choosing a Matrix 
 
In order to determine the optimal conditions for detecting the primary fatty acid 
amides (PFAMs), four sample PFAMs (lauramide (C12:0), palmitamide (C16:0), 
oleamide (C18:1
9
), and stearamide (C18:0)) were compared by varying which matrix was 
used, the sample to matrix ratio, the analysis time, and the attenuation of the laser.  The 
sample to matrix ratio was run using the ten different matrixes:  DHB, CHCA, caffeic 
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acid, 4- nitroaniline, 2-naphthalene boronic acid, CTAB, dithranol, retinoic acid, Vitamin 
D, and sinapic acid.  Unless otherwise noted, the sample spot size was 0.5 μL and the 
spectrum was collected for 1 min.   
2,5-dihydroxybenzoic acid (DHB, MW = 154.12) contains a benzene ring with 
two alcohol groups and a carboxylic acid group.  The attenuation of the laser was set to 
nine when using DHB as the matrix.  Figure 3-4 shows the profile of the DHB matrix 
with no analytes.  Figure 3-5 shows the signal of four PFAMs (C12:0, C16:0, C18:1
9
, and 
C18:0) using DHB as the matrix.  The MALDI plate was sonicated in reagent grade 
methanol and allowed to dry before spotting.  In order to determine the best spotting 
conditions, a series of solutions was made from a 0.5 M solution of DHB in methanol and 
a 10 mM total mix of the four PFAMs:  C12:0, C16:0, C18:1
9
, and C18:0 where the ratio 
of the moles of DHB to the moles of total amides was varied (Figure 3-6).  The errors 
were high for some of the mixtures due to poor signal-to-noise ratio.  It was determined 
that a ratio near 1000:1 would be the best when working with the DHB matrix.  However, 
the overall concentration may need to be increased so that the signal is significantly 
higher than the baseline.  The results from this experiment were difficult to reproduce due 
to the degradation of the laser, eventually making it impossible to use DHB as the matrix.   
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Figure 3- 4 MALDI profile of the DHB matrix.   
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Figure 3- 5 MALDI spectrum of the PFAM mixture (C12:0, C16:0, C18:1
9
, and C18:0) using DHB 
as the matrix.  Approximately 20 pmol of each PFAM and 500 nmol of DHB was spotted. 
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Figure 3- 6  Plot of the log of the average intensity of the analyte peak divided by the mole of 
analyte in the sample vs the log of the ratio of moles of DHB to moles of amides.   
 
Alpha-cyano-4-hydroxycinnamic acid (CHCA, MW = 189.17) is a cinnamic acid 
derivative.  The attenuation of the laser was set to 7 when using CHCA as the matrix.  
The MALDI plate was sonicated in reagent grade methanol and allowed to dry before 
spotting.  Figure 3-7 shows the profile of the matrix.  Figure 3-8 shows the signal of four 
PFAMs (C12:0, C16:0, C18:1
9
, and C18:0) using CHCA as the matrix.  In order to 
determine the best spotting conditions, a series of solutions was made from a 0.2 M 
solution of CHCA in methanol and a 10 mM total mix of the four PFAMS where the ratio 
of the moles of CHCA to the moles of total amides was varied (Figure 3-9).  The 
concentration of the CHCA was limited by the solubility of CHCA in methanol.  Again, 
the ratio 1000:1 showed the best signal with limited interference from the background.   
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Figure 3- 7 MALDI profile of the CHCA matrix.   
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Figure 3- 8  MALDI spectrum of the PFAM mixture (C12:0, C16:0, C18:1
9
, and C18:0) using DHB 
as the matrix.  Approximately 20 pmol of each PFAM and 100 nmol of CHCA was spotted. 
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Figure 3- 9 Plot of the log of the average intensity of the analyte peak divided by the mole of 
analyte in the sample vs the log of the ratio of moles of CHCA to moles of amides.   
 
3,4-dihydroxycinnamic acid (caffeic acid, MW = 180.16) is a phenolic compound 
similar to cinnamic acid but contains more hydroxyl groups.  The attenuation of the laser 
was set to 7 when using caffeic acid as the matrix.  Figure 3-10 shows the profile of the 
matrix.  The MALDI plate was sonicated in reagent grade methanol and allowed to dry 
before spotting.  In order to determine the best spotting conditions, a series of solutions 
was made from a 0.2 M solution of caffeic acid in methanol and a 10 mM total mix of the 
four PFAMS where the molar ratio of caffeic acid to total amides was varied.  After 
analyzing all the samples, it was determined that caffeic acid would not work as a matix 
for analyzing PFAMs because there was no signal for the PFAMs in any of the specta.   
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Figure 3- 10  MALDI profile of the caffeic acid matrix. 
 
4-Nitroaniline (MW = 138.13) is a benzene ring with a nitro group and an amino 
group in the para position.  The attenuation of the laser was set to 7 when using 
4-nitroaniline as the matrix.  The MALDI plate was sonicated in reagent grade methanol 
and allowed to dry before spotting.  Figure 3-11 shows the profile of the matrix.  
Figure 3-12 shows that even when the spot contains a mixture of PFAMs, the matrix 
signal was predominate.  In order to determine the best spotting conditions a series of 
solutions was made from a 0.2 M solution of 4-nitroaniline in methanol and a 10 mM 
total mix of the four PFAMS where the ratio of the moles of 4-nitroaniline to the moles 
of total amides was varied (Figure 3-13).  This data had to be carefully analyzed by 
scanning the data list to find the m/z corresponding to the PFAMs.  Overall the results 
from CHCA were better than the results from the 4-nitroaniline.   
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Figure 3- 11  MALDI profile of the 4-nitroaniline matrix.   
 
500
400
300
200
100
0
in
te
n
s
it
y
300250200150100
m/z
1
2
3
.0
5
7
1
5
4
.0
6
9
1
8
2
.0
8
4
2
5
9
.0
9
6
2
8
2
.2
9
3
2
4
4
.0
7
62
2
9
.0
9
1
9
6
.0
9
5
1
3
9
.0
5
1
6
7
.0
8
1
2
1
4
.0
9
2
 
Figure 3- 12  100 – 300 m/z MALDI profile of the 4-nitroaniline matrix.  Although the spot 
contained a mixture of PFAMs, the matrix signal is predominant making PFAM analysis difficult.   
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Figure 3- 13  Plot of the log of the average intensity of the analyte peak divided by the mole of 
analyte in the sample vs the log of the ratio of moles of 4- nitroaniline to moles of amides.  
  
 
Cetyltrimethyl ammonium bromide (CTAB, MW = 364.45) has a long carbon 
chain and a bromide ion.  The attenuation of the laser was set to 12 when using CTAB as 
the matrix.  The MALDI plate was sonicated in reagent grade methanol and allowed to 
dry before spotting.  In order to determine the best spotting conditions, a series of 
solutions was made from a 0.5 M solution of CTAB in methanol and a 10 mM total mix 
of the four PFAMS where the ratio of the moles of CTAB to the moles of total amides 
was varied.  Figure 3-14 shows the profile of the matrix.  After analyzing all the samples, 
it was determined that CTAB would not work as a matix for analyzing PFAMs since 
there was not enough signal to positively identify the PFAMs in any of the spectra.  Guo 
et al. have shown that CTAB actually suppresses the matrix signal when added at low 
concentrations to the matrix:analyte mixture allowing for better detection of the analyte, 
but does not work as the matrix alone [19].  
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Figure 3- 14  MALDI profile of the CTAB matrix. 
 
Dithranol (MW = 226.2), unlike the other compounds chosen to be studied as a 
possible matrix, contains two benzene rings.  The attenuation of the laser was set to 9 
when using dithranol as the matrix.  The MALDI plate was sonicated in reagent grade 
methanol and allowed to dry before spotting.  Figure 3-15 shows the profile of the matrix.  
Figure 3-16 shows the signal of four PFAMs (C12:0, C16:0, C18:1
9
, and C18:0) using 
dithranol as the matrix.  Because of background noise only C18:1
9
 and C18:0 can be seen 
on the graph.  In order to determine the best spotting conditions, a series of solutions was 
made from a 0.2 M solution of dithranol in choloroform and a 10 mM total mix of the 
four PFAMs where the ratio of the moles of dithranol to the moles of total amides was 
varied (Figure 3-17).  Dithranol is not soluble in methanol.  Because chloroform had to 
be used as the solvent, a glass syringe was used to spot the MALDI plate so that smaller 
spots could be applied to the plate to prevent the spot from spreading while drying.  The 
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main problem with using dithranol as the matrix is that there is a matrix peak with almost 
the same m/z ratio as the C18:0 analyte signal.  The two signals could be differentiated 
by looking at the data table for an exact mass.  Although the analytes had reasonable 
signal intensities, the signal from the matrix was significantly higher making it difficult to 
detect the analyte.       
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Figure 3- 15  MALDI profile of the dithranol matrix.   
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Figure 3- 16  MADLI spectrum of the PFAM mixture (C12:0, C16:0, C18:1
9
, and C18:0) using 
dithranol as the matrix.  Approximately 450 pmol of each PFAM and 45 nmol of dithranol was 
spotted.   
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Figure 3- 17  Plot of the log of the average intensity of the analyte peak divided by the mole of 
analyte in the sample vs the log of the ratio of moles of dithranol to moles of amides.   
 
All-trans-retinoic acid (MW = 300.44) is also known as vitamin A.  The 
attenuation of the laser was set to 10 when using vitamin A as the matrix.  The MALDI 
plate was sonicated in reagent grade methanol and allowed to dry before spotting.  
Figure 3-18 shows the profile of the matrix.  Figure 3-19 shows the signal of four PFAMs 
(C12:0, C16:0, C18:1
9
, and C18:0) using vitamin A as the matrix.  Because of the high 
background noise only C16:0 and C18:0 can be identified on the spectrum.  In order to 
determine the best spotting conditions, a series of solutions was made from a 0.5 M 
solution of vitamin A in 1:1 methanol:choloroform and a 10 mM total mix of the four 
PFAMS where the ratio of the moles of vitamin A to the moles of total amides was varied 
(Figure 3-20).  Vitamin A was not soluble in 100% methanol.  Because chloroform had to 
be added, a glass syringe was used to spot the MALDI plate so that smaller spots could 
be applied to the plate to prevent the spot to spread while drying.  Although there are not 
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any overlapping peaks between the analyte and the matrix, the spectrum for vitamin A 
was noisy.  For this matrix, there does not seem to be much difference in the analyte 
signal no matter which ratio was used for the analysis.  This matrix would be better if the 
software allowed for background subtraction.   
4000
3000
2000
1000
0
in
te
n
s
it
y
1000800600400200
m/z
1
7
7
.1
6
3
3
0
1
.2
2
1
5
5
5
.4
4
7
5
1
0
.4
3
9
3
2
3
.2
0
5
5
9
9
.4
1
3
6
2
3
.4
2
2
 
Figure 3- 18  MALDI profile of the vitamin A matrix.   
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Figure 3- 19  MALDI spectrum of the PFAM mixture (C12:0, C16:0, C18:1
9
, and C18:0) using 
vitamin A as the matrix.  Approximately 100 pmol of each PFAM and 20 nmol of vitamin A was 
spotted.   
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Figure 3- 20  Plot of the log of the average intensity of the analyte peak divided by the mole of 
analyte in the sample vs the log of the ratio of moles of vitamin A to moles of amides.   
 
Vitamin D3 (D3, MW = 384.64) was also examined as a possible matrix.  The 
attenuation of the laser was set to 10 when using vitamin D3 as the matrix.  The MALDI 
plate was sonicated in reagent grade methanol and allowed to dry before spotting.  
Figure 3-21 shows the profile of the matrix.  This matrix was tested by mixing a 10:1 
solution of 0.2 M vitamin D3 in methanol and 10 mM total mix of the four PFAMS.  It 
was determined that vitamin D3 would not work as a matrix, because the attenuation was 
on the minimum setting and very little signal was obtained.   
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Figure 3- 21  MALDI profile of the vitamin D3 matrix.   
 
Sinapic acid (MW = 224.21) is commonly used for negative mode ionization.  
The attenuation of the laser was set to 7 when using sinapic acid as the matrix.  The 
MALDI plate was sonicated in reagent grade methanol and allowed to dry before 
spotting.  Figure 3-22 shows the profile of the matrix.  This matrix was tested by mixing 
a 50:1 ratio of moles made from a solution of 0.2 M sinapic acid in methanol (containing 
0.1 % by volume TFA) and 10 mM total mix of the four PFAMs.  It was determined that 
sinapic acid would not work as a matrix, because the sensitivity for detecting PFAMs was 
much better in the positive mode.   
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Figure 3- 22  MALDI profile of the sinapic acid matrix.   
 
2-Naphthalene boronic acid (MW = 171.99) was examined as a possible matrix.  
The attenuation of the laser was set to 10 when using 2-naphthalene boronic acid as the 
matrix.  The MALDI plate was sonicated in reagent grade methanol and allowed to dry 
before spotting.  This matrix was tested by mixing a 100:1 molar ratio made from a 
solution of 0.1 M 2-naphthalene boronic acid in methanol and 10 mM total mix of the 
four PFAMS.  Figure 18 shows the profile of the matrix.  It was determined that 
2-naphthalene boronic acid would not work as a matrix, because the PFAMs were not 
ionized using this matrix.  Additionally, the matrix signal by itself was not very strong.   
Overall the two best matrices were DHB and CHCA.  The major problem was 
that the instrument was never designed to run DHB so over time, as the laser degrades 
from use, the laser no longer has enough energy to ablate the matrix.  A few additional 
studies were done with DHB until the laser degraded.  CHCA ended up to be the best 
matrix, but its solubility properties in methanol limited the solution parameters.  The 
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other matrixes either had too much noise in the baseline in order to be able to detect the 
PFAMs or did not absorb the 337 nm wavelength effectively enough.    
 
 
3.5.3  Attenuation Study 
 
Initially the attenuation was adjusted by aiming the laser at a spot of matrix and 
adjusting the laser attenuation for the highest intensity of the matrix spots.  Once it was 
determined that DHB and CHCA were the best matrixes, a series of runs were done 
where the spectrum for the mixture of the four PFAMs was collected for each attenuation 
setting.  DHB was varied from 6 – 10 (below 6 no signal was obtained) and CHCA was 
varied from 2 – 10.  For these runs, the run time was 1 min and the spectrum was 
collected from 100 to 400 m/z.  Figure 3-23 shows the data from the average of three 
spots for both DHB and CHCA.  Each spot was a 100:1 molar ratio of matrix (40 μM 
stock solution) to PFAM (10 mM total mixture of stock solutions).  From this study it 
was determined that for DHB the attenuation should be set to 10 and for CHCA it should 
be set to 4, lower than previous runs.  It is important to note that these results will change 
as the laser degrades, but when the optimization is checked it is better to examine the 
analyte’s signal rather than the matrix signal.   
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Figure 3- 23  Plot of the intensity of the analyte peak vs the attenuation setting on the laser.  
Each of the data points were the average from three spots. 
 
 
3.5.4  Determining Analysis Time 
 
Initially all of the matrixes were compared by analyzing the integrated spectrum 
collected over 1 min.  In order to determine the best run time for collecting the data, a 
series of runs were done with CHCA and DHB as the matrix and the PFAM; 
concentration (100:1 ratio with 10 mM total PFAMs in methanol) was held constant so 
that just the length of analysis was varied (0.5, 1.0, 3.0, 5.0, and 10.0 min (Figures 3-24 
and 3-25).  Each of the data points had to be multiplied by the time, in seconds, of 
analysis.  This was necessary since the software automatically divides by the time, but 
this experiment was designed to look at the total signal collected from one spot.   
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Figure 3- 24  Plot of the intensity of the analyte peak vs the time in minutes of the analysis time 
for DHB.  Each of the data points were multiplied by the time in seconds of analysis.   
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Figure 3- 25  Plot of the intensity of the analyte peak vs the time in minutes of the analysis time 
for CHCA.  Each of the data points were multiplied by the time in seconds of analysis.   
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Without the corrections, the DHB runs look the same and for CHCA the shorter 
the run time the better the signal; however, once the data has been corrected for the 
length of analysis (data shown above), 3 min run times look the best for both matrixes.  
There might be slight improvement over 3 min for CHCA if the run time was extended to 
10 min, but not significantly enough to justify the longer analysis time.  By plotting the 
signal to noise ratio for DHB (Figure 3-26) and CHCA (Figure 3-27), the results show 
that a 3 min run time was required for an optimal signal.   
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Figure 3- 26  Plot of the signal to noise ratio vs the run time using DHB as the matrix.  The 
greatest signal to noise ratio was with a three min run time for each of the PFAMs analyzed.   
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Figure 3- 27  Plot of the signal to noise ratio vs the run time using CHCA as the matrix.  The 
greatest signal to noise ratio with the least amount of error was with a three min run time for each 
of the PFAMs analyzed. 
 
 
3.5.5  Optimizing Additives 
 
Adding salts or acids to the matrix and analyte mixture can increase the signal 
strength of the analytes.  Ayorinde et al. used sodium acetate as a dopant in order to 
detect fatty acid methyl esters on the MALDI-TOF [17].  For this study, a series of salts 
(sodium acetate, lithium acetate, potassium acetate, and ammonium acetate) and TFA 
were added to the spots to see if any improvement in the signal was made.   
In order to test the different salt additives, the matrix to analyte ratio was 1000:1 
in methanol so that each spot contained 420 nmol DHB, 100 pmol each PFAM with 
20 nmol of salt.  These runs were compared to spots where methanol was added in place 
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of the salt solution.  The spots were 0.5 μL and the run time was 1 min long.  
Unfortunately, in this case, the salt suppressed the signal.  The best [M + salt]
+
 signal 
peak had the same intensity as the [M+H]
+
 signal peak in the same spectrum 
(Figure 3-28).  Except for C18:1
9
, adding salt to the spot decreased even the combined 
signal of the [M+salt]
+
 signal and the [M+H]
+
 signal for each PFAM.   
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Figure 3- 28  Plot of the intensity of the analyte peak for each salt examined with the four 
PFAMs.  Each signal is the average of three trials were the [M+H]
+
 and the [M+salt]
+
 signal were 
combined.  The blank run only contained [M+H]
+
 peaks because methanol was added in place of 
a salt solution.  Four PFAMs were in each spot with the DHB matrix at a ratio of 1000:1.   
 
Another approach to increasing the analyte signal was adding trifluoroacetic acid 
(TFA) to the spot.  In order to test the acid as an additive two different concentrations 
were examined:  0.1 % and 0.5 % by volume.  For this experiment the matrix to analyte 
ratio was 100:1 in methanol made with either 0.2 M DHB or 0.2 M CHCA and a 10 mM 
mixture of four PFAMs.  These runs were compared to spots where methanol was added 
in place of the TFA.  The spots were 0.5 μL and the run time was 3 min long.  When 
analyzing the DHB spots the attenuation was set to 10, but turned down to 4 when 
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analyzing the CHCA spots.  Adding TFA at 0.1 % either does not affect the PFAM signal 
or slightly improves the signal, however adding more TFA decreases the signal 
(Figure 3-29).  
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Figure 3- 29  Plot of the intensity of the analyte peak for each concentration of TFA examined 
with the four PFAMs for each matrix.  Each signal is the average of three trials.  Four PFAMs 
were in each spot with the DHB or CHCA matrix at a ratio of 100:1.   
 
 
3.5.6  Detection Limits 
 
After the parameters were optimized a series of solutions were made where the 
concentration of the PFAM was decreased.  Before optimizing the MS parameters and the 
spotting conditions the detection limit was approximately 15 pmol when CHCA was used 
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as the matrix.  The final detection limit experiment was run over two days (Figure 3-30).  
The amount of matrix, CHCA, in each spot was held constant while the concentration of 
PFAMs was diluted before mixing with the CHCA solution, therefore the ratio of matrix 
to analyte varied with each set of spots.  Using the optimized parameters, the detection 
limit for C12:0 was approximately 2 pmol, while the detection limit for C16:0, C18:0 and 
C18:1
9
 was approximately 200 fmol.  It is important to note that these detection limits are 
dependent on the condition of the nitrogen laser.   
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Figure 3- 30  Detection limits of four PFAMs using CHCA for the matrix.  The matrix to analyte 
ratios were 500:1, 5000:1, and 50,000:1.   
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3.5.7  Problems 
 
One of the problems with the MALDI detection method is that the nitrogen laser 
continually degrades.  Initially, samples were able to be analyzed using DHB as the 
matrix, but over time, as the laser degraded the laser was no longer powerful enough to 
create the plume of ions with the DHB compound.  Unfortunately, this MALDI source 
was optimized to use CHCA as the matrix.  It is generally accepted that analysis done by 
MALDI MS is only qualitative and not quantitative because only a portion of the sample 
spotted on the MALDI plate is ablated during analysis and the spot may not be 
homogeneous.  However, throughout these experiments the intensity of the m/z peak was 
used to compare the results when optimizing the parameters.  Further studies would have 
to be done in order to determine how much of the sample is actually analyzed.   
 
 
3.6  Conclusions 
 
A series of matrixes (DHB, CHCA, caffeic acid, 4- nitroaniline, 2-naphthalene 
boronic acid, CTAB, dithranol, retinoic acid, Vitamin D, and sinapic acid) were 
examined in attempt to develop a MALDI MS method to analyze PFAM samples.  After 
a series of experiments comparing the analysis of C12:0, C16:0, C18:0 and C18:1
9
 using 
the different matrixes, it was determined that DHB and CHCA were the best suited for 
analysis.  After exploring MALDI-TOF-MS for the detection of PFAMs as an alternative 
to the current GC/MS method [1, 21], it was determined that this ionization source was 
not sensitive enough to allow for trace detection.  On average, the detection limits were in 
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the pmol range, so this project was ended while other PFAM detection methods 
(Chapter 4) were explored.  Additionally, quantization statistics would have to be worked 
out to determine the accuracy of the method.   
 
 
126 
3.7  References 
 
1. Sultana, T. and M.E. Johnson, Sample preparation and gas chromatography of 
primary fatty acid amides. Journal of Chromatography A, 2006. 1101(1-2): p. 
278-285. 
2. Pasch, H. and W. Schrepp, MALDI-TOF Mass Spectrometry of Synthetic 
Polymers. 2003, Germany: Springer. 214 pp. (approx.). 
3. Cotter, R.J., Time-of-Flight Mass Spectrometry Instrumentation and Applications 
in Biological Research. 1997, Washington, DC: American Chemical Society. 
4. Przybylski, M., W. Weinmann, and T.A. Fligge, Mass Spectrometry, in Handbook 
of Spectroscopy, G. Gauglitz and T. Vo-Dinh, Editors. 2003, Wiley-VCH: 
Weinheim. 
5. Hoffmann, E.d. and V. Stroobant, Mass Spectrometry:  Principles and 
Applications. 2nd ed. 2002, New York: John Wiley & Sons, LTD. 407. 
6. Schiller, J., J. Arnhold, S. Benard, M. Mueller, M. Petkovic, O. Zschoernig, and 
K. Arnold, MALDI-TOF mass spectrometry and 31P NMR spectroscopy in lipid 
research. Recent Research Developments in Lipids, 2001. 5(Pt. 1): p. 179-200. 
7. Hensel, R.R., R.C. King, and K.G. Owens, Electrospray sample preparation for 
improved quantitation in matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry. Rapid communications in mass spectrometry, 1997. 11(16): p. 
1785-1793. 
8. Hanton, S.D., P.A. Cornelio Clark, and K.G. Owens, Investigations of matrix-
assisted laser desorption/ionization sample preparation by time-of-flight 
secondary ion mass spectrometry. Journal of the American Society for Mass 
Spectrometry, 1999. 10(2): p. 104-111. 
9. Perera, I.K., J. Perkins, and Kantartzoglou, Spin-coated samples for high 
resolution matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry of large proteins. Rapid Commun. Mass Spectrom. FIELD Full 
Journal Title:Rapid Communications in Mass Spectrometry, 1995. 9(2): p. 180-
187. 
10. Trimpin, S., A. Rouhanipour, R. Az, H.J. Rader, and K. Mullen, New aspects in 
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: a 
universal solvent-free sample preparation. Rapid Communications in Mass 
Spectrometry, 2001. 15(15): p. 1364-1373. 
11. Dale, M.J., R. Knochenmuss, and R. Zenobi, Graphite/Liquid Mixed Matrixes for 
Laser Desorption/Ionization Mass Spectrometry. Analytical Chemistry, 1996. 
68(19): p. 3321-3329. 
127 
12. Wei, J., J.M. Buriak, and G. Siuzdak, Desorption-ionization mass spectrometry on 
porous silicon. Letters to Nature, 1999. 399(6733): p. 243. 
13. Marto, J.A., F.M. White, S. Seldomridge, and A.G. Marshall, Structural 
Characterization of Phospholipids by Matrix-Assisted Laser 
Desorption/Ionization Fourier Transform Ion Cyclotron Resonance Mass 
Spectrometry. Analytical Chemistry, 1995. 67(21): p. 3979-3984. 
14. Benard, S., J. Arnhold, M. Lehnert, J. Schiller, and K. Arnold, Experiments 
towards quantification of saturated and polyunsaturated diacylglycerols by 
matrix-assisted laser desorption and ionization time-of-flight mass spectrometry. 
1999, Elsevier. p. 115-125. 
15. Schiller, J., J. Arnhold, S. Benard, M. Muller, S. Reichl, and K. Arnold, Lipid 
analysis by matrix-assisted laser desorption and ionization mass spectrometry: a 
methodological approach. Analytical Biochemistry, 1999. 267(1): p. 46-56. 
16. Schiller, J., J. Arnhold, H.J. Glander, and K. Arnold, Lipid analysis of human 
spermatozoa and seminal plasma by MALDI-TOF mass spectrometry and NMR 
spectroscopy - effects of freezing and thawing. Chemistry and physics of lipids, 
2000. 106(2): p. 145-156. 
17. Ayorinde, F.O., K. Garvin, and K. Saeed, Determination of the fatty acid 
composition of saponified vegetable oils using matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry. Rapid Communications in 
Mass Spectrometry, 2000. 14(7): p. 608-615. 
18. Hanton, S.D., D.M. Parees, and K.G. Owens, MALDI PSD of low molecular 
weight ethoxylated polymers. International Journal of Mass Spectrometry, 2004. 
238(3): p. 257-264. 
19. Guo, Z., Q. Zhang, H. Zou, B. Guo, and J. Ni, A Method for the Analysis of Low-
Mass Molecules by MALDI-TOF Mass Spectrometry. Analytical Chemistry, 2002. 
74(7): p. 1637-1641. 
20. Gluckmann, M. and M. Karas, The initial ion velocity and its dependence on 
matrix, analyte and preparation method in ultraviolet matrix-assisted laser 
desorption/ionization. Journal of Mass Spectrometry, 1999. 34(5): p. 467-477. 
21. Sultana, T., Primary fatty acid amides in mammalian tissues:  Isolation and 
analysis by HPTLC and SPE in conjunction with GC/MS, in Chemistry and 
Biochemistry. 2005, Duquesne University: Pittsburgh. p. 257. 
 
 
128 
 
 
Chapter 4  
 
 
Developing a LC/APCI-MS Separating and  
Detection Method for PFAMs Analysis 
 
 
4.1  Abstract 
 
There are many significant lipids whose resting levels in biological systems are at 
nanomolar concentrations or below.  After evaluating several different analytical 
techniques including time-of-flight mass spectrometry (TOF-MS) with a matrix-assisted 
laser desorption and ionization (MALDI) source (Chapter  3) and reverse phase liquid 
chromatography with the use of single quadrapole mass spectrometry with either an 
electrospray source (ESI) or and atmospheric pressure chemical ionization source 
(APCI), it was determined that APCI allowed for the lowest detection limits.  This 
chapter describes the details of developing the method in order to detect trace levels of 
primary fatty acid amides (PFAMs).  Optimization experiments were done with four fatty 
amides:  lauramide (C12:0), oleamide (C18:1
9
), palmitamide (C16:0), and stearamide 
(C18:0), before expanding the method to include all even saturated PFAMs between 
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lauramide (C12:0) and behenamide (C22:0), plus some PFAMs with one degree of 
unsaturation:  C18:1 and C22:1.  The limitations of the method will be discussed.    
 
 
4.2  Introduction  
 
Primary fatty acid amides (PFAMs), neutral, single chain, bioactive lipids, are 
part of a class of lipid signaling molecules [1-4].  It has been hypothesized that 
monitoring the concentration of specific primary fatty acid amides will allow for 
diagnosis of ocular surface disease [5, 6] and affective disorders such as depression [5].  
In some diseases, the ratio of amide to its corresponding fatty acid may be more 
important than the quantity of amides present when diagnosing certain diseases [6].  
Small changes in the carbon chain length change how the amide affects the system; 
specifically oleamide (C18:1
9
) has been found to influence sleep [5, 7, 8], erucamide 
(C22:1
13
) repairs the circulatory system [9, 10], and linoleamide (C18:2
9,12
) effects Ca
2+
 
signaling [11].  C18:1
9
 is the most commonly studied PFAM and has also been found to 
influence the memory processes [12], to decrease body temperature [13] and locomotor 
activity [7], suppress pain [14] and to regulate the voltage-gated Na
+
 channel [15, 16] and 
the GABA
A
 receptor [7, 12, 16].  The symptoms observed with increasing the dosage of 
amides vary with the type of unsaturation in the same chain length [3, 8].  For example, 
trans-9,10-octadecenoamide did not induce sleep for as long as cis-9,10-octadecenoamide 
at the same dosage [8].  Currently, the pathway involving the biological synthesis of 
PFAMs is unknown.  It is hypothesized that the biosynthetic pathway for oleamide either 
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involves one of the following proteins:  peptidylglycine alpha-amidating monooxygenase 
(PAM) [17, 18], cytochrome c [19] or fatty acid amide hydrolase (FAAH) [17, 20].  
While FAAH is usually expected to degrade the PFAM, Bisogno et al. has shown that 
FAAH can also synthesize PFAM when the concentration of ammonium ion and the 
corresponding FFA concentration is high [21]. 
In order to study the biological pathways involving PFAMs, and to quantitate 
novel PFAMs in biological samples, analytical methods need to be improved to 
accurately determine the structure of the PFAMs at femtomole levels or below.  Although 
there are methods available to study a few common PFAMs, the published methods do 
not include the complete series needed to quantify all the PFAMs found in biological 
samples.  Madl and Mittelbach developed a liquid chromatography separation method 
followed by atmospheric pressure chemical ionization mass spectrometry for detection 
(LC/APCI – MS).  The lower detection limits for long chain amides around 20 fmol [22]. 
Only C14:0, C16:0, C18:1
9
 and C18:0 were included in the separation protocol with an 
internal standard.  Sultana achieved similar results (lower detection limit between 50 and 
150 fmol depending on amide) using gas chromatography mass spectrometry (GC/MS) 
with an HP5-MS column (Agilent Technologies) for analysis [23].  This GC method was 
not able to separate the positional and geometric isomers.  Baseline separation of C18:1
9
, 
elaidamide (C18:1
trans 9
), petroselenamide (C18:1
6
), petroselaidamide (C18:1
trans 6
), 
vaccenamide (C18:1
trans 11
), octadecenoamide (C18:1
13
), arachidamide (C20:0), 
behenamide (C22:0), and erucamide (C22:1
13
) was achieved using a highly polar column 
(BPX-70, SGE) allowing for the determination of the placement of the double bonds, but 
the samples needed to be derivatized first.  The reaction between the amides and 
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N, N,-bis-trimethylsilyltrifluoroacetamide (N, N-BSTFA) has a low percent yield and 
often forms other products, increasing the detection limit of the method and causing 
problems with quantitation.  Other GC/MS methods have been developed to analyze 
C18:1
9
 in biological samples [24, 25] and plastic materials [26, 27].  These methods only 
examined the samples for a few specific PFAMs for qualitative analysis.   
 
 
4.3  Summary of the GC/MS Method 
 
While the LC/MS method was being developed, the samples were run on both the 
GC/MS and the LC/MS to compare detection limits, total analysis time, and separation 
limitations.  The method was initially developed by Sultana [23, 28] and then adapted by 
Dent (Duquesne University).   
Sultana’s method was transferred to a Varian GC/MS/MS system (CP-3800 GC 
with Saturn 2000 mass selective detector and CP-8400 autosampler) by Dent.  The 
column was a Varian VF5-MS (0.25 mm internal diameter, 0.25 μm film thickness, 30 m 
long).  The GC method used for analysis was as follows:  starting temperature was 55 
o
C, 
ramped to 150 
o
C at 40 
o
C/min, held at 150 
o
C for 3.62 min, and finally ramped to 275 
o
C 
at 10 
o
C/min and held for 6.5 min.  Helium was used as a carrier gas with a flow of 
1 mL/min.  The mass range was 50 to 350 m/z in chemical ionization (CI) mode, with 
methanol as the CI gas.  The temperature of the injection port was 250 
o
C with an 
injection volume of 1 μL unsplit.  The sample was diluted in 2-propanol to avoid 
methylation that occurs in the injection port when the sample was diluted in methanol.   
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4.4  LC/APCI-MS Method 
 
This project was initially started after Sommer et al. demonstrated that femtomole 
detection of PFAMs was possible using APCI-MS [29].  In addition a previous graduate 
student in the Johnson lab, Tara Carpenter, started developing a reverse phase LC 
gradient to separate a series of PFAMs [30, 31].  These two ideas were combined to 
develop a reverse phase LC method using a Waters XTerra MS C18 (5 μm, 3.9 x 20 mm) 
column for the separation and an APCI-MS probe on the Waters ZMD MS for detection.  
Detection limits and reproducibility were examined.   
 
 
4.4.1  Reagents 
 
Methanol used for the LC/MS analysis was HPLC grade from either Thermo 
Fisher Scientific (Pittsburgh, PA) or J.T. Baker (Phillipsburgh, NJ).  Distilled water was 
deionized with a Barnstead (Dubuque, IA) Nanopure water system.  Both the methanol 
and the water were filtered with 0.22 μm Nylon membrane filters from either Millipore 
(Billerica, MA) or Whatman International (Maidstone, England) prior to use.  The mobile 
phase for the HPLC analysis contained formic acid (99% pure) from Acros Organics 
(Morris Plains NJ) in both the methanol and water.  These solutions were made up fresh 
each day and sonicated in a 2210 Branson Ultrasonic cleaner (Danbury, CT) for 20 min 
to mix and degas.  Heptadecanoic-D33-Acid was from CDN Isotopes (Quebec, Canada).  
Lauric acid, myristic acid, heptadecanoic acid and stearic acid were from Thermo Fisher 
Scientific.  Oleic acid, tridecanoic acid and behenic acid were from Sigma (St. Louis, 
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MO) and arachidic acid was from Acros.  All the other fatty acids were from ICN 
Biomedicals Inc. (Aurora, OH).  The primary fatty acid amide (PFAM) standards [C12:0, 
tridecanoamide (C13:0), myristamide (C14:0), C16:0, heptadecanoamide (C17:0), 
heptadecano-D33-amide (C17D33:0), C18:0, C18:1
9
, C18:1
trans 9
, C18:1
6
, C18:1
trans 6
, 
C18:1
trans 11
, C18:1
13
, C20:0, C22:0, and C22:1
13
] were synthesized in house from their 
corresponding fatty acids with a greater than 95% purity as verified by GC/MS [28].   
Toluene (HPLC grade) and chlorotrimethylsilane (98%) (TMS) used for silanization of 
the glassware were from Acros Organics.   
 
 
4.4.2  Instrument 
 
The HPLC/MS system was a Waters 2695 separations module with a Waters 2487 
dual wavelength detector operated at 210 nm to monitor the gradient and a Waters ZMD 
MS (Milford, MA) with an APCI probe in positive mode to monitor the separation.  Data 
was analyzed using Waters MassLynx 4.1 software.  Single ion mode was used to 
monitor the mass to charge ratios corresponding to the [M+H]
+
 peak for the PFAMs of 
interest.  Each channel monitored one or two mass to charge ratios for the time during 
which the corresponding peaks were expected to elute to minimize background noise.  
When calculating the peak area for an analyte, the corresponding mass to charge ratio 
chromatogram was extracted before integrating.  For the HPLC separation, a Waters 
XTerra MS C18 (5 μm, 3.9 x 150 mm) column with a Waters XTerra MS C18 (5 μm, 
3.9 x 20 mm) guard column and an inline filter were used.  The solvents were sonicated 
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in a 2210 Branson Ultrasonic cleaner (Danbury, CT) for 20 min to degas before running; 
during the run the in-line degasser was used.   
 
 
4.4.3  Silanization Procedure 
 
In order to silanize the vials, clean vials were soaked in 1 M NaOH for 30 min 
before rinsing with ultrapure water and drying completely.  The vials were flushed with 
argon to remove any moist air before filling with 10 % TMS in toluene.  The vials were 
capped after flushing the head space with argon and allowed to sit overnight, then rinsed 
with toluene.  The vials were stored in the drying oven (60 
o
C) until needed.  Prior to 
using, the vials were rinsed with methanol and dried completely.  It was necessary to re-
silanized the vials after each use.   
 
4.4.4  MS Optimization 
   
It was necessary to determine which MS conditions produced the best ionization 
of the PFAMs using the APCI probe on the Waters ZMD.  A series of experiments were 
run to test how much the temperature of the probe, the gas flows, the applied voltages, 
and the magnification of the detector signal influenced the signal response.  Unless 
otherwise noted, the following conditions were used for optimization experiments.  A 
20 μL injection of a 0.1 mM each mixture of C12:0, C18:19, and C18:0 was loaded onto 
the column.  More PFAMs were added once the MS parameters had been optimized in 
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order to determine the limits of the separation.  Unless otherwise noted, a 25 min gradient 
was used where the column was equilibrated in 90:10 methanol:water before injection.  
After injection, the gradient was ramped linearly to 95:5 methanol:water over 10 min 
before returning to the initial conditions (2 min ramp).  The mobile phase was held at the 
initial conditions for 13 min before doing the next injection.  Formic acid (0.1 %) was in 
both the methanol and the water.  The flow rate was held constant at 1 mL/min.  The 
starting APCI-MS parameters were as follows:  corona 3.0 kV, sample cone 25 V, 
extraction cone 2 V, RF lens 0 V, source temperature 130 
o
C, desolvation temperature 
530 
o
C, desolvation gas flow 600 L/hr, and the cone gas flow 100 L/hr.  The nitrogen gas 
source was from a high pressure liquid nitrogen dewar.  Once a parameter had been 
optimized, the setting was used for subsequent experiments optimizing the other MS 
parameters.  For these experiments, the three mass to charge ratios corresponding to the 
PFAMs being analyzed were monitored throughout the analysis in one channel.   
In order to optimize the temperature setting for the APCI heater, a series of 
injections were done where all the parameters were held constant except for the 
temperature of the APCI heater, which was varied from 450 to 650 
o
C.  Three injections 
were done at each temperature setting.  By comparing at the peak areas, it was 
determined that 500 
o
C was the best setting for the APCI heater; however, after several 
experiments, the APCI heater was turned down to 450 
o
C to lengthen the life of the 
heater.  For the remaining optimization experiments, 500 
o
C was used as the setting for 
the APCI heater.  Results from varying the heater temperature are shown in Figure 4-1.   
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Figure 4- 1  Resulting peak areas from injecting 670 pmol of each PFAM (C12:0, C18:1
9
, and 
C18:0) on the XTerra MS C18 column while varying the APCI heater temperature setting.  Results 
are the average of three injections with the standard deviation.   
 
Next the nitrogen flow for the cone gas was optimized.  For this experiment, all of 
the APCI-MS parameters were held constant except for the cone gas setting which was 
varied from 100 
o
C to 250 
o
C.  Two injections of 670 pmol each PFAM were done at 
each gas flow setting.  The results are shown in Figure 4-2.  The cone gas was optimized 
at 150 L/hr in this experiment, but, as the method was developed, the gas flow was 
eventually turned down to 50 L/hr to reduce the background noise in the separation 
experiments.  For the remaining optimization experiments, 150 L/hr was used as the 
setting for the cone gas.   
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Figure 4- 2  Resulting peak areas from injecting 670 pmol of each PFAM (C12:0, C18:1
9
, and 
C18:0) on the XTerra MS C18 column while varying the cone gas flow setting.  Results are the 
average of two injections with the standard deviation.   
 
In order to optimize the setting for the desolvation gas flow, all the parameters 
were held constant except the setting for the desolvation gas flow.  The flow rate was 
varied between 300 and 600 L/hr.  Two injections of 670 pmol each PFAM were done at 
each gas flow setting.  The results are shown in Figure 4-3.  It was determined that the 
desolvation gas was optimized at 400 L/hr.   
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Figure 4- 3  Resulting peak areas from injecting 670 pmol of each PFAM (C12:0, C18:1
9
, and 
C18:0) on the XTerra MS C18 column while varying the desolvation gas flow setting.  Results are 
the average of two injections with the standard deviation.   
 
Once the gas flows and temperature settings were optimized, the corona voltage 
was optimized.  Three injections of 670 pmol each PFAM were done at each voltage 
setting.  The corona voltage was varied between 2.8 and 3.2 kV, while the rest of the MS 
parameters were held constant.  The results are shown in Figure 4-4.  It was determined 
that the corona voltage was optimized at 3 kV.   
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Figure 4- 4  Resulting peak areas from injecting 670 pmol of each PFAM (C12:0, C18:1
9
, and 
C18:0) on the XTerra MS C18 column while varying the corona pin voltage setting.  Results are 
the average of three injections with the standard deviation.   
 
The cone voltage was optimized by varying the setting from 15 to 35 V, while the 
other MS parameters were held constant.  PFAMs (670 pmol each) was injected in 
triplicate at each voltage setting.  The results are shown in Figure 4-5.  This experiment 
shows that the optimal cone voltage setting was 25 V.   
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Figure 4- 5  Resulting peak areas from injecting 670 pmol of each PFAM (C12:0, C18:1
9
, and 
C18:0) on the XTerra MS C18 column while varying the cone voltage setting.  Results are the 
average of three injections with the standard deviation.   
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The optimized MS parameters are as follows:  corona 3.0 kV, sample cone 25 V, 
extraction cone 2 V, RF lens 0 V, source temperature 130 
o
C, desolvation temperature 
450 
o
C, desolvation gas flow 400 L/hr, and the cone gas flow 150 L/hr.  These parameters 
needed to be adjusted each time maintenance was done on the MS, but the parameters 
were optimized by infusing a mixture of the three PFAMs (C12:0, C18:1
9
, and C18:0) in 
75:25 methanol:water with 0.3 % formic acid and adjusting the parameters to get the 
highest signal on the tune page.   
The final parameter to optimize was the magnification of the detector.  Unlike the 
other optimization experiments, this parameter was optimized after the LC separation was 
developed.  At this point in developing the method, it was determined it would be better 
to analyze the slope of a short calibration curve in order to determine the best setting for 
the magnification of the detector.  This experimental set up also ensured that the 
background noise did not increase causing the detection limit to increase.  A 25 min 
gradient was used where the column was equilibrated in 75:25 methanol:water before 
injection.  After injection, the gradient was ramped linearly to 95:5 methanol:water over 
30 min before returning to the initial conditions.  The mobile phase was held at the initial 
conditions for 10 min before doing the next injection.  Formic acid (0.3 %) was in both 
the methanol and the water.  The flow rate was held constant at 1 mL/min and a 20 μL 
injection was done.  The APCI-MS parameters were as follows:  corona 3.5 kV, sample 
cone 30 V, extraction cone 3 V, RF lens 0.1 V, source temperature 130 
o
C, desolvation 
temperature 450 
o
C, desolvation gas flow 450 L/hr, and the cone gas flow 50 L/hr.  Two 
injections of each of the three concentrations (2 pmol, 20 pmol, and 200 pmol) were done 
at each magnification setting (varied between 550 and 800).  Data from the 600, 650, 
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700, and 800 settings is shown in Figure 4-6.  For these experiments, the mixture 
included C12:0, C14:0, C16:0, C17:0, C18:0, C18:1
9
, C22:0, and C22:1
13
.  C17D33:0 
was used as an internal standard so the concentration was held constant in each of the 
mixtures making the slope zero.  It was determined that 700 was the best magnification 
setting.  The slopes of the signal to noise ratio were also plotted, which showed that 800 
would be the best setting; however doing a detection limit test showed that 700 was the 
best detector magnification setting.   
 
 
  
Figure 4- 6  Resulting slopes from duplicate injections of three different concentrations of the 
PFAM mixture on the XTerra MS C18 column at four different magnification setting.  Results are 
shown comparing the slope of the line from the peak areas and when the detector magnification 
is set to 600, 650, 700, and 800.  
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4.4.5  Separation Optimization 
 
In addition to optimizing the gradient between methanol and water to improve the 
separation between the PFAMs, the concentration of formic acid in the mobile phase had 
to be optimized.  The concentration of formic acid had to be examined to determine what 
range improved the ionization of the PFAMs in the APCI-MS source.  Also, experiments 
were done to see if it was necessary to silanize the glass vials used for injection and 
which solvents could be used for dilution the samples.  Unless otherwise noted, the 
optimized MS parameters were used.   
The initial gradient was 25 min long and the column was equilibrated in 90:10 
methanol:water before injection (20 μL).  This gradient was a shortened version of the 
gradient developed by Carpenter et al. [30].  After injection the gradient was ramped 
linearly to 95:5 methanol:water over 10 min before returning to the initial conditions.  
The mobile phase was held at the initial conditions for 13 min before doing the next 
injection.  Formic acid (0.1 %) was in both the methanol and the water.  The flow rate 
was held constant at 1 mL/min.  However, as more PFAMs were added to the mixture, 
the gradient ramp had to be slowed down and more water added to the initial conditions.  
The gradient ended up being 45 min long and the column was equilibrated with 75:25 
methanol:water before injection.  After injection, the gradient was ramped linearly to 
95:5 methanol:water over 30 min before returning to the initial conditions (5 min ramp).  
The mobile phase was held at the initial conditions for 10 min before doing the next 
injection.  0.1 % formic acid was in both the methanol and the water.  This gradient 
separated all of the completely saturated PFAMS with even chain lengths varying from 
C12:0 to C22:0 plus the odd chain lengths C13:0 and C17D33:0.  The resulting 
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chromatogram from injecting 200 pmol each of eight PFAMs is shown in Figure 4-7.  
This method also partially separated a series of PFAMs with the same chain length and 
the same degree of unsaturation.  The experiments done to optimize the analysis are 
discussed in detail below.   
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Figure 4- 7  Chromatogram showing the separation of eight different PFAMs (200 pmol of each 
was injected) before the gradient was optimized.  The percentage of methanol is plotted on the 
right axis with the dotted line.   
 
A simple test was done in order to determine whether silanization of the glass 
vials was necessary.  For this experiment, a mixture (20 pmol of each PFAM) of six 
different C18:1 PFAMs were used.  There was not a complete separation between the 
different PFAMs so C18:1
9
, C18:1
trans 11
, and C18:1
13
 co-eluted in the first peak, 
C18:1
trans 9
 and C18:1
6
 co-eluted in the second peak, and C18:1
trans 6
 eluted in the third 
peak.  Six injections were done from three different silanized vials and three different 
non-silanized vials.  Results (Figure 4-8) showed that using silanized vials slightly 
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improved the peak areas.  Statistically at the 95 % confidence level there is no difference 
between the two measurements; however, because an increase in peak areas was noticed 
when the same concentration was prepared in a silanized vial as opposed to a non-treated 
vial, silanized vials were used for the experiments. 
 
 
Figure 4- 8  Average results from injecting (20 pmol of each PFAM) of six different C18:1 PFAMs 
were used.  There was not a complete separation between the different PFAMs so C18:1
9
, 
C18:1
trans 11
, and C18:1
13
 co-eluted in the first peak, C18:1
trans 9
 and C18:1
6
 co-eluted in the 
second peak, and C18:1
trans 6
 eluted in the third peak.  Two different mixtures were made:  one 
using a silanized glass vial and the other using a non silanized glass vial.  The error bars are the 
standard deviation of the three injections.   
 
In order to optimize the formic acid concentration, two injections of the PFAM 
mixture were done at three different concentrations (2 pmol, 20 pmol, and 200 pmol) for 
four different concentrations of formic acid in the mobile phase (0, 0.1, 0.3 and 0.5 %).  
For these experiments, ten PFAMs (C12:0, C14:0, C16:0, C17:0, C18:0, C18:1
9
, 
C18:1
trans 9
, C18:1
trans 6
, C22:0, and C22:1
13
) and the internal standard (C17D33:0) were 
monitored.  The results shown in Figure 4-9 show that 0.3 % formic acid in the mobile 
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phase gave the best ionization of the PFAMs.  It is important that the mobile phase be 
prepared daily to prevent the formic acid from degrading [32].    
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Figure 4- 9  Average results from injecting a series of PFAMs (C12:0, C14:0, C16:0, C17:0, 
C18:0, C18:1
trans 6
, C18:1
trans 9
, C18:1
9
, C22:0, and C22:1
13
 from left to right in each group) at 
three different mixture concentrations (200 pmol, 20 pmol, and 2 pmol injected) at each 
concentration of formic acid (0 %, 0.1 %, 0.3 % and 0.5 %) in the mobile phase.   
 
Another examined parameter was the solvent that the sample was dissolved in for 
injection onto the column.  Initially, all the samples were dissolved in either 100 % 
methanol or 1:1 methanol:chloroform (stock solution).  However, as the method was 
developed and the results were compared to GC/MS data, it was convenient to dissolve 
the sample in 2-propanol so that the same solution could be run on both instruments.  
Since only 20 μL of the solution was injected onto the column, neither the peak areas nor 
the retention times varied among any of these solvents.  This data is not shown.   
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A separation with ten PFAMs was done, but the entire spectrum between 250 m/z 
and 350 m/z was monitored during the run.  The MAP function was used in 
MassLynx 4.1 to plot all the data (Figure 4-10).  From this 2D graph a pattern can be seen 
in the elution pattern.  This type of plot may be useful in indentifying additional PFAMs 
in biological samples; however, further studies would have to be done to determine 
whether the additional spots would be impurities or more PFAMs.  The MAP plot also 
shows the major impurities contributing to the total ion count background.   
 
Figure 4- 10  MAP plot of the separation between nine PFAMs (C16:0, C17:0, C18:0, C18:1
trans 6
, 
C18:1
trans 9
, C18:1
9
, C20:0, C22:0, and C22:1
13
) where the MS scanned from 250 m/z to 350 m/z.  
The arrows mark the signals from impurities.   
 
 
4.4.6  C18:1  Separation Optimization 
 
After the RP-LC conditions were optimized, further studies were done in order to 
test the limits of the separation and determine whether it would be possible to completely 
separate a series of C18:1 PFAMs.  The gradient described above was able to separate 
C16:0 
C17:0 
C18:0 
C20:0 
C22:
0 
C22:1
13 
C18:1  
 
147 
between a double bond in the same location, but in the cis versus the trans orientation.  
However, in a mammalian tissue sample, it is more likely that the double bond would be 
found in a different location still in the cis orientation as opposed to the trans orientation 
in the same location [33].  Longer gradients, increasing the temperature, longer columns, 
and additional solvents were varied to improve the separation.  The elution order of the 
C18:1 series is shown in Figure 4-11.  In order to show the separation between the C18:1 
PFAMs and positively identify the different PFAMs, each PFAM was injected separately 
(20 pmol each).   
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Figure 4- 11  LC/APCI-MS separation and detection of a series of C18:1 compounds with the 
double bond in different positions.  20 pmol of each amide was injected separately in 20 μL of 
methanol.  Only m/z 282 was monitored.  The chromatograms are overlaid to show elution order.  
Peak 1:  C18:1
trans 11
, peak 2: C18:1
9
, peak 3:  C18:1
13
, peak 4:  C18:1
trans 9
, peak 5:  C18:1
6
, and 
peak 6:  C18:1
trans 6
.   
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Although the peaks were not completely separated, there was some difference in 
retention times for each of the C18:1 PFAMs.  The data shown above and data from a 
gradient where the ramp was 60 min long were loaded into the DryLab Program 
version 2.05 from LC Resources Inc. (Walnut Creek, CA).  Unfortunately the gradients 
predicted by the program to improve the separation were unstable and were not able to be 
copied using the LC/MS.  From this study, it was determined that a better separation 
would be needed in order to be able to use a computational approach to optimizing the 
gradient.    
Longer gradients were formed by increasing the initial percentage of water in the 
mobile phase, reducing the slope of the gradient, or adding a hold at the initial conditions 
before starting the gradient.  Figure 4-12 shows two examples of what happened to the 
separation as the slope of the gradient was reduced.  For each of the runs, 2 pmol each 
mixture of PFAMs (C18:1
trans 11
, C18:1
9
, C18:1
13
, C18:1
trans 9
, C18:1
6
, C18:1
trans 6
) was 
injected.  Gradient A was 75 min long and the column was equilibrated with 75:25 
methanol:water before injection.  After a 30 min hold at the initial conditions, the 
gradient was ramped linearly to 85:15 methanol:water over 30 min before returning to the 
initial conditions.  The mobile phase was held at the initial conditions for 10 min before 
doing the next injection.  Gradient B was 75 min long and the column was equilibrated 
with 75:25 methanol:water before injection.  After a 30 min hold at the initial conditions, 
the gradient was ramped linearly to 90:10 methanol:water over 30 min before returning to 
the initial conditions.  The mobile phase was held at the initial conditions for 10 min 
before doing the next injection.  For both of these gradients, the mobile phase contained 
0.1 % formic acid and the injections were done at room temperature.  After several 
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different approaches to reducing the slope of the gradient, it was determined that a 
gradual ramp would not separate the series.  The separation between the PFAMs was 
slightly improved because a shoulder formed on the first peak, but the overall analysis 
was significantly lengthened.   
 
 
Figure 4- 12  LC/APCI-MS separation and detection of a series of C18:1 positional isomers.  
2 pmol of each amide was injected as a mixture and only m/z 282 was monitored.  Two 
chromatograms using two different gradients are over laid to show the effects of slowing down the 
gradient.  The inlay depicts the differences between the two gradients.   
 
Another approach to improving the separation between the C18:1 series of 
PFAMs was to observe how temperature affected the separation.  Increasing the 
temperature changes the viscosity of the mobile phase allowing for faster flow rates and 
faster mobile phase-stationary phase exchange, but for every 10 
o
C increase in 
temperature the retention factor is reduced by 2 to 3 [34].  Figure 4-13 shows a series of 
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injections done with the same gradient only the column temperature was varied between 
30 
o
C and 40 
o
C.  10 pmol of each C18:1
trans 11
, C18:1
9
, C18:1
13
, C18:1
trans 9
, C18:1
6
, 
C18:1
trans 6
 was injected as a mixture onto the column.  As expected, increasing the 
temperature did improve peak height so that the peak shape was sharper and the width 
decreased.  Unfortunately, the resolution between the analytes decreased because the 
elution time decreased as the temperature increased.  The resolution between the three 
peaks varied slightly, but a trend was not noticeable.  By plotting the plate heights versus 
the temperature and the plate number versus the temperature (Figure 4-14), it was 
determined that the plate height increased and the plate number decreased as the 
temperature increased.  Also, since no shoulders were formed on the peaks, this approach 
to optimizing the separation was not continued.  The data is not shown, but increasing the 
temperature of the longer gradients did not improve the separation either.   
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Figure 4- 13  LC/APCI-MS separation and detection of a series of C18:1 compounds with the 
double bond in different positions.  10 pmol of each amide was injected as a mixture and only m/z 
282 was monitored.  Four chromatograms are shown where the same gradient was used, but the 
column temperature was varied.  Peak 1 is the co-elution of C18:1
trans 11
, C18:1
9
, and C18:1
13
, 
peak 2 is the co-elution of C18:1
trans 9
, and C18:1
6
, and peak 3 is C18:1
trans 6
. 
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Figure 4- 14  The trends in plate height (left) and plate number (right) as the temperature was 
increased.  Peak 1 is the co-elution of C18:1
trans 11
, C18:1
9
, and C18:1
13
, peak 2 is the co-elution 
of C18:1
trans 9
, and C18:1
6
, and peak 3 is C18:1
trans 6
. 
 
Plate number was also increased by connecting two Waters XTerra MS C18 
(5 μm, 3.9 x 150 mm) columns together still using the Waters XTerra MS C18 (5 μm, 
3.9 x 20 mm) guard column and an inline filter.  It is common to use either a longer 
column [35] or two columns in a series [36, 37], when more complex separations are 
desired.  For these experiments, the gradient was ramped from 75:25 methanol: water to 
80:20 methanol: water over 60 min before returning to initial conditions.  The flow rate 
was 0.7 mL/min, which was limited by the upper pressure limits of the LC system and the 
columns.  Results are shown in Figure 4-15.  Connecting two columns in a series 
improved the separation slightly, as a shoulder could be seen on the first peak, but the 
C18:1 series compounds still were not completely separated.  Based on retention times 
from when the PFAMs were injected separately, the shoulder was suspected to be 
C18:1
trans 11
.  Very little improvement was made, while the analysis time tripled for the 
C18:1 PFAMs.  Although the PFAMs were retained on the column longer to allow for 
increased resolution, the extra band broadening from the slower flow rate limited the 
152 
resolution.  This approach might have improved the separation more if the packing 
allowed for higher flow rates.   
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Figure 4- 15  Mixture of 6 C18:1 amides separated using 2 C18 XTerra columns connected in a 
series.  Peak 1 is the co-elution of C18:1
trans 11
 (suspected shoulder peak), C18:1
9
, and C18:1
13
, 
peak 2 is the co-elution of C18:1
trans 9
, and C18:1
6
, and peak 3 is C18:1
trans 6
. 
 
The final approach to improving the separation between the C18:1 series was to 
add 2-propanol to the mobile phase.  2-propanol was either added at a constant 
percentage to the mobile phase or slowly added into mobile phase up to 10 %.  From 
these experiments, the best gradient was when the column was equilibrated in 73:25:2 
methanol:water:2-propanol.  After injection, the initial conditions were held for 30 min 
before ramping to 83:15:2 over 30 min.  The column was returned to initial conditions for 
10 min before the next injection.  Figure 4-16 shows the resulting chromatogram when 
20 pmol of each: C18:1
trans 11
, C18:1
9
, C18:1
13
, C18:1
trans 9
, C18:1
6
, C18:1
trans 6
 were 
injected as a mixture onto the column.  Again, the shoulder was expected to be 
C18:1
trans 11
 based on the elution order from previous experiments.   
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Figure 4- 16  Mixture of six C18:1 amides separated using two C18 XTerra columns connected in 
a series.  Peak 1 is the co-elution of C18:1
trans 11
 (suspected shoulder peak), C18:1
9
, and C18:1
13
, 
peak 2 is the co-elution of C18:1
trans 9
, and C18:1
6
, and peak 3 is C18:1
trans 6
. 
 
 
4.4.7  Detection Limits 
 
Throughout the optimization procedure the detection limit was monitored.  The 
best detection limits for C16:0, C18:1 and C18:0 were 10 fmol of each, but the detection 
limits for the other PFAMs in the mixture were higher:  C12:0 (1 pmol), C13:0 
(100 fmol), C14:0 (200 fmol), and C17:0 (200 fmol).  Unfortunately, these detection 
limits were dependent on the condition of the instrument so the detection limits were 
usually in the low pmol range.  From running these experiments, it was hypothesized that 
the cleanness of the cones and corona pin, the vacuum seal, and the gas flow affected the 
ionization of the PFAMs.  It was also important for the formic acid to be added to the 
mobile phase daily to prevent the formic acid from degrading.   
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4.4.8  Problems 
 
One of the biggest problems with the set up was that the nitrogen came from a 
liquid nitrogen dewar.  Depending on how much liquid nitrogen was left in the tank, the 
gas flow varied throughout the day.  Figure 4-17 shows how the response factor (slope of 
the line when the area of the analyte signal divided by the area of the standard signal is 
plotted versus the concentration of the analyte divided by the concentration of the 
standard) changed throughout 28 injections.  The first eight injections were done on one 
day with a nitrogen dewar that was almost empty.  The last twenty injections were done 
on another day with a nitrogen dewar that had just been filled and delivered.  Each 
injection was done with 16 μM of each PFAM (C16:0, C17:0, C17D33:0, C18:0, C18:19, 
and C20:0).  Because the concentration of both the analyte and the internal standard was 
the same, the response factor is just the ratio of the peak area of the sample compared to 
the peak area in the internal standard.  It is important to note that the plotted gas flows are 
the values at the start of the run and the standard deviation was calculated separately for 
each day.  Overlaying this data shows that the gas flow does influence the response 
factors, but the starting values of the gas flow saved in the software cannot be used to 
distinguish a good run from a bad run.  The percent error in the response factors after the 
nitrogen dewar was changed was varied between 4-10 % depending on the PFAM.   
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Figure 4- 17  Plot of the response factors (left axis) from five different PFAMs over the course of 
28 injections.  The starting gas flows are plotted in the right axis.  Each PFAM was added to the 
mixture so that 320 pmol of each was injected onto the column.  C17D33:0 was used as the 
internal standard at the same concentration.  The first eight injections used a different nitrogen 
dewar than the rest of the injections.   
 
In order to test the influence of the gas flow on the response factors, a nitrogen 
tank was set up to provide the gas flows.  Each PFAM (C12:0, C18:1
9
, and C18:0) was 
added to the mixture so that 50 pmol of each was injected onto the column.  10 pmol of 
C17D33:0 was used as the internal standard.  The first three and the last three injections 
used a nitrogen dewar while the middle injections used a nitrogen tank.  See Figure 4-18.  
The standard deviation was calculated separately for each type of nitrogen used.  This 
shows that a steady gas flow will improve the reproducibility of the method.  The percent 
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error of the response factors using the nitrogen tank was varied between 2-3 % depending 
on the PFAM.   
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Figure 4- 18  Plot of the response factors from five different PFAMs over the course of 
12 injections.  Each PFAM was added to the mixture so that 50 pmol of each was injected onto 
the column.  10 pmol of C17D33:0 was used as the internal standard.  The first three and the last 
three injections used a nitrogen dewar while the middle injections used a nitrogen tank.   
 
In order to determine whether the ionization efficiency was varying throughout 
the separation, isocratic conditions, where most of the PFAMs co-eluted, was run 
multiple times to determine the error in the response factor.  For this experiment the 
mobile phase was 95:5 methanol:water with 0.3 % formic acid.  The chromatogram is 
shown in Figure 4-19.  The response factors from 18 consecutive injections are shown in 
Figure 4-20.   
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Figure 4- 19 LC/APCI-MS separation and detection of eight PFAMs.  1000 pmol of each amide 
was injected as a mixture.  All of the m/z ratios corresponding to the PFAMs were monitored in 
one channel.  Isocratic elution with 95:5 methanol:water with 0.3 % formic acid.   
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Figure 4- 20  Plot of the response factors (left axis) from seven different PFAMs over the course 
of 18 injections.  The starting gas flows are plotted on the right axis.  Each PFAM was added to 
the mixture so that 1 nmol of each was injected onto the column.  C17D33:0 was used as the 
internal standard.   
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Initially starting this project, some interference was expected from contaminants, 
especially C18:0, C18:1
9
, C22:1
13
 because they are used as slip additives in plastics [26, 
27, 38, 39].  However, as the method was developed it was determined that the solvents 
contained other contaminants that interfered with the analysis.  These compounds had the 
same mass to charge ratio and similar polarity as the PFAMs on the LC/APCI-MS, but a 
different fragmentation pattern on the GC/MS.  Distilling the solvents used for sample 
preparation eliminated most of the interference.   
Using this method, there is a partial separation between the C18:1 series, but this 
method alone cannot tell the difference between bond position and orientation.  
Unfortunately, the best methods of detecting the PFAMs does not allow for the use of 
capillary columns (see section 4.5.3) for the separation method.  The pressure limits 
require the use of flow rates through the column that are two to three times lower than the 
required flow rates for APCI-MS analysis.   
A five point calibration curve over three orders of magnitude (10 pmol – 4 nmol) 
using this method and triplicate injections was analyzed.  C17D33:0 was used as the 
internal standard.  Although the data could be fit to a line, the error in each response 
factor was still approximately 20 % when standards were used to check the accuracy of 
the curve.   
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4.4.9  Conclusions 
 
The final method for the LC/APCI-MS method was done at room temperature 
with the PFAMs dissolved in 2-propanol so that analysis could be done on both 
instruments (LC/APCI-MS - 20 μL injected and CG/MS – 1 μL injected).  The final 
gradient was 45 min long and the column was equilibrated with 75:25 methanol:water 
before injection.  After injection, the gradient was ramped linearly to 95:5 
methanol:water over 30 min and then held at 95:5 for 5 min before returning to the initial 
conditions.  The mobile phase was held at the initial conditions for 5 min before doing 
the next injection.  0.3 % formic acid was in both the methanol and the water.  The 
resulting chromatogram when 300 pmol of each PFAM is injected is shown in 
Figure 4-21.  The MS parameters are as follows:  corona 3.0 kV, sample cone 25 V, 
extraction cone 2 V, RF lens 0 V, source temperature 130 
o
C, desolvation temperature 
450 
o
C, desolvation gas flow 400 L/hr, and the cone gas flow 150 L/hr.  These are 
average values for each of the parameters since they needed to be adjusted each time 
maintenance was done on the MS.  Channel one was used to monitor for C12:0 and 
C14:0 by scanning the mass to charge ratios 200 and 228 starting at 5.0 after injection to 
13.5 min.  Channel two was used to monitor for C16:0 by scanning the mass to charge 
ratio 256 from 16.0 to 17.0 min.  Channel three was used to monitor for the C18:1 
isomers by scanning the mass to charge ratio 282 from 17.0 to 22.0 min.  Channel four 
was used to monitor for the internal standards C17D33:0 and C17:0 by scanning the mass 
to charge ratios 270 and 303 from 16.0 to 23.0 min.  Channel five was used to monitor 
for the C18:0 by scanning the mass to charge ratio 284 from 21.0 to 25.0 min.  Channel 
six was used to monitor for C20:0 by scanning the mass to charge ratio 312 from 24.5 to 
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29.0 min.  Channel seven was used to monitor for the C22:1 isomers by scanning the 
mass to charge ratio 338 from 26.0 to 33.0 min.  Channel eight was used to monitor for 
C22:0 by scanning the mass to charge ratio 340 from 29.0 to 38.0 min.   
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Figure 4- 21  LC/APCI MS of 12 amides.  300 pmol of each amide in 20 μL of 1:1 
chloroform:methanol was injected.  The channels were overlaid to show the separation.  (1) 
C12:0 and (2) C14:0 are detected on channel 1 by monitoring m/z 200 and m/z 228.  Channel 2:  
(3) C16:0 - m/z 256.  Channel 3:  (4) C18:1
9
, (5) C18:1
trans 9
, (6) C18:1
trans 6
 - m/z 282.  Channel  4:  
(7) C17D33:0 and (8) C17:0 - m/z 303 and m/z 270.  Channel 5: (9) C18:0 - m/z 284.  Channel 6:  
(10) C20:0 – m/z 312.  Channel 7:  (11) C22:1
13
 – m/z 338.   
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Figure 4- 22  Retention time of the saturated PFAMs under gradient elution.   
 
 
4.5  LC/ESI-MS Method 
 
An attempt to separate a series of PFAMs with the same degree of unsaturation 
but the double bond in different positions was done with a 0.3 μm particle size reverse 
phase column.  The smaller particle size should allow for a higher separation power.  
Because of the high back flow pressure, low flow rates and ESI-MS were used to separate 
and detect the PFAMs.  Ammonium acetate was added to the mobile phase to increase 
the ionization efficiency when using ESI-MS for detection.  Comparisons were made to 
the APCI-MS detection method by using a 3.9 μm i.d. reverse phase column and ESI-MS 
detection.   
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4.5.1  Reagents 
 
Methanol used for the LC/MS analysis was HPLC grade from Thermo Fisher 
Scientific (Pittsburgh, PA).  Distilled water was deionized with a Barnstead (Dubuque, 
IA) Nanopure water system.  All of the mobile phase solvents were filtered with 0.22 μm 
Nylon membrane filters from Whatman International (Maidstone, England) and sonicated 
in a 2210 Branson Ultrasonic cleaner (Danbury, CT) for 20 min prior to use.  The 
ammonium acetate added to the mobile phase was from Thermo Fisher Scientific.  
Heptadecanoic-D33-Acid was from CDN Isotopes (Quebec, Canada).  Lauric acid, 
myristic acid, heptadecanoic acid and stearic acid were from Thermo Fisher Scientific.  
Oleic acid and behenic acid were from Sigma (St. Louis, MO) and arachidic acid was 
from Acros.  All the other fatty acids were from ICN Biomedicals Inc. (Aurora, OH).  
The primary fatty acid amide (PFAM) standards [C12:0, (C14:0, C16:0, C17:0, 
C17D33:0, C18:0, C18:1
9
, C18:1
trans 9
, C18:1
trans 6
, C22:0, and C22:1
13
] were synthesized 
in house from their corresponding fatty acids with a greater than 95% purity as verified 
by GC/MS [28].    
 
 
4.5.2  Instrument Set-up for LC/ESI-MS  
 
The HPLC/MS system was a Waters 2695 separations module with a Waters 2487 
dual wavelength detector operated at 210 nm to monitor the gradient and a Waters ZMD 
MS (Milford, MA) with an ESI probe in positive mode to monitor the separation.  Data 
was analyzed using Waters MassLynx 4.1 software.  Single ion mode was used to 
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monitor the mass to charge ratios corresponding to the [M+H]
+
 peak for the PFAMs of 
interest; the MS program was set up to monitor several mass to charge ratios in one 
channel.   
For the HPLC separation, either a Waters XTerra MS C18 (5 μm, 3.9 x 150 mm) 
column with a Waters XTerra MS C18 (5 μm, 3.9 x 20 mm) guard column and an inline 
filter or a C18 Acclaim column from Dionex (3 μm, 1 x 150 mm) with an inline filter was 
used.  During the run the in-line degasser was used.  All separations were done at room 
temperature (about 28 
o
C). 
 
 
4.5.3  Microbore Column Experiments 
 
When using the larger XTerra column (5 μm, 3.9 x 150 mm), it was determined 
that a simple gradient would not completely separate a series of PFAMs with the same 
carbon chain length, but varying the position of the double bond (data shown in section 
4.4.5).  One attempt to improve the separation was to use a column with a smaller particle 
size (C18 Acclaim column from Dionex with 3 μm particles), but because of pressure 
limitations the flow rate had to be reduced to 8 μL/min; therefore, APCI-MS could not be 
used to analyze these samples.  Initially, isocratic runs were done in order to test the 
system.  Figure 4-23 shows the separation between C12:0, C18:1
9
, and C18:0 when the 
mobile phase was 85 % methanol and 15 % water.  A 2 μL injection was done.  ESI-MS 
settings were as follows:  capillary 3 kV, sample cone 10 V, extraction cone 5 V, RF lens 
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0.1 V, source temperature 80 
o
C, desolvation temperature 100 
o
C, desolvation gas flow 
150 L/hr, and the cone gas flow 50 L/hr.   
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Figure 4- 23  Separation between three PFAMs using the Dionex Acclaim column.  660 pmol of 
each PFAM was injected onto the column (2 μL injection).   
 
Unfortunately, running in isocratic mode did not separate the C18:1 series.  
Several gradients were tried in order to improve the separation, but, because the runs 
were not reproducible from run to run, it was difficult to monitor trends in the separation 
as the mobile phase was varied.  Ammonium acetate was added into the mobile phase at 
varying concentrations between 1 and 5 mM, but again the trends were not reproducible.  
After several more experiments, it was determined that either the injection volume 
affected the chromatogram or the mass load was too high for the column.  The Van 
Deemter curve was not studied, but it was possible that the flow rate was below the 
optimal range for the column.  The detection limit for this set-up was approximately 
60 pmol of PFAM injected onto the column.  In conclusion, although this path should 
have been explored further, the parameters were limited by the instrument capabilities so 
further studies were not done.   
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4.5.4  Separation and Detection Limits 
 
In order to determine whether or not further development of the PFAM separation 
on the smaller column should be continued, the detection limits using ESI MS as the 
detector were examined.  These experiments also allowed for a direct comparison 
between the ESI-MS source and APCI-MS source.  For this HPLC separation, a Waters 
XTerra MS C18 (5 μm, 3.9 x 150 mm) column with a Waters XTerra MS C18 (5 μm, 
3.9 x 20 mm) guard column and an inline filter were used.  During the run the in-line 
degasser was used.  Before injecting, the column was equilibrated in 75:25 
methanol:water.  After injection, the gradient was ramped linearly to 95:5 methanol:water 
over 30 min before returning to the initial conditions.  The mobile phase was held at the 
initial conditions for 10 min before doing the next injection.  The concentration of 
ammonium acetate in the mobile phase was varied.  The flow rate was held constant at 
1 mL/min, but the flow was split so only part of the eluent was directed into the MS.  
ESI-MS settings were as follows:  capillary 4.5 kV, sample cone 40 V, extraction cone 
5 V, RF lens 0.2 V, source temperature 100 
o
C, desolvation temperature 100 
o
C, 
desolvation gas flow 640 L/hr, and the cone gas flow 50 L/hr.  These values varied 
slightly every time maintenance was done on the MS.   
In order to optimize the concentration of ammonium acetate in the mobile phase, 
a series of injections were done with 200 pmol of each PFAM except the internal 
standard C17D33:0 where only 20 pmol was injected at the varying concentrations of 
ammonium acetate (2.5, 5, 7.5, 10, and 15 mM) in the mobile phase.  For these 
experiments, the flow was split so that 430 μL/min was directed into the MS.  
Figure 4-24 shows the resulting peak areas as the concentration of ammonium acetate 
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was changed for each PFAM.  This experiment concludes that 10 mM ammonium acetate 
should be added to the mobile phase to improve the ionization efficiency of the PFAM 
when using ESI.   
 
 
Figure 4- 24  Resulting peak areas from injecting 200 pmol of each PFAM (except C17D33:0 
which was 20 pmol) on the XTerra MS C18 (5 μm) column with varying concentrations of 
ammonium acetate in the mobile phase.   
 
After the signal had been optimized, the detection limit was determined using 
10 mM ammonium acetate in the mobile phase.  The gradient and the column were the 
same as above but this time only 80 μL/min was directed into the MS.  Because the 
results were going to be compared to results from other experiments, silanized glassware 
was used to prevent sample loss.  A series of injections were done, varying the amount of 
each PFAM loaded from 5 pmol to 30 pmol.  It was determined that the detection limit 
was approximately 10 pmol, approximately 2-3 orders of magnitude higher than for 
APCI-MS (data shown in section 4.4.6). 
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In order to determine whether the results were reproducible from run to run, 
several injections of a mixture of C16:0, C17:0, C18:0, C18:1
9
, C20:0, C22:0 and C22:1
13
 
(1 nmol each) and C17D33:0 (500 pmol).  Results are shown in Figure 4-25.  Depending 
on the PFAM, the error (relative standard deviation) in the response factor varied from 
3-7 % which was approximately the same error in the response factors when APCI-MS 
was used for detection.   
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Figure 4- 25 – Plot of the response factors from seven different PFAMs over the course of 23 
injections.  Each PFAM was added to the mixture so that 1 nmol of each was injected onto the 
column.  C17D33:0 was used as the internal standard.   
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4.5.5  Conclusions 
 
The major problem with working with packing material with a smaller particle 
size was that the back pressure increase limited the working range of the flow rate.  The 
lower flow rates increased the elution times, but did not increase the resolution.  The 
loading volume was also limited.  Unfortunately, the Waters 2695 was not capable of 
doing reproducible injections at 2-5 μL, so the separation on the C18 Acclaim column 
from Dionex was not fully explored.  All of the analysis done at the lower flow rate had 
to be done using ESI-MS as the detector because the APCI probe was not capable of 
handling the lower flow rates.  At the same time, the detection limits using ESI-MS as the 
detector were tested.  After optimizing the concentration of ammonium acetate in the 
mobile phase, it was determined that ESI would not be as sensitive as APCI-MS for 
detecting the PFAMs.   
 
 
4.6  LC/APCI-MS Quantitation 
 
Because of the amount of error in the calculations when the full mixture of the 
PFAMs was analyzed as a standard mixture or as a series of spikes, another gradient was 
developed for four of the saturated PFAMs and the internal standards.  The shorter 
gradient allowed for a three point calibration curve and the sample to be run in one day.  
Because the total analysis time was reduced, the instrumental variations during the 
analysis were also reduced.  The results reduced the relative standard deviation in peak 
areas from run to run using the same concentration.   
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4.6.1  Reagents 
 
Methanol was HPLC grade from either Thermo Fisher Scientific or J.T. Baker 
(Phillipsburgh, NJ).  Distilled water was deionized with a Barnstead (Dubuque, IA) 
Nanopure water system.  Both the methanol and the water were filtered with 0.22 μm 
Nylon membrane filters from Whatman International (Maidstone, England) prior to use 
on the HPLC.  The mobile phase for the HPLC analysis contained formic acid (99% 
pure) from Acros Organics (Morris Plains NJ) in both the methanol and water.  These 
solutions were made up fresh each day and sonicated in a 2210 Branson Ultrasonic 
cleaner (Danbury, CT) for 20 min to mix and degas.  Heptadecanoic-D33-Acid was from 
CDN Isotopes (Quebec, Canada).  Heptadecanoic acid and stearic acid were from 
Thermo Fisher Scientific.  Oleic acid, and behenic acid were from Sigma (St. Louis, MO) 
and arachidic acid was from Acros.  All the other fatty acids were from ICN Biomedicals 
Inc. (Aurora, OH).  The primary fatty acid amide (PFAM) standards [C16:0, C17:0, 
C17D33:0, C18:0, C20:0, C22:0, and C22:1
13
] were synthesized in house from their 
corresponding fatty acids with a greater than 95% purity as verified by GC/MS [28].   
Toluene (HPLC grade) and chlorotrimethylsilane (98%) (TMS) were from Acros 
Organics.   
 
 
4.6.2  Experimental Parameters 
 
The HPLC/MS system was a Waters 2695 separations module with a Waters 2487 
dual wavelength detector operated at 210 nm to monitor the gradient and a Waters ZMD 
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MS (Milford, MA) with an APCI probe in positive mode to monitor the separation.  Data 
was analyzed using Waters MassLynx 4.1 software.  Single ion mode was used to 
monitor the mass to charge ratios corresponding to the [M+H]
+
 peak for the PFAMs of 
interest.  Each channel monitored one mass to charge ratios corresponding to the [M+H]
+ 
signal for each PFAM in the mixture.  For the HPLC separation, a Waters XTerra MS C18 
(5 μm, 3.9 x 150 mm) column with a Waters XTerra MS C18 (5 μm, 3.9 x 20 mm) guard 
column and an inline filter were used.  The column was equilibrated in 80:20 
methanol:water with 0.3 % formic acid.  After injection, the gradient was ramped linearly 
to 100 % methanol with 0.3 % formic acid over 10 min.  The mobile phase was then 
returned to the initial conditions (5 min ramp) and flushed for 5 min before doing the next 
injection.  All separations were done at room temperature (about 28 
o
C) with both 
gradients.  APCI-MS settings were as follows:  corona 3 kV, sample cone 30 V, 
extraction cone 5 V, RF lens 0.1 V, source temperature 130 
o
C, APCI probe temperature 
450 
o
C, desolvation gas flow 450 L/hr, and the cone gas flow 50 L/hr.  These values 
varied slightly every time maintenance was done on the MS.   
 
 
4.6.3  Results and Discussion 
 
From previous experiments, it was known that there was less error in the response 
factors when a shorter gradient was used.  A gradient was then developed to separate only 
a few of the saturated PFAMs and the internal standards.  The shorter gradient separated 
C16:0, C17D33:0, C17:0, C18:0, C20:0, and C22:0 with a 20 min LC method.  The 
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mixture contained 1.2 nmol of each PFAM except C17D33:0 where only 320 pmol was 
added to the mixture.    
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Figure 4- 26 – Separation of four saturated PFAMs (1.2 nmol each) and the internal standards.   
 
A three point (2 nmol, 1.2 nmol, and 600 pmol) calibration curve was run.  Three 
injections were done of each solution and averaged together.  Three separate calibration 
curves were run on separate days.  When using C17D33:0 as an internal standard to 
calculate the response factors, the calibration curve had approximately 36 % error.  The 
error was calculated by calculating the concentration of several standard mixtures in 
which the concentration was known.  The calculated concentrations were then compared 
to the actual concentration values.  When the C17D33:0 signals were ignored and a basic 
linear calibration curve was used the error was reduced to approximately 1 %.  An 
example set of data is shown in Table 4-1.   
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 Basic Calibration Method Response Factor Method 
Concentration C16:0 C17:0 C18:0 C20:0 C22:1
13 
C16:0 C17:0 C18:0 C20:0 C22:1
13 
100 μM 101% 101% 101% 102% 99% 100% 93% 95% 86% 101% 
60 μM 97% 97% 97% 94% 104% 98% 89% 91% 75% 114% 
30 μM 103% 103% 103% 107% 96% 94% 85% 87% 70% 112% 
Average 100% 100% 100% 101% 99% 97% 89% 91% 77% 109% 
Table 4- 1  The percent recovery of the standard mix at three different concentrations.  Each of 
the values reported are the average of three injections.  Two methods of calculations were used:  
basic calibration method and the response factor method (see Appendix A).   
 
  
4.6.4  Conclusions 
 
The shorter gradient method reduced the instruments error.  The shorter gradient 
was 20 min long and the column was equilibrated with 80:20 methanol:water before 
injection.  After injection, the gradient was ramped linearly to 100 % methanol over 
10 min before returning to the initial conditions.  0.3 % formic acid was in both the 
methanol and the water.  The error in the basic linear calibration curve was reduced to 
approximately 1 %.   
 
 
4.7  Conclusions 
 
After exploring several different alternative PFAMs detection methods 
(MALDI-MS (Chapter 3), LC/ESI-MS, and LC/APCI-MS) it was determined that 
LC/APCI-MS was the best alternative to analyzing the PFAMs with GC/MS.  The 
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analysis time was slightly longer for the LC method (45 min) than the GC method 
(25 min plus cooling), but the detection limits were roughly the same when comparing 
the number of moles loaded onto the column (meaning that the concentration detection 
limits in the analyte solution were better by about an order of magnitude for 
LC/APCI-MS, given the larger injection volume of the LC).   
The advantage of using LC/MS over GC/MS was that derivatization was not 
needed, which can improve detection limits and reduce total analysis time.  A GC/MS 
method similar to the method developed by Sultana and Johnson [23] or Gee, Groen and 
Johnson [40, 41] was used as the standard (comparison) method when developing the 
LC/MS method. The main modification was to use chemical ionization and an ion trap 
MS rather than derivatization, electron ionization, and quadrupole MS, as this method 
was simpler and avoided derivatization.  Because of the complexity of the lipids found in 
a typical tissue sample, detailed analysis of a specific class requires some form of sample 
preparation prior to introduction to the final analytical instrument.  Sultana and Johnson 
showed that amides could be isolated from a Folch-Pi lipid extract by a two-stage solid 
phase extraction (SPE) method, provided some care is exercised in the choice of solvents 
[23].  Because C22:1
13
 and C18:1
9
 are commonly used as slip additives in plastic, 
considerable care had to be taken to minimize the blank contribution of these compounds.  
Experiments showing the analysis of PFAMs in bovine omentum are discussed in 
Chapter 6.  
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Chapter 5    
 
 
Separations of the “Polar” Neutral Lipid Classes 
 
 
5.1  Abstract 
 
The biological role of primary fatty acid amides (PFAMs), a class of neutral 
lipids, is not fully understood.  It is suspected that being able to monitor the concentration 
of PFAMs will allow for the diagnosis of ocular surface disease and affective disorders.  
A Folch-Pi extraction method removes the neutral lipids from the biological tissue 
sample.  In order to be able to detect and monitor the PFAMs in biological systems, 
further purification is necessary.  A solid phase extraction (SPE) method has been 
developed to isolate the PFAM fraction from the lipid extract, but the method is not 
automated and is sometimes irreproducible.  In this chapter, microchips platforms are 
used in attempts to scale down the SPE method, while normal phase liquid 
chromatography (NP-LC) columns are used to automate the separation.  The eluent from 
the NP-LC can be directed into the mass spectrometer with an electrospray source for 
monitoring.   
 
179 
5.2  Background 
 
Lipidomics is the science of fingerprinting the entire cellular lipidome in order to 
enable, among other things, studies of lipid metabolism and lipid-mediated signaling [1].  
In reality it is impossible, with current analysis techniques, to do a complete, 
comprehensive analysis of the total lipids found in a complex tissue.  One common 
approach is to focus on one or a few classes of lipids with similar polarities.  Once the 
lipids have been separated by class, further separations or simply direct infusion onto the 
MS [1, 2] are done to analyze the lipids within the class.   
Initial studies of the neutral lipid classes in this lab started with the development 
of a TLC analysis [3].  This analysis method included the following lipid classes as 
standards:  cholesterol esters (CE), triacylglycerols (TAG), free fatty acids (FFA), 
diacylglycerols (DAG), cholesterol (Ch), primary fatty acid amides (PFAMs), 
monoacylglycerols (MAG), N-acylglycines (NAG), and N-acyl ethanolamines (NAE).  
Polar lipids in the mixture did not move from the baseline.  The lipid classes were 
scraped off the thin layer chromatography (TLC) plate for further analysis [4].  In order 
to improve sample capacity, the solid phase extraction (SPE) method was developed [3].  
The SPE method to purify the PFAM fraction involved a silica based column and an 
amine based column.  There were some problems with reproducing this method.  The 
grade of solvent mattered and the volume of other neutral lipids present influenced the 
results.  The method protocol had to be further modified so that plastic consumables were 
not used, in order to reduce contamination.  Because of the number of different lipid 
classes, it is impossible to completely study all the lipids in a complex sample at one 
time.  For this study, only the “polar” neutral lipids were studied, with a focus on the 
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PFAMs, which are part of the fatty acyls group.  An extensive list of lipids can be found 
at www.lipidmaps.org.   
Class Name 
(abbreviation) 
Example 
Name (subclass) 
Fatty Acyls (FA) 
 
Oleic Acid (Free Fatty Acids - FFAs ) 
 
Lauramide (Primary Fatty Acid Amide - PFAM) 
 
Anandamide (N-acyl Ethanolamines - NAE) 
 
N-arachidonoyl glycine (N-acyl Amino Acids - NAAs) 
Glycerolipids (GL) 
 
1-monooyl-rac-glycerol (Monoacylglycerol - MAG) 
 
1,2-Dipalmitoyl-rac-glycerol (Diacylglycerol - DAG) 
 
 
Tristearin (Triacylglycerol – TAG) 
 
Table 5- 1  Example lipids for each subclass of interest grouping them by lipid class.  
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Due to problems with reproducibility and contamination, and lengthy analysis 
time with SPE, an automated method is preferred for the purification step of the PFAMs 
and other neutral lipid analysis.  Normal phase columns have been used to separate a few 
classes of lipids [5-10], but reverse phase columns have also been used [11, 12].  
Carpenter et al. showed that if three C18 analogs - NAG, FFA, and PFAM - are 
combined in the same separation, the NAG analog will elute first from a C8 column [11].  
A similar separation of the three C18 analogs was done by Merkler et al. [13].  In this 
case a Phenomenex Luna C8(2) column was used.  These reverse phase liquid 
chromatography (RP-LC) methods did not explore whether the lipid classes would 
overlap when more lipids were included in the separation, but our experience with RP 
separation of lipids (Chapter 4) leads us to believe that a single RP column does not have 
the resolving power or peak capacity to separate a large set of lipids across several 
classes.  Another reverse phase method has been developed by Perona and 
Ruiz-Gutierrez to separate the MAG, DAG, and TAG lipid classes [10].  The gradient 
varied between acetone and acetonitrile.  This gradient partially separates the different 
lipids within the class, but baseline separation was not achieved between the individual 
lipids – only the classes.   
A normal phase separation was used by Chapman et al. to purify the NAEs from 
the TAGs also found in the seed extracts [7].  In this method, the NAE fraction was 
collected, derivatized, and analyzed by GC/MS to identify each of the NAEs present in 
the sample.  Sommer et al. developed normal phase gradients to separate a variety of 
polar and nonpolar lipid classes [6].  One gradient used methyl t-butyl ether, methanol, 
2-propanol, ammonium acetate and water to separate several polar lipid classes (DAG, 
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FFA, MAG, cerebroside, glycerolphosphoethanolamine, glycerophosphoinositol, 
glycerophosphocholine, gangliosides, sphingomyelin and 
monoacylglycerophosphocholine).  Baseline separation was not achieved between each 
lipid class.  Another gradient was developed using methyl t-butyl ether, n-heptane, acetic 
acid, 2-propanol, ammonium acetate, and methanol to separate the nonpolar lipid classes 
(cholesteryl ester, fatty acid methyl ester, triacylglycerol, DAG, free cholesterol, and 
MAG).  In both cases, the eluent was split and directed into the ESI-MS in order to 
monitor the separation.  Another separation using a similar column was developed by 
Christie to separate a series of polar lipid classes [14].  The mobile phases were slightly 
different than other normal phase gradients reported; iso-hexane, methyl-tert-butyl ether, 
2-propanol, chloroform, acetic acid, water, and triethylamine were included in the solvent 
mixes.  This separation spanned phospholipids through sterol esters.   
 
 
5.3  Standards and Reagents 
 
The methanol, methyl t-butyl ether, and 2-propanol used for the LC/MS analysis 
were HPLC grade from J.T. Baker (Phillipsburgh, NJ).  The chloroform was Optima 
grade from Thermo Fisher Scientific (Pittsburgh, PA).  Toluene (HPLC grade) was from 
Acros Organics.  The n-heptane was from Alfa Aesar (Ward Hill, MA).  Distilled water 
was deionized with a Barnstead (Dubuque, IA) Nanopure water system.  The post column 
feed for MS detection was 10 mM ammonium acetate (Thermo Fisher Scientific) in 
60:40 methanol:2-propanol.  All of the mobile phases were filtered with 0.22 μm Nylon 
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membrane filters from Whatman International (Maidstone, England) and sonicated for 
20 min in a 2210 Branson Ultrasonic cleaner (Danbury, CT) prior to use.  The acetic acid 
was from Aldrich (St. Louis, MO).  The acetyl chloride was from Mallinckrodt (Paris, 
KY).  The sodium hydroxide and potassium carbonate was from Thermo Fisher 
Scientific.  Heptadecanoic-D33-acid was from CDN Isotopes (Quebec, Canada).  Lauric 
acid, myristic acid, heptadecanoic acid and stearic acid were from Thermo Fisher 
Scientific.  Oleic acid and behenic acid were from Sigma (St. Louis, MO) and arachidic 
acid was from Acros.  All the other fatty acids were from ICN Biomedicals Inc. (Aurora, 
OH).  The primary fatty acid amide (PFAM) standards [lauramide (C12:0), myristamide 
(C14:0), palmitamide (C16:0), heptadecanoamide (C17:0), heptadecano-D33-amide 
(C17D33:0), stearamide (C18:0), oleamide (C18:1
9
), arachidamide (C20:0), behenamide 
(C22:0), and erucamide (C22:1
13
)] were synthesized in house from their corresponding 
fatty acids with a greater than 95% purity as verified by GC/MS [4].  1-Monopalmitoyl-
rac-glycerol (MAG) and tristearin (TAG) were from Sigma (St. Louis, MO) 99 % purity 
and 1,2-dipalmitoyl-rac-glycerol (DAG) was from MP Biomedicals (Solon, Ohio).  The 
stearoyl ethanolamide (NAE) and N-oleoylglycine (NAG) were from the Cayman 
Chemical Company (Ann Arbor, MI).  The lipids were dissolved in 1:1 chloroform: 
methanol.  The spherical silica gel packing was from Sorbent Technologies (Atlanta, 
GA).  The epoxy was 5 min set from the local hardware store. 
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5.4  Oleamide Extraction on a Microchip 
5.4.1  Set up 
 
Two different attempts were made to scale down the SPE method to fit on a 
microchip.  One attempt focused on the recovery of C18:1
9
, while the other determined 
whether the column was long enough for the classes of lipids to be separated.  In both 
cases, the fractions were collected and analyzed by GC/MS.   
The set-up used for the C18:1
9
 recovery (Figure 5-1) was simpler than the set- ups 
used for the reaction experiments described in Chapter 2.  Two of the valves used for 
controlling the flow were removed leaving only the injection valve.  For this set up the 
syringe pump (Harvard Compact Infusion Pump model 975) was connected to an 
injection valve (Rheodyne 7725).  The valve contained a 2 μL sample loop for loading 
the lipid mixture.  A piece of fused silica capillary (75 μm i.d. x 36 cm, Polymicro 
Technologies L.C.C., Phoenix, AZ) was fitted to the inlet side of the microchip with 
PEEK fittings and a plastic holder.  A piece of capillary was also connected to the outlet 
side of the microchip and went into the collection vial.  The flow rate was set to 
20 μL/min, but the flow varied depending on the condition of the microchip column, 
because the syringe pump does not have a back pressure regulator.  The actual flow rate 
due to back pressure was estimated to be 1 μL/min.  Fused silica capillaries (75 μm i.d.) 
were used to connect each of parts, except PEEK tubing (0.005 ID) was used to connect 
the syringe (SGE glass 5 mL) to the valve.  It is important to use glass syringes instead of 
plastic syringes because there are amides on the surface of the plastic syringes from the 
manufacturing process.  These amides would have been extracted by the solvents needed 
for this extraction and would be detected when analyzing.  Also, the plastic syringes are 
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not compatible with chloroform used in the mobile phase.  By comparing eluant volumes, 
it was obvious that the flow rate varied throughout the extraction.   
 
Collection Vial
Valve with 
Injection 
Port
Waste
0.005 X 0.62 PEEK Tubing
2 μL sample loop
75 μm Si fused capillary
Microchip 
Holder
Syringe 
Pump
 
 
Figure 5- 1  Diagram of the oleamide extraction on a microchip set up. 
 
Before packing the microchip, the channel was conditioned by pumping about 
20 μL each of the following solutions through the microchip:  1 M sodium hydroxide, 
deionized water, and methanol.  The microchip was packed with Sorbent Technologies’ 
Spherical Silica Gel bulk packing (100 Å pore size, 20 μm diameter).  A slurry was made 
with the stationary phase and methanol and was loaded through the inlet side of the 
microchip.  The stationary phase was packed up against the weir by pulling a vacuum on 
the outlet side, then flushed with methanol and deionized water.  In order to hold the 
stationary phase in place in the straight microchip design, the microchips were baked 
overnight at 115 
o
C in a Pro-Set II Stabil Therm Electric Oven (Blue Island, IL).  The 
straight microchip design is shown in Figure 5-2.   
Methanol was pushed through by hand reverse flow in order to check that the 
silica packing was going to stay in place and wash out any debris away from the weir in 
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the straight chip design.  Then the microchip was put in the holder and flushed with 
hexane to prepare for the extraction.  It was estimated that the microchip holds no more 
than 0.2 μg of packing.   
  
 
Figure 5- 2  Diagram of the straight design microchip.  This microchip design was used for 
previous experiments.  This microchip was packed with Phenomenex’s Luna C18 bulk packing 
(100 Å pore size, 15 μm diameter) and baked overnight at 115 
o
C.  
 
 
5.4.2  Separation Conditions 
 
A few experiments have been done to show that C18:1
9
 can be retained on a 
microchip packed with silica and then selectively eluted off with a series of solvent 
washes containing different ratios of chloroform, methanol, acetic acid, and 2-propanol.  
From the estimated amount of packing on the microchip (0.2 μg) and the upper load limit 
on the solid phase extraction tubes [4], it was determined that 1 ng of C18:1
9
 should be 
loaded onto the microchip.  The other lipids were not used because it was assumed at the 
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time that the GC/MS cannot detect them without derivatization and the higher mass load 
for the microchip was below the detection limit on the HPTLC plates.   
For this experiment, the microchip column was flushed with chloroform for 
30 min, collecting the last 15 min as a blank.  Then 2 μL of 1 μg/μL C18:19 in chloroform 
was loaded onto the column while chloroform was flushed through the system for 
15 min.  A larger mass load was used to ensure detection by the GC/MS.  In order to 
elute the C18:1
9
 from the column, three elution steps were done for 15 min each:  95:5:1 
chloroform: methanol: acetic acid, 2:1 chloroform: methanol, and 100 % methanol.  The 
collection vial was changed at each step when the mobile phase was changed.  The 
fractions were reconstituted in 30 μL of internal standard, 0.25 ng/μL deuterated 
heptadecanoamide (C17D33:0), and dissolved in 2-propanol.   
 
 
5.4.3  GC/MS Conditions 
 
An Agilent Technologies Network GC/MS system (6890 GC with 5973 mass 
selective detector and 7683 series injector) was used for the analysis.  In the C18:1
9
 
recovery experiments, the following GC/MS conditions were used:  the column was an 
HP-5MS (0.25 mm internal diameter, 0.25 μm film thickness, 30 m long, Agilent 
Technologies).  The GC/MS method used for analysis was as follows:  starting 
temperature was 55 
o
C, ramped to 150 
o
C at 40 
o
C per min, held at 150 
o
C for 3.62 min, 
ramped to 300 
o
C at 10 
o
C per min and finally held at 300 
o
C for 2 min.  Electron impact 
ionization (EI) at 70 eV was used and mass range was kept from 40 to 400 m/z.  Four 
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ions:  59, 62, 72, and 76, were monitored in order to detect the internal standard and the 
C18:1
9
.  The temperatures of the injection port and the transfer line were 250 
o
C and 
280 
o
C respectively.  Injection volume was 1 μL splitless.  This method was developed 
by Sultana [4]. 
 
 
5.4.4  Results and Discussion 
 
Figure 5-3 shows the GC/MS chromatograms from the last four fractions.  Results 
from the C18:1
9
 recovery experiments showed some C18:1
9
 coming off during loading, 
so either the mass load was too great for the microchip column or the flow rate was too 
high.  Most of the C18:1
9
 came off during the 95:5:1 chloroform: methanol: acetic acid 
fraction, but small amounts came off in the following washes.  The final wash, 100% 
methanol, caused column bleed.  These experiments showed that a more sensitive method 
is needed for the analysis of the fractions, so that the mass load can be reduced.  
Derivatizing the lipids before analysis will lower the detection limits on the GC/MS [4].  
Also, switching to the T-chip design (next section) would increase the mass load because 
a portion of the packing would not be degraded in the baking process.  The column length 
on the T-chip design microchip was more controlled because the length was always the 
distance between the two weirs.  The column length on the straight design microchip 
depends on how much packing stays in the channel, when the packing was pulled tightly 
against the weir.   
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Figure 5- 3  (A)  Fraction collected from loading 2 μL of C18:1
9
 in chloroform.  (B)  Fraction 
collected from elution with 95:5:1 chloroform: methanol: acetic acid.  (C)  Fraction collected from 
elution with 2:1 chloroform: methanol.  (D)  Fraction collected from elution with methanol.  The 
arrows mark the elution times for C18:1
9
 and C17D33:0.   
 
 
5.5  Lipid Separation on a Microchip 
5.5.1  Set up 
 
Before packing the microchip used for the lipid extraction, it was conditioned by 
pumping about 20 μL each of the following solutions through the microchip:  1 M 
sodium hydroxide, deionized water, and methanol.  The slurry was made of the stationary 
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phase and methanol and was loaded through the side arm of the t-chip design.  The 
microchip was packed with Sorbent Technologies’ Spherical Silica Gel bulk packing 
(100 Å pore size, 20 μm diameter).  The stationary phase was packed up against the weirs 
by pulling a vacuum on the outlet sides, then flushed with methanol and deionized water.  
In order to hold the stationary phase in place in the T-chip design, epoxy was added to the 
side arm.  After the epoxy dried, the microchip was put in the holder and flushed with 
hexane to prepare for the extraction.  It was estimated that the microchip holds no more 
than 0.2 μg of packing.   
 
 
 
 
Figure 5- 4  Diagram of the T-chip design microchip.  This microchip design was used for SPE 
experiments.  This microchip was packed with Sorbent’s spherical silica gel (100 Å, 20 μm).   
 
The set-up used for the lipid extraction (Figure 5-5) was simpler than the set-ups 
used for the C18:1
9
 extractions.  All of the valves used for controlling the load were 
removed because of contamination problems.  For this set up, the syringe pump (Harvard 
Apparatus Pump II) was connected to the microchip with polethylene tubing (0.38 ID) 
fitted over the needle (25 G) and a piece of fused silica capillary (75 μm i.d.) that was 
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fitted to the inlet side of the microchip with PEEK fittings and a plastic holder.  A piece 
of capillary was also connected to the outlet side of the microchip and going into the 
collection vial.  A syringe pump was used to pump the solvents through the column.  It is 
important to use glass syringes instead of plastic syringes because there are amides on the 
surface of the plastic syringes from the manufacturing process.  These amides would have 
been extracted by the solvents needed for this extraction and would be detected when 
analyzing.  Also, the plastic syringes were not compatible with chloroform in the mobile 
phase.  Even though the syringe pump was set to 20 μL/min, the actual flow rate due to 
back pressure was estimated to be 1 μL/min.  After comparing eluent volumes, it was 
obvious that the flow rate varied throughout the extraction.   
 
 
 
 
Figure 5- 5  Diagram of the lipid extraction on a chip set up. 
 
5.5.2  Separation Conditions 
 
In order to be able to work with the other lipid classes, the samples were 
derivatized before running on the GC/MS.  The upper mass load for the microchip was 
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below the detection limit on the HPTLC plates.  For these experiments, a 0.1 mM mixture 
of both tristearin (TAG) and myristic acid (FFA) in methanol was used.   
The microchip column was flushed with hexane for 30 min, collecting the entire 
fraction as the blank.  Then 5 μL of the lipid mixture in methanol was loaded onto the 
column while hexane was flushed through the system for 10 min.  In order to elute the 
lipids from the column, three elution steps were done for 20 min each:  90:10 hexane: 
ethyl acetate, 80:20 hexane: ethyl acetate, and 100 % methanol.  The collection vial was 
changed at each step when the mobile phase was changed.  The fractions were dried 
down and stored in the freezer until transterification and analysis on the GC/MS.   
 
 
5.5.3  Transterification 
 
Before analysis on the GC/MS the lipids were derivatized.  The methods from 
Lepage [15] and Masood et al. [16] were adapted for small volumes by Mr. Timothy 
Fahrenholz (Duquesne University).  The fractions were dried down and then resuspended 
in 20 μL of toluene and 80 μL of 0.05 mg/mL butylate hydroxytoluene (BHT) in 
methanol in a 1.5 mL vial.  The solution was cooled on ice before 20 μL of cold acetyl 
chloride was dripped into the vial.  The vial was capped off (in this case two septa were 
used to ensure a good seal) to prevent evaporation.  The vial was heated at 100 
o
C for 
three hours, with mixing every 30 min.  During the reaction the vials were only placed a 
quarter of the way into the heating block slots to allow a reflux to occur.  After the 
solution cooled, 250 μL of 6 % potassium carbonate and 300 μL of toluene were added.  
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The solution was centrifuged at 2.0 x 1000 rpm for 2 min to separate.  The top layer was 
removed and saved for analysis, while 300 μL of toluene was added to the bottom layer.  
The bottom layer was centrifuged again, and the new top layer was added to the aliquot 
removed after the first centrifuge step.  The volume of the combined top layers was 
diluted to 1 mL with toluene for analysis.  This solution was stored in the refrigerator 
until the GC/MS analysis could be performed.   
 
 
5.5.4  GC/MS Conditions 
 
An Agilent Technologies Network GC/MS system (6890 GC with 5973 mass 
selective detector and 7683 series injector) was used for the analysis.  For the lipid 
separation experiment the following conditions were used for the analysis.  The column 
was a Phenomenex BPX 70 (0.25 mm internal diameter, 0.25 μm film thickness, 60 cm 
long, SGE).  The GC/MS method used for analysis was as follows:  starting temperature 
was 80 
o
C, after a 5 min hold ramped at 10 
o
C/min to 220 
o
C, and finally held at 220 
o
C 
for 5 min.  Injection volume was 1 μL spiltless.  The mass range was 20 to 800 m/z.  The 
temperature of the injection port was 200 
o
C. 
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5.5.5  Results and Discussion 
 
Figure 5-6 shows a good run from separating TAG and FFA.  Based on flow rate 
calculations, it was estimated that 600 pmol of each lipid was loaded onto the microchip.  
The signal in the blank fraction could be a combination of contamination and/or carry 
over from lipids left in the chip set up from the last experiment.  FFA showed promise of 
being retained on the microchip.  TAG was found in every fraction.  When looking the 
percent recoveries (see Table 5-2), all of them are low, putting the concentration of the 
methyl esters below the calibration curve done with standards on the GC/MS.  The 
percent recovery was tested by reacting an aliquot of sample that did not go through the 
microchip.  Fahrenholz (Duquesne University) was getting approximately 70 % recovery 
from the transterification process.  However, these results show that the percent recovery 
was less than 1 %.  Further experiments could not determine the source of error.     
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Figure 5- 6  600 pmol each of tristearin (TAG) and myristic acid (FFA) loaded onto the microchip 
and then eluted off in three fractions.  Each fraction was converted into corresponding methyl 
esters and then analyzed on the GC/MS.  Each bar is an average of three injections on the 
GC/MS.   
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 Tristearin Myristic Acid 
Blank Avg 0.13% 1.37% 
Load Avg 0.14% 0.89% 
90:10 Avg 0.23% 0.71% 
80:20 Avg 0.16% 1.80% 
MeOH Avg 0.14% 1.69% 
 
Unseparated Mix 0.19% 0.79% 
 
Table 5- 2  Percent recoveries based on loading 600 pmol of both tristearin (TAG) and myristic 
acid (FFA).  All values are an average of three injections on the GC/MS.  The un-separated mix 
was a separate trial and did not go through the microchip.   
 
 
5.6  Normal Phase Liquid Chromatography Purification Method 
5.6.1  Normal Phase LC (small column)/ESI MS 
 
A normal phase LC method was developed using gradient elution so that each 
lipid class would be in a different fraction.  Markers for each lipid class were monitored 
with ESI MS while the gradient was being optimized.  The first gradient developed used 
a 1 mm i.d. NP column.   
 
 
5.6.1.1  Experimental Conditions 
 
In order to automate the SPE extraction method, a normal phase liquid 
chromatography (NP-LC) method was followed by fraction collection.  The HPLC 
system was a Dionex (Bannockburn, IL) UltiMate 3000 LC pump with manual injection 
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(2 μL sample loop) and a Foxy Jr. fraction collector (Teledyne ISCO, Lincoln, NE).  For 
the separation, a YMC polyvinyl alcohol coated silica (PVA-Sil) (1.0 x 150 mm, 5 μm 
particles) column with an inline filter was used.  The solvents were sonicated for 20 min 
to degas and mix before use; during the run, the in-line degasser was used.  The mobile 
phase was a mixture of solvent A (0.5% methyl t-butyl ether in n-heptane) and solvent B 
(0.02 % acetic acid and 10 % 2-propanol in methyl t-butyl ether).  Before injecting, the 
column was equilibrated in 85 % solvent A and 15 % solvent B.  The initial conditions 
were held for 15 min before ramping to 45 % solvent A and 55 % solvent B over 5 min.  
The final conditions were held for 10 min to wash the column before returning to the 
initial conditions.  The column was flushed for 15 min at the initial conditions before the 
next injection.  The flow rate throughout the method was 100 μL/min.   
When monitoring the separation was required, the eluent was directed into a 
Waters ZMD MS (Milford, MA) with an electrospray (ESI) probe in positive mode.  In 
order to increase the ionization efficiency, a post column feed (10 mM ammonium 
acetate in 60:40 2-propanol:  methanol) was used at a flow rate of 50 μL/min.  Single ion 
mode was used to monitor the mass to charge ratios corresponding to the ion with the 
strongest signal for each lipid marker for each class and each lipid was monitored in a 
separate channel.  Channel 1 was set to 353 m/z for the monoacylglycerols (MAG) 
[M+Na]
+
 peak, channel 2 was set to 256 m/z for the primary fatty acid amides (PFAM – 
C16:0 was used as the standard) [M+H]
+
 peak, channel 3 was set to 592 m/z for the 
diacylglycerols (DAG) [M+Na]
+
 peak, and channel 4 was set to 350 m/z for the n-aceyl 
ethanolamine (NAE) [M+Na]
+ 
peak.  In order to set the MS parameters, a mixture of 5 μL 
of 2 mM DAG, 5 μL of 2 mM MAG, 100 μL of 1 mM PFAM, and 100 μL of 1 mM NAE 
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was dried down and then reconstituted in 500 μL of Solvent A and 250 μL of the post 
column feed.  The concentrations were different for each lipid class because the 
ionization efficiency of each class was different.  The mixture was infused into the MS at 
50 μL/min.  The parameters MS were set as follows:  the capillary was 3.50 kV, the cone 
voltage was 40 V, the extractor was 5 V, the RF lens was 0.10 V, the source block 
temperature was set to 110 
o
C, the desolvation temperature was set of 450 
o
C, the cone 
gas was 50 L/hr and the desolvation gas was 150 L/hr.  These parameters varied over 
time as maintenance was done on the instrument.   
When a complete analysis of the PFAM lipid class was required, the eluant was 
directed to the fraction collector.  Based on retention times of the lipid classes when the 
flow was directed into the MS, the eluant was collected from 15 min to 24 min as one 
fraction.  The sample was dried down and then reconstituted into 100 μL of 16 μM 
C17D33:0 in 2-propanol for further analysis with the RP-LC separation followed by 
atmospheric pressure chemical ionization (APCI-MS) for detection (Results shown in 
Chapter 6).   
 
 
5.6.1.2  Results and Discussion 
 
The development of the normal phase LC separation was based on the separation 
described by Sommer et al. [6].  In order to monitor the separation, the eluant was 
directed into the MS with an ESI source.  Data was collected from several different 
gradients separating the same lipid mixture; then the separation was optimized using the 
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DryLab Program version 2.05 from LC Resources Inc. (Walnut Creek, CA).  The 
optimized gradient is described in the experimental conditions section 5.6.1.1.  The 
resulting chromatogram is shown in Figure 5-7.  The test lipid mixture contained 
560 pmol of each PFAM, 200 pmol of MAG, 200 pmol of DAG and 5 nmol of NAE.  A 
higher concentration of the PFAM class was needed to keep the four lipid class’ signals 
on the same scale because of the differences in the ionization efficiency between the 
classes.  Switching to a larger column would increase the sample capacity and allow for 
more concentrated fractions (after drying down and reconstituting) to be loaded onto the 
reverse phase column. 
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Figure 5- 7  Optimized separation between four neutral lipid classes on the 1 x 150 mm normal 
phase column.  Each lipid class was monitored on a separate channel on the MS.  Channel 1 was 
set to 353 m/z for the MAG (1-monopalmitoyl-rac-glycerol) [M+Na]
+
 peak, channel 2 was set to 
270 m/z for the PFAM (C17:0) [M+H]
+
 peak, channel 3 was set to 592 m/z for the DAG (1,2-
dipalmitoyl-rac-glycerol) [M-Na]
+
 peak, and channel 4 was set to 350 m/z for the NAE (stearoyl 
ethanolamide) [M+Na]
+ 
peak.  The lipid mix injected contained 560 pmol of PFAM, 200 pmol of 
MAG, 200 pmol of DAG and 5 nmol of NAE. 
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The mass load tolerance of the column was estimated by running several dilutions 
of the lipid mix.  The peak areas from the chromatograms were plotted against the 
concentration of the lipids to determine the upper limit of the linear response range.  The 
mass load was approximately 8 nmol of PFAM and approximately 600 pmol each of 
MAG and DAG.  The mass load of each individual lipid class loaded onto the column 
was not examined, so the PFAM load might be affected by the amount of other classes of 
lipids present in the mixture.   
In order to make sure that all of the PFAMs expected in the omentum tissue
A
 
would co-elute on the normal phase column, a mixture of seven PFAMs:  C16:0, C17:0, 
C18:0, C18:1
9
, C20:0, C22:0 and C22:1
13
 (560 pmol each) was injected onto the normal 
phase column.  The separation conditions were the same as for the full lipid separation, 
except the MS method was changed to monitor the mass-to-charge ratio corresponding to 
the [M+H]
+
 signal for each of the PFAMs in the mixture.  The results are shown in 
Figure 5-8.  These results show that all the PFAMs roughly co-eluted and the small 
difference in the retention times were in the opposite order from the reverse phase 
separation (the longer chain PFAMs eluted first).   
 
                                               
A
 Unpublished manuscript – Kroniser, K.M. and M.E. Johnson, Liquid Chromatography 
Mass Spectrometry Analysis of Primary Fatty Acid Amides in Bovine Omentum. 
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Figure 5- 8  The normal phase LC separation of a mixture of seven different PFAMs to make 
sure there was no separation occurring within the class.  The experimental conditions were the 
same as the lipid separation except the m/z corresponding to the [M+H]
+
 signal for each PFAM 
were monitored.  The mixture contained 560 pmol of each PFAM. 
 
 
5.6.2  Normal Phase LC (big column)/APCI MS 
 
After developing the gradient on a 1 mm i.d. NP column, it was determined that a 
larger sample capacity would be needed for the 2D/LC analysis method.  The gradient 
from the 1 mm NP column was scaled for the 4.6 mm i.d. NP column.  Because of the 
higher flow rate going through the 4.6 mm i.d. column, the lipid markers were monitored 
with APCI-MS.   
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5.6.2.1  Experimental Conditions 
 
In order to increase the sample load capacity of the NP-LC method a larger 
column (YMC PVA-Sil 4.6 x 250 mm column (5 μm particles) with a guard column and 
an inline filter) was used.  The HPLC system was a Dionex UltiMate 3000 LC pump with 
manual injection (20 μL sample loop).  For the separation, the solvents were sonicated for 
20 min to degas and mix before use; during the run, the in-line degasser was used.  The 
mobile phase was a mixture of solvent A (0.5% methyl t-butyl ether in n-heptane) and 
solvent B (0.02 % acetic acid and 10 % 2-propanol in methyl t-butyl ether).  Before 
injecting, the column was equilibrated in 85 % solvent A and 15 % solvent B.  The initial 
conditions were held for 15 min before ramping to 45 % solvent A and 55 % solvent B 
over 5 min.  The final conditions were held for 10 min to wash the column before 
returning to the initial conditions.  The column was flushed for 5 min at the initial 
conditions before the next injection.  The flow rate throughout the method was 1 mL/min 
with the post column feed (10 mM ammonium acetate in 60:40 methanol:2-propanol) 
added at 0.5 mL/min after the column.   
Because of the higher flow rates being used in the LC separation, the eluant was 
monitored using the Waters ZMD MS with an APCI probe in positive mode.  Single ion 
mode was used to monitor the mass to charge ratios corresponding to the lipid marker for 
each class and each lipid was monitored in a separate channel.  Channel 1 was set to 
353 m/z for the monoacylglycerols (MAG) [M+Na]
+
 peak, channel 2 was set to 270 m/z 
for the primary fatty acid amides (PFAM) [M+H]
+
 peak, channel 3 was set to 592 m/z for 
the diacylglycerols (DAG) [M+Na]
+
 peak, and channel 4 was set to 350 m/z for the 
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n-aceyl ethanolamine (NAE) [M+Na]
+ 
peak.  In order to set the MS parameters, a mixture 
of 5 μL of 2 mM DAG, 5 μL of 2 mM MAG, 100 μL of 1 mM PFAM, and 100 μL of 
1 mM NAE was dried down the reconstituted in 500 μL of Solvent A and 250 μL of the 
post column feed.  The concentrations were different for each lipid class because the 
ionization efficiency of each class was different.  The mixture was infused into the MS at 
150 μL/min.  The parameters MS were set as follows:  the capillary was 3.00 kV, the 
cone voltage was 30 V, the extractor was 5 V, the RF lens was 0.10 V, the source block 
temperature was set to 130 
o
C, the desolvation temperature was set of 450 
o
C, the cone 
gas was 50 L/hr and the desolvation gas was 450 L/hr.  These parameters varied over 
time as maintenance was done on the instrument.   
 
 
5.6.2.2  Results and Discussion 
 
Initially, a mixture of lipids was infused into the MS to determine the best 
additive to increase the ionization.  Although formic acid works the best for improving 
the signal in the reverse phase separation of the PFAMs (Chapter 4), formic acid was not 
soluble in hexane.  The same solution used for the post column feed for the 1 mm column 
and ESI detection was used at a higher flow rate in order to be able to detect some of the 
neutral lipid classes.  The gradient is described in the experimental conditions 
section 5.6.2.1.  The resulting chromatogram is shown in Figure 5-9.  The test lipid 
mixture contained 15 nmol of PFAM, 30 nmol of MAG, 30 nmol of DAG and 15 nmol of 
NAE.  Only MAG and NAE were detected under these conditions.  After running these 
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experiments, it was determined that APCI would not work for monitoring the separation.  
The APCI probe allowed for directing the entire eluent into the MS, but the conditions 
could not be optimized to detect all the lipid classes in the mixture.  The lipid classes 
ionized better when methanol was used as the mobile phase as opposed to the n-heptane 
needed for this normal phase separation.   
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Figure 5- 9  The normal phase LC separation of a mixture of four different lipid classes.  Each 
lipid class was monitored on a separate channel on the MS.  Channel 1 was set to 353 m/z for 
the MAG (1-monopalmitoyl-rac-glycerol) [M+Na]
+
 peak, channel 2 was set to 270 m/z for the 
PFAM (C17:0) [M+H]
+
 peak, channel 3 was set to 592 m/z for the DAG (1,2-dipalmitoyl-rac-
glycerol) [M-Na]
+
 peak, and channel 4 was set to 350 m/z for the NAE (stearoyl ethanolamide) 
[M+Na]
+ 
peak.  The lipid mix injected contained 15 nmol of PFAM, 30 nmol of MAG, 30 nmol of 
DAG and 15 nmol of NAE, but only the MAG and NAE classes were detected. 
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5.6.3  Normal Phase LC (big column)/ESI MS 
 
After developing the gradient on a 1 mm i.d. NP column, it was determined that a 
larger sample capacity would be needed for the 2D/LC analysis method.  Because of poor 
sensitivity when monitoring the lipid markers with APCI-MS, the eluent was split and the 
lipid markers were monitored with ESI-MS.  The gradient was then optimized on the 
4.6 mm i.d. NP column.   
 
 
5.6.3.1  Experimental Conditions 
 
In order to increase the mass load for the separation, a larger column (YMC 
PVA-Sil 4.6 x 250 mm column with 5 μm particles) was used for the NP-LC method.  
Before the column there was an inline filter followed by a YMC PVA-Sil 4.0 x 20 mm 
guard column.  The HPLC system was a Dionex UltiMate 3000 LC pump with manual 
injection (20 μL or 200 μL sample loop) and a Foxy Jr. fraction collector.  The solvents 
were sonicated for 20 min to degas and mix before use; during the run, the in-line 
degasser was used.  The mobile phase was a mixture of solvent A (0.5% methyl t-butyl 
ether in n-heptane) and solvent B (0.02 % acetic acid and 10 % 2-propanol in methyl 
t-butyl ether).  When using gradient #1, the column was equilibrated before injection in 
60 % solvent A and 40 % solvent B.  After the injection, the gradient was ramped to 
50 % solvent A and 50 % solvent B over 20 min and held for 5 min before returning to 
the initial conditions.  The column was flushed for 5 min at the initial conditions before 
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the next injection.  When using gradient #2, the column was equilibrated before injection 
in 95 % solvent A and 5 % solvent B.  After the injection, the gradient was ramped to 
50 % solvent A and 50 % solvent B over 40 min before returning to the initial conditions.  
The column was flushed for 15 min at the initial conditions before the next injection.  
The flow rate throughout both gradients was 1 mL/min and the separations were done at 
room temperature.   
When monitoring the separation was required, the eluent was directed into a 
Waters ZMD MS with an ESI probe switching between positive mode and negative 
mode.  The eluent was split after the column so that the flow rate into the MS was 
approximately 200 μL/min.  In order to increase the ionization efficiency, a post column 
feed (10 mM ammonium acetate in 60:40 methanol:2-propanol) was added to the split 
portion of the eluent at a flow rate of 150 μL/min.  Single ion mode was used to monitor 
the mass to charge ratios corresponding to the lipid marker for each class and each lipid 
was monitored in a separate channel.  Channel 1 was set to 353 m/z for the 
monoacylglycerol (MAG) [M+Na]
+
 peak, channel 2 was set to 270 m/z for the primary 
fatty acid amide (PFAM) [M+H]
+
 peak, channel 3 was set to 592 m/z for the 
diacylglycerol (DAG) [M+Na]
+
 peak, channel 4 was set to 350 m/z for the n-aceyl 
ethanolamine (NAE) [M+Na]
+ 
peak, channel 5 was set to 281 m/z for the fatty acid 
(FFA) [M-H]
-
 peak, channel 6 was set to 338 m/z for the n-aceyl glycine (NAG) [M-H]
-
 
peak, and channel 7 was set to 914 m/z for the triacylglycerol (TAG) [M+Na]
+ 
peak.  In 
order to set the MS parameters, a mixture of 600 μL of 2 mM TAG, 150 μL of 2 mM 
NAG, 75 μL of 0.1 mM FFA, 75 μL of 2 mM DAG, 150 μL of 2 mM MAG, 150 μL of 
1 mM PFAM, and 150 μL of 1 mM NAE was dried down the reconstituted in 1 mL of 
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Solvent A and 500 μL of the post column feed.  The concentrations were different for 
each lipid class because the ionization efficiency of each class was different.  The 
mixture was infused into the MS at 50 μL/min.  Two set of parameters were used:  one 
for positive mode and one for negative mode detection.  For positive mode detection, the 
capillary was 4.00 kV, the cone voltage was 70 V, the extractor was 5 V, and the RF lens 
was 0.10 V.  For negative mode detection, the capillary was 4.00 kV, the cone voltage 
was 45 V, the extractor was 1 V, and the RF lens was 0.10 V.  The following parameters 
were the same for both modes of detection:  the source block temperature was set to 
110 
o
C, the desolvation temperature was set of 450 
o
C, the cone gas was 50 L/hr and the 
desolvation gas was 200 L/hr.  These parameters varied over time as maintenance was 
done on the instrument. 
When analysis of the PFAM lipid class was required, the entire eluent was 
directed to the fraction collector.  Based on retention times of the lipid classes when the 
flow was directed into the MS, the eluent from 31 min to 35 min was collected as one 
fraction.  Periodically the separation had to be monitored in order to adjust for any 
variation in retention times.  The time the fraction was collected was then adjusted 
accordingly.  The fraction was dried down and then reconstituted into 100 μL of 16 μM 
C17D33:0 in 2-propanol for further analysis with the RP-LC/APCI-MS (Results shown 
in Chapter 6).   
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5.6.3.2  Results and Discussion 
 
The development of the 4.6 mm i.d. NP-LC separation was based on the 
optimized gradient from the 1 x 150 mm normal phase column.  In order to monitor the 
separation, the eluent was split before being mixed with the post column feed and then 
directed into the MS with an ESI probe.  Data was collected from several different 
gradients separating the same lipid mixture; then the separation was optimized using the 
DryLab Program.  The optimized gradient is described in the experimental conditions 
section 5.6.3.1 as gradient #1.  The resulting chromatogram shown in Figure 5-10 used 
gradient #1 and only monitored for the lipid classes detected in positive mode.  This lipid 
mixture contained 15 nmol of each PFAM, 30 nmol of MAG, 30 nmol of DAG, and 
15 nmol of NAE.  Using this gradient, the four lipid classes in the mix separated and 
eluted in less than 15 min.  When the NAG and FA lipid markers were added to the mix 
they co-eluted with the MAG and DAG lipid markers respectively.  It was suspected that 
the DAG standard was actually a mixture of isomers.   
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Figure 5- 10  Optimized separation between four neutral lipid classes on the 4.6 x 250 mm 
normal phase column using gradient #1.  Each lipid class was monitored on a separate channel 
on the MS.  The lipid mix contained 15 nmol of PFAM, 30 nmol of MAG, 30 nmol of DAG, and 
15 nmol of NAE.  A 20 μL sample loop was used.   
 
The separation had to be further optimized to be able to separate all the lipid 
classes.  The optimized gradient is described in the experimental conditions 
section 5.6.3.1 as gradient #2.  This gradient was able to separate seven different lipid 
class markers:  TAG, FA, DAG, NAG, MAG, PFAM, and NAE.  For this separation, 
(Figure 5-11) the lipid mixture contained:  120 nmol TAG, 750 nmol of FA, 15 nmol of 
DAG, 30 nmol of NAG, 30 nmol of MAG,  15 nmol of PFAM, and 15 nmol of NAE.   
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Figure 5- 11  Optimized separation between seven neutral lipid classes on the 4.6 x 250 mm 
normal phase column using gradient #2.  Each lipid class was monitored on a separate channel 
on the MS.  The lipid mix contained 120 nmol TAG, 750 nmol of FA, 15 nmol of DAG, 30 nmol of 
NAG, 30 nmol of MAG, 15 nmol of PFAM, and 15 nmol of NAE.  A 20 μL sample loop was used.   
 
After the separation was optimized, the injection volume was varied while the 
mass load was held constant in order to determine whether the injection solvent 
(80:20 heptane:2-propanol) had any affect on the separation.  Figure 5-12 shows the 
results from a 200 μL injection of the same lipid mixture.  When the injection volume 
was increased, the DAG lipid marker eluted earlier and the peaks for the MAG, NAG, 
PFAM, and NAE lipid markers broadened.  If separation is needed between the FA and 
DAG lipid classes, the injection volume has to be less than 50 μL.   
 
210 
60x10
6
50
40
30
20
10
0
in
te
n
s
it
y
50403020100
time (min)
T
A
G
F
A
D
A
G
M
A
G
N
A
G P
F
A
M
N
A
E
 
Figure 5- 12  Separation between seven neutral lipid classes on the 4.6 x 250 mm normal phase 
column using gradient #2.  Each lipid class was monitored on a separate channel on the MS.  
The lipid mix contained 120 nmol TAG, 750 nmol of FA, 15 nmol of DAG, 30 nmol of NAG, 
30 nmol of MAG, 15 nmol of PFAM, and 15 nmol of NAE.  A 200 μL sample loop was used.   
 
The reproducibility of the separation was tested, by injecting the same mass load 
five times at three different injection volumes (20, 100 and 200 μL).  The variation in 
response times for the PFAM (C17:0) was less than 1.5 %.  Because of the change in 
peak shape, the injection volume had to be same when comparing results.  The larger 
injection volume (200 μL) was chosen so that the mass load could maximize for the 
2D/LC experiments (Chapter 6).   
In order to make sure that all of the PFAMs expected in the omentum tissue 
A
 
would co-elute on the 4.6 mm i.d. NP column using gradient #1, a mixture of eight 
                                               
A
 Unpublished manuscript – Kroniser, K.M. and M.E. Johnson, Liquid Chromatography 
Mass Spectrometry Analysis of Primary Fatty Acid Amides in Bovine Omentum. 
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PFAMs:  C16:0, C17:0, C17D33:0, C18:0, C18:1
9
, C20:0, C22:0 and C22:1
13
 (15 nmol 
each) was injected (20 μL injection) onto the 4.6 mm i.d. NP column.  The detection 
conditions were the same as for the lipid separation, except the MS method was changed 
to monitor the mass-to-charge ratio corresponding to each of the PFAMs in the mixture.  
The resulting chromatogram from using gradient #1 is shown in Figure 5-13.  These 
results show that all the PFAMs co-eluted in a 2.5 min window (the longer chain PFAMs 
eluted first).  The separation was more defined using the 4.6 mm i.d. column versus the 
1 mm i.d. column.   
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Figure 5- 13  The normal phase LC separation using gradient #1 of a mixture of eight different 
PFAMs to make sure there was no separation occurring within the class.  The experimental 
conditions were the same as the lipid separation except the m/z corresponding to the [M+H]
+
 
signal for each PFAM were monitored.  The mixture contained 15 nmol of each PFAM in a 20 μL 
injection volume. 
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In order to make sure that all of the PFAMs expected in the omentum tissue
A
 
would co-elute on the 4.6 mm i.d. NP column using gradient #2, a mixture of eight 
PFAMs:  C16:0, C17:0, C17D33:0, C18:0, C18:1
9
, C20:0, C22:0 and C22:1
13
 (50 nmol 
each) was injected (200 μL injection) onto the 4.6 mm normal phase column.  The 
detection conditions were the same as for the lipid separation, except the MS method was 
changed to monitor the mass-to-charge ratio corresponding to each of the PFAMs in the 
mixture.  The resulting chromatogram from using gradient #2 is shown in Figure 5-14.  
These results show that all the PFAMs co-eluted in a 7 min window (the longer chain 
PFAMs eluted first).  Using the second gradient and the larger injection volume the peaks 
were broader, with less resolution between peaks.   
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Figure 5- 14 The normal phase LC separation using Gradient #2 of a mixture of eight different 
PFAMs to make sure there was no separation occurring within the class.  The experimental 
conditions were the same as the lipid separation except the m/z corresponding to the [M+H]
+
 
signal for each PFAM were monitored.  The mixture injected contained 50 nmol of each PFAM in 
a 200 μL injection volume. 
                                               
A
 Unpublished manuscript – Kroniser, K.M. and M.E. Johnson, Liquid Chromatography 
Mass Spectrometry Analysis of Primary Fatty Acid Amides in Bovine Omentum. 
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5.7  Conclusions 
 
The initial attempts to scale down SPE purification method were done with 
columns on a glass microchip.  The experiments showed some promise that the method 
would work, but reproducibility was an issue.  Optimizing the method on the microchip 
was problematic because of the packing degrading and clogs so the same column could 
not be used throughout the entire experiment.  After several different attempts, it was 
determined that the current microchip design did not contain enough stationary phase 
particles to be able to effectively retain and then selectively elute off the lipid classes.  
Redesigning the microchip to include a longer column and less dead volume zones would 
increase the reproducibility of these methods.  Secondly, replacing the syringe pump with 
a pump with back pressure correction would keep the flow constant from one extraction 
to the next.   
Replacing the SPE purification method with a NP gradient followed by fraction 
collection improves the reproducibility of the method.  Because the gradient can be 
monitored when problems occur, this eliminates time spent on problem solving due to 
day-to-day variation in retention time.  The NP separation can be monitored using 
ESI-MS, unlike the SPE method where only fractions can be analyzed.  If complete 
recovery of the sample is not required, the separation could be monitored in real time 
while collecting fractions.  Secondly, the same column was used for each extraction, 
rather than the two freshly hand packed columns needed to complete the SPE method.  
One of the limitations of the NP method is that because the separation has been analyzed 
using ESI-MS, the elution pattern was only known for the lipid classes that ionize.  
Further, the method was only set up to monitor for one example in each lipid class with 
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the exception of the PFAMs; therefore, the band width of the entire class was unknown.  
By following the trends of chromatography, the PFAM fraction was assumed to only 
have PFAMs.  Each separation by itself it shorter using the NP column as opposed to the 
SPE method.  However, multiple SPE tubes can be run at the same time, so if more than 
four separations were done, the SPE method was shorter.  
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Chapter 6  
 
 
Two Dimensional Liquid Chromatography Separations 
and Mass Spectrometry Analysis of Primary Fatty Acid 
Amides  
 
 
6.1  Abstract 
 
In order to be able to study the biological role of primary fatty acid amides 
(PFAMs), a class of neutral lipids, an off-line two-dimensional liquid chromatography 
method was developed.  It is suspected that being able to monitor the concentration of 
PFAMs will allow for the diagnosis certain diseases and disorders.  In order to be able to 
detect and monitor the PFAMs in biological systems, several different analytical methods 
need to be combined in order to be able to completely analyze the complex raw tissue 
extract for a specific class of lipids.  For this method, the Folch-Pi extraction method was 
used to remove the neutral lipids from the omentum tissue.  Two normal phase liquid 
chromatography methods were developed to separate the neutral lipids by class.  This 
part of the method could be monitored with electrospray mass spectrometry or the PFAM 
fraction could be collected for further separation.  The purified PFAM fraction was 
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separated by chain length and degree of saturation using reverse phase liquid 
chromatography.  The final analysis was done with atmospheric pressure chemical 
ionization mass spectrometry.  Results include separations done with a standard mix and 
separations done with PFAMs spiked into bovine omentum tissue samples. 
 
 
6.2  Introduction  
 
The number of research articles published on the pharmacology and discovery of 
PFAMs increased substantially following discovery of oleamide and other amides in the  
cerebrospinal fluid of sleep deprived cats [1].  GC/MS studies of human plasma in luteal 
phase women found five PFAMs [2]. Hamberger and Stenhagen detected erucamide in 
body organs from pig (lung, kidney, liver, and brain) and rat (lung, liver, spleen, brain, 
and intestine) [3].  More recently, oleamide, myristamide (C14:0), palmitamide (C16:0), 
stearamide (C18:0), and erucamide (C22:1
13
) were found in human meibomian gland 
secretions [4].  In this work bovine omentum has been chosen as the model tissue for 
testing the analysis method.  Omentum has been used to increase blood flow to the brain 
in Alzheimer patients [5]  and treat progressive ischemia [6].  Wakamatsu et al. extracted 
erucamide from bovine mesentery and showed that several different long chain amides 
can induce angiogenesis [7].  Another study has found gangliosides in omentum tissue 
[8].  Preliminary experiments in this laboratory have shown that a few PFAMs were 
present in omentum.  Furthermore, the work by Wakamatsu et al. has not been repeated, 
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and a more definitive measure of PFAMs present in omentum, particularly erucamide, is 
needed. 
GC/MS methods have been developed to analyze oleamide in biological samples 
[9, 10] and plastic materials [11, 12].  These methods only examined the samples for a 
few specific PFAMs for qualitative analysis.  Hanus et al. reported finding 156 pmol of 
C18:1
9
 per milliliter of cerebrospinal fluid and 35 pmol of C18:1
9
 per milliliter of plasma 
from male Sprague-Dawley rats [10].  Arafat et al. reported finding 15 nmol/mL C16:0, 
17 nmol/mL C16:1
9
, 113 nmol/mL C18:1
9
, 13 nmol/mL C18:1
trans 9
, and 8 nmol/mL 
C18:2
9,12
 in human plasma [2].  HPLC with UV detection or HPLC with refractive index 
(RI) detection can be done, but the amides being analyzed need to be fully separated by 
chromatography to be positively identified [13, 14].  The detection limits are about 
100 μM for UV detection  [14] and about 3 mM for RI [13], and so are inadequate for 
typical amide concentrations in biological tissue or fluid. 
 
 
6.3  Standards and Reagents 
 
All solvents used for SPE were HPLC grade solvents (except chloroform which 
was Optima grade) from Thermo Fisher Scientific (Pittsburgh, PA).  All the SPE solvents 
except the chloroform needed to be distilled before using to remove impurities.  The 
methanol, methyl t-butyl ether, and 2-propanol used for the LC/MS analysis were HPLC 
grade from J.T. Baker (Phillipsburgh, NJ).  Distilled water was deionized with a 
Barnstead (Dubuque, IA) Nanopure water system.  All mobile phase solvents were 
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filtered with 0.22 μm Nylon membrane filters from Whatman International (Maidstone, 
England) prior to use.  The mobile phase for the reverse phase HPLC analysis contained 
0.3 % formic acid (99% pure) from Acros Organics (Morris Plains NJ) in both the 
methanol and water.  The post column feed for the ESI-MS detection method was 10 mM 
ammonium acetate (Thermo Fisher Scientific) in 60:40 2-propanol: methanol.  These 
solutions were sonicated for 20 min to mix and degas.  Heptadecanoic-D33-acid was 
from CDN Isotopes (Quebec, Canada).  Heptadecanoic acid and stearic acid were from 
Thermo Fisher Scientific.  Oleic acid and behenic acid were from Sigma (St. Louis, MO) 
and arachidic acid was from Acros.  All the other fatty acids were from ICN Biomedicals 
Inc. (Aurora, OH).  The primary fatty acid amide (PFAM) standards [palmitamide 
(C16:0), heptadecanoamide (C17:0), heptadecano-D33-amide (C17D33:0), stearamide 
(C18:0), oleamide (C18:1
9
), arachidamide (C20:0), behenamide (C22:0), and erucamide 
(C22:1
13
)] were synthesized in house from their corresponding fatty acids with a greater 
than 95% purity as verified by GC/MS [15].   Stock solutions for the PFAMs were 1 mM 
in 1:1 chloroform: methanol.  The small amount of chloroform in the injection sample did 
not affect the retention time or peak shape.  1-Monopalmitoyl-rac-glycerol (MAG) was 
from Sigma 99 % purity and 1,2-dipalmitoyl-rac-glycerol (DAG) was from MP 
Biomedicals (Solon, Ohio).  The bovine omentum sample came from a local abattoir and 
was stored at -20 
o
C until analysis.  Toluene (HPLC grade) and chlorotrimethylsilane 
(98%) (TMS) were from Acros Organics.  The SPE packing materials – Discovery-Si and 
Discovery-NH2 - were from Supelco (Bellefonte, PA).  The argon and nitrogen gases 
were from Airgas (Radnor, PA).  The desiccant (magnesium sulfate anhydrous) was 
technical grade from Aldrich.   
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6.4  Sample Preparation 
6.4.1  Silanization Method 
 
Glass vials used for fraction collection were silanized before use, because the 
analysis was done at low concentrations and lipids tend to stick to glass.  Clean vials 
were soaked in 1 M NaOH for 30 min before rinsing with ultrapure water and drying 
completely.  The vials were flushed with argon to remove any moist air before filling 
with 10 % TMS in toluene.  The vials were capped after flushing the head space with 
argon and allowed to sit overnight, then rinsed with toluene.  Prior to using, the vials 
were rinsed with methanol and dried completely.  The vials were silanized before each 
use.  Plastic vials, centrifuge tubes, and SPE tubes cannot be used because the slip 
additives added to the plastic are often C18:0, C18:1
9
, and C22:1
13
 [11, 12, 16, 17].   
 
 
6.4.2  Lipid Extraction Method 
 
The lipids were extracted using a sample preparation method previously 
developed in this laboratory for extracting lipids from N18TG2 cells, then modified for 
tissue samples  [15, 18].    The solvents used in this method were distilled first because 
they contained impurities with the same mass-to-charge ratio as the PFAMs in the 
LC/MS analysis.  Blanks were run to check for any additional contamination.  In order to 
improve reproducibility between samples, several grams of bovine omentum tissue was 
blended together.  Portions (0.5 – 1 g depending on the experiment) were homogenized in 
a volume of 2:1 chloroform: methanol 20 times the weight of the tissue sample.  After 
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adding C17:0  (IS1) as an internal standard, the sample was transferred to a silanized 
50 mL glass centrifuge tube.  Methanol (
1
/5 of the total volume) was used to rinse the 
homogenizer and then added to the sample.  The sample was centrifuged with an Avanti 
J-20 XP Centrifuge from Beckman Coulter and a JS 5.3 rotor (30 min at 1500 g) and the 
liquid was decanted into a clean centrifuge tube.  Additional chloroform was added to the 
sample to make the solvent ratio 2:1 chloroform: methanol.  A volume of 0.88 % aqueous 
KCl equal to 
1
/5 the total volume of the sample was added.  The sample was agitated 
before freezing the sample in order to separate the sample into two phases.  The bottom 
phase was dried down after the top phase had been removed and completely dried down 
by blowing nitrogen over the sample and then pulling a vacuum.  The sample was 
reconstituted in 1 mL of 80:20 n-heptane: 2-propanol.  Sonication was needed to 
completely dissolve the sample.   
 
 
6.5  Solid Phase Extraction Method 
 
The extraction was followed by SPE to separate out the PFAM fraction using the 
method previously described [18].  After washing the column (3 mL silanized glass SPE 
tube containing 0.5 g of unbonded silica (Discovery-Si from Supelco) in-between two 
frits), a series of solvents was passed through the column, where the sixth fraction was 
saved and dried down.  In order to further separate the PFAMs from the other neutral 
lipids (monoacylglycerols, N-acylglycines, and N-acylethanolamines) in the fraction, the 
sample was loaded onto a second column (3 mL silanized glass SPE tube containing 0.5 g 
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of amino bonded phase (Discovery-NH2 from Supleco) packing in-between two frits).  
Again a series of solvents were passed through the column and the third fraction was 
saved and dried down.   
The analysis was done by GC/MS, LC/MS, or both.  The PFAM fraction was 
reconstituted into 150 μL of 16 μM C17D33:0 (instrumental internal standard, IS2) in 
2-propanol for further analysis.  The LC/MS method development was described in 
Chapter 4.  Detection limits for all the PFAMs (C16:0 – C22:0) were in the tens of 
femtomoles making the detection limit for the LC/MS analysis method one to two orders 
of magnitude lower than the detection limit for the GC/MS analysis method when 
comparing the amount of moles loaded onto the column.  The GC/EI-MS method was 
developed by Sultana and Johnson [18] and the GC/CI-MS method was developed by 
Dent (Duquesne University).  With the GC/EI-MS method, smaller chain amides (12 to 
14 carbons) had a detection limit of 30 pg (about 150 fmol), larger chain amides (16 to 22 
carbons) had a detection limit of 10 pg (about 40 fmol), and oleamide (C18:1
9
) had a 
detection limit of 5 pg (about 20 fmol).  Other lipids in the standard lipid mixture could 
be detected when each fraction from the SPE was loaded onto a HPTLC plate [15].  It 
was determined that 0.5 μg of oleamide and 20 μg of the other lipids can be separated 
using 500 mg of silica packing in the SPE purification method.   
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6.6  Separation Conditions 
6.6.1  Normal Phase LC/ESI MS Conditions 
 
In order to automate the SPE extraction method, a normal phase liquid 
chromatography (NP-LC) method was followed by fraction collection.  The HPLC 
system was a Dionex (Bannockburn, IL) UltiMate 3000 LC pump with manual injection 
(2 or 200 μL sample loop) and a Foxy Jr. fraction collector (Teledyne ISCO, Lincoln, 
NE).  The solvents were sonicated for 20 min to degas and mix before use; during the 
run, the in-line degasser was used.  The mobile phase was a mixture of solvent A (0.5% 
methyl t-butyl ether in n-heptane) and solvent B (0.02 % acetic acid and 10 % 2-propanol 
in methyl t-butyl ether).   
For the small scale normal phase purification method, a YMC PVA-Sil (1.0 x 
150 mm) column with an inline filter was used.  Before injecting 2 μL of the lipid extract, 
the column was equilibrated in 85 % solvent A and 15 % solvent B.  The initial 
conditions were held for 15 min before ramping to 45 % solvent A and 55 % solvent B 
over 5 min.  The final conditions were held for 10 min to wash the column before 
returning to the initial conditions.  The column was flushed for 15 min at the initial 
conditions before the next injection.  The flow rate throughout the method was 
100 μL/min.   
When monitoring the 1 mm i.d. NP separation, the eluent was directed into a 
Waters ZMD MS (Milford, MA) with an ESI probe in positive mode.  In order to 
increase the ionization efficiency, a post column feed (10 mM ammonium acetate in 
60:40 2-propanol:  methanol) was used at a flow rate of 50 μL/min for the 1 mm column.  
Single ion mode was used to monitor the mass to charge ratios corresponding to the lipid 
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marker for each class and each lipid was monitored in a separate channel.  Channel 1 was 
set to 353 m/z for the monoacylglycerols (MAG) [M+Na]
+
 peak, channel 2 was set to 270 
m/z for the primary fatty acid amides (PFAM) [M+H]
+
 peak, and channel 3 was set to 
592 m/z for the diacylglycerols (DAG) [M+Na]
+
 peak.  When analysis of the PFAM lipid 
class was required, the eluent was directed to the fraction collector.  Based on retention 
times of the lipid classes when the flow was directed into the MS, the eluent from 15 min 
to 24 min was collected as one fraction.  This fraction was dried down and then 
reconstituted into 100 μL of 16 μM C17D33:0 in 2-propanol for further analysis with the 
RP-LC/APCI-MS method.   
For the larger scale normal phase purification method, a YMC PVA-Sil (4.6 x 
250 mm) column was used for the separation of the lipid classes.  A 200 μL sample loop 
was used to load the lipid extract.  Before injecting, the column was equilibrated in 95 % 
solvent A and 5 % solvent B.  After the injection, the gradient was ramped to 50 % 
solvent A and 50 % solvent B over 40 min before returning to the initial conditions.  The 
column was flushed for 15 min at the initial conditions before the next injection.  The 
flow rate throughout the method was 1 mL/min and the entire separation was done at 
room temperature.   
When monitoring the 4.6 mm i.d. NP separation, the eluent was directed into the 
MS with an ESI probe in positive mode.  The eluant was split after the column so that the 
flow rate into the MS was approximately 200 μL/min.  In order to increase the ionization 
efficiency, a post column feed (10 mM ammonium acetate in 60:40 methanol:2-propanol) 
was added to the split portion of the eluent at a flow rate of 150 μL/min.  Single ion mode 
was used to monitor the mass to charge ratios corresponding to the lipid marker for each 
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class and each lipid was monitored in a separate channel.  Channel 1 was set to 353 m/z 
for the monoacylglycerol (MAG) [M+Na]
+
 peak, channel 2 was set to 270 m/z for the 
primary fatty acid amide (PFAM) [M+H]
+
 peak, channel 3 was set to 592 m/z for the 
diacylglycerol (DAG) [M+Na]
+
 peak, channel 4 was set to 350 m/z for the n-aceyl 
ethanolamine (NAE) [M+Na]
+ 
peak, channel 5 was set to 281 m/z for the fatty acid 
(FFA) [M-H]
-
 peak, channel 6 was set to 338 m/z for the n-aceyl glycine (NAG) [M-H]
-
 
peak, and channel 7 was set to 914 m/z for the triacylglycerol (TAG) [M+Na]
+
 peak.  
When analysis of the PFAM lipid class was required, the entire eluent was directed to the 
fraction collector.  Based on retention times of the lipid classes when the flow was 
directed into the MS, the eluent from the PFAM peak was collected as one fraction.  The 
retention time of the PFAM peak shifted over time, so the separation had to be 
periodically monitored and the collection times corrected accordingly.  This fraction was 
dried down and then reconstituted into 150 μL of 16 μM C17D33:0 in methanol for 
further analysis with the RP-LC/APCI-MS.  The development and limitations of these 
methods have been described in Chapter 5. 
 
 
6.6.2  Reverse Phase LC/APCI-MS Conditions  
 
The HPLC/MS system was a Waters 2695 separations module with a Waters 2487 
dual wavelength detector operated at 210 nm to monitor the gradient and a Waters ZMD 
MS (Milford, MA) with an APCI probe in positive mode to monitor the separation.  Data 
was analyzed using Waters MassLynx 4.1 software.  Single ion mode was used to 
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monitor the mass to charge ratios for the [M+H]
+ 
signal corresponding to the PFAMs of 
interest.  Each channel monitored one or two mass to charge ratios for the time the 
corresponding peaks were expected to minimize background noise.  For the qualitative 
RP-HPLC separation, a Water’s XTerra MS C18 (5 μm, 3.9 x 150 mm) column with a 
Water’s XTerra MS C18 (5 μm, 3.9 x 20 mm) guard column and an inline filter were 
used.  The solvents were sonicated for 20 min to degas before running; during the run the 
in-line degasser was used.  Two different gradients were developed in Chapter 4.  
Gradient #1 was qualitative and was used to determine which PFAMs present in the 
sample, while gradient #2 was shorter to reduce the uncertainty in the calculated values.   
Before injecting using gradient #1, the column was equilibrated in 75:25 
methanol:water with 0.3 % formic acid.  After injection, the gradient was ramped linearly 
to 95:5 methanol:water with 0.3 % formic acid over 30 min with a 5 min hold at the final 
conditions before returning to the initial conditions.  The mobile phase was held at the 
initial conditions for 5 min before doing the next injection.  The flow rate was held 
constant at 1 mL/min.  All separations were done at room temperature (about 28 
o
C) with 
both gradients.  APCI-MS settings were as follows:  corona 3 kV, sample cone 30 V, 
extraction cone 2 V, RF lens 0.2 V, source temperature 130 
o
C, APCI probe temperature 
450 
o
C, desolvation gas flow 450 L/hr, and the cone gas flow 50 L/hr.  These values 
varied slightly every time maintenance was done on the MS.  The development and 
limitations of the method have been described in Chapter 4.  Channel one was used to 
monitor for C12:0 and C14:0 by scanning the mass to charge ratios 200 and 228 starting 
at 5.0 after injection to 13.5 min.  Channel two was used to monitor for C16:0 by 
scanning the mass to charge ratio 256 from 16.0 to 17.0 min.  Channel three was used to 
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monitor for the C18:1 isomers by scanning the mass to charge ratio 282 from 17.0 to 
22.0 min.  Channel four was used to monitor for the internal standards C17D33:0 and 
C17:0 by scanning the mass to charge ratios 270 and 303 from 16.0 to 23.0 min.  Channel 
five was used to monitor for the C18:0 by scanning the mass to charge ratio 284 from 
21.0 to 25.0 min.  Channel six was used to monitor for C20:0 by scanning the mass to 
charge ratio 312 from 24.5 to 29.0 min.  Channel seven was used to monitor for the 
C22:1 isomers by scanning the mass to charge ratio 338 from 26.0 to 33.0 min.  Channel 
eight was used to monitor for C22:0 by scanning the mass to charge ratio 340 from 29.0 
to 38.0 min. 
Before injecting using gradient #2, the same column was equilibrated in 80:20 
methanol:water with 0.3 % formic acid.  After injection, the gradient was ramped linearly 
to 100 % methanol with 0.3 % formic acid over 10 min.  The mobile phase was then 
returned to the initial conditions and flushed for 5 min before doing the next injection.  
All separations were done at room temperature (about 28 
o
C) with both gradients.  
APCI-MS settings were as follows:  corona 3 kV, sample cone 30 V, extraction cone 2 V, 
RF lens 0.2 V, source temperature 130 
o
C, APCI probe temperature 450 
o
C, desolvation 
gas flow 450 L/hr, and the cone gas flow 50 L/hr.  These values varied slightly every 
time maintenance was done on the MS.  The development of the method has been 
discussed in Chapter 4.  For this method, each mass to charge ratio corresponding to the 
PFAMs in the mixture was monitored in a separate channel for the duration of the run.   
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6.6.3  GC/MS Conditions 
 
A Varian GC/MS/MS system (CP-3800 GC with Saturn 2000 mass selective 
detector and CP-8400 autosampler) was used for the analysis of PFAMs.  The column 
was a Varian VF5-MS (0.25 mm internal diameter, 0.25 μm film thickness, 30 m long).  
The GC/MS method used for analysis was as follows:  starting temperature was 55 
o
C, 
ramped to 150 
o
C at 40 
o
C/min, held at 150 
o
C for 3.62 min, and finally ramped to 275 
o
C 
at 10 
o
C/min.  Helium was used as a carrier gas with a flow of 1 mL/min.  The mass 
range was 50 to 350 m/z in chemical ionization (CI) mode, with methanol as the CI gas.  
The temperature of the injection port was 250 
o
C with an injection volume of 1 μL 
unsplit.  The sample was reconstituted in 2-propanol to avoid methylation that occurs in 
the injection port when the sample is diluted in methanol. 
 
 
6.7  Results and Discussions 
 
Initial experiments were done by purifying the PFAMs from the bovine omentum 
lipid extract using the SPE method.  In this case, approximately 1 g of bovine omentum 
tissue was used for the extraction and 100 μL of the 1 mL lipid extract was loaded onto 
the first SPE column.  Gradient #1 was used for the RP-LC analysis.  For these 
experiments the samples were analyzed by both the LC/MS and the GC/CI-MS.  The 
results are shown in Table 6-1.  The GC/CI-MS analysis was done by Dent.  The amounts 
in the table were first corrected for any changes in the instrument from run to run using 
the response of C17D33:0 and then for dilutions during the sample preparation.  Next the 
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amounts were corrected for percent extracted using the percent recovery of C17:0.  
Sultana and Johnson showed that although the percent recovery of each PFAM from 
sample is not exactly the same, the percent recoveries are similar [18].  The amounts 
from three separate injections on the instrument were averaged together before 
subtracting any PFAMs found in the blank samples.  Finally, the numbers were divided 
by the starting mass of the wet tissue before averaging the results of three separate 
extractions.  C18:0 and C18:1
9
 have the largest error because of possible contamination 
from any plastic used during the sample preparation.  Because the detection limit was 
higher on the GC/MS, the LC/MS method detected more types of PFAMs.  
Unfortunately, further studies showed that these numbers were irreproducible.   
 
PFAM LC/MS Method
 
 (nmol/g)
 
GC/MS Method
  
(nmol/g)
 
Palmitamide (C16:0) 2.47 ± 1.24 1.41 ± 0.10 
Stearamide (C18:0) 2.23 ± 1.32 2.09 ± 1.19 
*Oleamide (C18:1
9
)   20.05 ± 2.76 11.43 ± 1.71 
*Arachidamide (C20:0) 0.86 ± 0.82 -- 
*Behenamide (C22:0) 1.91 ± 0.22 -- 
Erucamide (C22:1
13
) 118.79 ± 139.15 111.47 ± 22.83 
Table 6- 1  Values are reported at nmol of PFAM per gram of wet tissue and are the average of 
three separate extractions/analysis.  Values were corrected using both internal standards before 
the blank was subtracted to get the final values.  The percent recovery for the LC/MS method was 
30% while the percent recovery for the GC/MS method was 32%.  The error is the 95 % 
confidence level.  The asterisk denotes which reported PFAMs values were statically different 
between the two methods.   
 
An exact comparison cannot be made between this data and previously published 
data.  Hanus et al. reported C18:1
9
 concentrations in male Sprague-Dawley rats at 
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156 pmol/mL in cerebrospinal fluid and 35 pmol/mL of plasma [10], which is 
significantly lower than the amount found in the bovine omentum tissue.  Arafat et al. 
reported finding 15 nmol/mL of C16:0 and 113 nmol/mL of C18:1
9
 in human plasma [2].  
These values are higher than what was found in the bovine omentum, but C18:1
9
 is more 
concentrated than C16:0.  However, the rough orders of magnitude are similar.  
Wakamatsu et al. qualitatively studied omentum tissue but only reported finding C22:1
13
, 
which was found at the highest concentration in this study [7]. That result alone is 
intriguing, given the (scant) evidence for erucamide as an angiogenic agent, and suggests 
that further study of the role of PFAMs in angiogenesis is warranted. 
Validation experiments were done by spiking known amounts of the PFAM 
standards into the bovine omentum tissue before extraction.  A set of spikes were done by 
adding 2 times, 3 times, and 4 times (see table 6-2) the amount of PFAMs found in the 
tissue sample.  For each of these samples, 100 μL of the lipid extract was loaded onto the 
SPE column.  The RP-LC/APCI-MS results (using gradient #1) are summarized in 
table 6-3.  Because the recovered values did not consistently increase as the concentration 
of the PFAM increased, it was hypothesized that the concentration of each PFAM was 
not homogeneous throughout the entire bovine omentum tissue.  At times, the blank 
tissue had more PFAMs than the spiked sample.  In future experiments, the error between 
the lipid extracts with the same spike concentration was reduced by blending several 
grams of bovine omentum tissue together before the lipids were extracted from 1 g 
portions.   
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PFAM C16:0 C18:0 C18:1
9 
C20:0 C22:1
13 
2X spike 4 4 40 4 200 
3X spike 6 6 60 6 300 
4X spike 8 8 80 8 400 
Table 6- 2  The amount (nmols) added of each PFAM to the tissue before extraction. 
 
PFAM C16:0 C18:0 C18:1
9
 C20:0 C22:1
13
 
2X spike 7.56 20.58 41.06 3.30 127.60 
3X spike 2.34 -3.10 16.90 0.67 15.57 
4X spike 8.27 22.87 46.22 4.29 84.78 
Table 6- 3  The amount (nmol/g of wet tissue) recovered from the extraction after subtracting the 
amount found in the blank.   
 
After the NP-LC purification method (Chapter 5) and the RP-LC method 
(Chapter 4) were developed, the two methods were combined.  Initially, standards were 
used to test the method.  By calculating the percent recovery through the method with 
standards, the error in the method could be calculated.  To determine the recovery of the 
fraction collection, 2 μL of the PFAM mixture (560 pmol each) was injected onto the 
1 mm i.d. NP-LC column.  Three fractions were saved as they eluted from the column:  
10 min to 15 min to check for any PFAM loss, 15 min to 24 min to collect the PFAMs, 
and 24 min to 30 min to check for any PFAM loss.  The eluent was dried down and then 
reconstituted in 2-propanol which contained 16 μM of the internal standard (C17D33:0) 
for analysis with the gradient #1 RP-LC method followed by APCI-MS for detection.  
Results are shown in Table 6-4.  This experiment showed that the recovery in the 15 to 
24 min fraction of all the PFAMs was close to 100 % for each PFAM except C22:0.  It is 
suspected that contamination caused the error because the peak shape was different from 
calibration runs. 
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PFAM Percent 
Recovered 
Standard 
Deviation 
95 % Confidence 
Level 
C16:0 82 % 7 % 17 % 
C18:0 95 % 6 % 15 % 
C18:1
9
 86 % 3 % 7 % 
C20:0 93 % 10 % 24 % 
C22:0 217 % 24 % 61 % 
C22:1
13
 94 % 37 % 91 % 
Table 6- 4  Percent recoveries of each PFAM collected from the 1 mm i.d. NP column.  C17:0 
was used to correct for the variation between extractions, while C17D33:0 was used to correct for 
the variation in instrument response.   
 
The NP-LC method using the 4.6 mm i.d. column was also validated using 
standards.  Because of the higher flow rates, 1.5 mL fractions were collected from 32 min 
to 42.5 min.  For this experiment 30 nmol of each PFAM (C16:0, C17:0, C18:0, C18:1
9
, 
C20:0, C22:0, and C22:1
13
) was loaded as a mixture in 80:20 n-hetane:2-propanol onto 
the 4.6 mm i.d. NP column.  Each fraction was collected in a silanized glass vial, dried 
down, and reconstituted in 100 μL of 16 μM C17D33:0.  Each fraction was injected once 
onto the RP-LC column using gradient #1 and analyzed with APCI-MS.  The mixture 
was injected three separate times onto the NP-LC column.  The peak areas were corrected 
using the C17D33:0 as the internal standard and the results were reported as a percentage 
of the total signal.  There was some shift in the signal between trials, but all of the 
PFAMs eluted between fractions 3-6 corresponding to 35-41 min in the gradient.  
Figure 6-1 is a reconstructed chromatogram from the three trials averaged together 
showing the elution from the 4.6 mm i.d. NP column.  The reconstructed chromatogram 
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agrees with the elution order when the eluent was monitored in real time with the 
ESI-MS (Figure 5-14).   
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Figure 6- 1  The data from the three trials were averaged together and replotted as one 
“chromatogram” showing the elution from the 4.6 mm i.d. NP-LC column.   
 
Using the RP-LC gradient #1 alone there was over 20 % error in the back 
calculations when trying to quantify the results.  After propagating the error and adding 
in the experimental error from sample loss, the final numbers were insignificant 
compared to the error values.  The error was a combination of run-to-run variation on the 
instruments, variation in extraction efficiency from one sample to the next, variations in 
tissue samples, and experimental error from the sample preparation procedure.  In order 
to reduce the error caused by the APCI-MS, a shorter gradient (described as the 
gradient #2 in the RP-LC/APCI-MS conditions section) was developed where only six 
PFAMs were monitored by the MS.  This method allowed for a three point calibration 
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curve and the sample injections to be run in triplicate on the same day.  In order to test 
this method, 20 nmol of each PFAM (C16:0, C17:0, C18:0, C20:0, and C22:0) were 
injected (200 μL injection) onto the normal phase column.  The PFAMs were collected as 
two fractions (34 – 38 min and 38 – 42 min) which were combined during drying down.  
The sample was then reconstituted in 150 μL of 16 μM C17D33:0 in methanol before 
running the RP-LC/APCI-MS in triplicate using gradient #2.  Although the second 
internal standard (C17D33:0) was added before analysis, the error from the calibration 
curve was smaller when the peak areas were not corrected with the response factors.  The 
samples did need to be corrected with the first internal standard (C17:0) to correct for any 
sample loss during the purification separation.  Results are shown in Figure 6-2 and 
Table 6-5.  The data shows that at the 95 % confidence level, the experimental data 
agrees with the actual quantities added to the mixture.  See Appendix A for calculation 
procedures, except the values do not have to be corrected for dilutions since a lipid 
extraction was not done.   
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Figure 6- 2-  Percent recovery of each individual PFAM (C16:0, C18:0, C20:0, and C22:0) when 
collected off of the NP-LC column and then further separated with the RP-LC column using 
gradient #2.  20 nmol of each PFAM including C17:0 was loaded onto the NP column twice.  Error 
bars are the 95 % confidence limit.  The asterisks show when the data was statistically different 
from 100 %.   
PFAM C16:0 C18:0 C20:0
 
C22:0 
Sample 1 93 % 94 % 84 % 78 % 
Sample 2 111 % 108 % 85 % 37 % 
Sample 1 error 12 % 11 % 12 % 33 % 
Sample 2 error 5 % 3 % 3 % 11 % 
Sample 1 95 % C.L. 29 % 28 % 29 % 82 % 
Sample 2 95 % C.L. 11 % 8 % 8 % 28 % 
Table 6- 5  Percent recovery of each individual PFAM (C16:0, C18:0, C20:0, and C22:0) when 
collected off of the NP-LC column and then further separated with the RP-LC column using 
gradient #2.  20 nmol of each PFAM including C17:0 was loaded onto the NP column twice.  The 
values were calculated using a basic calibration curve.   
 
 
The method on the 1 mm i.d. NP-LC column was verified by analyzing the PFAM 
content in omentum tissue.  The lipid extract was reconstituted in 5 mL of 80:20 
n-heptane:2-propanol instead of 1 mL and then 2 μL of the sample was injected onto the 
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normal phase column.  The PFAM fraction was collected and reconstituted in 50 µL of 2-
propanol containing 16 μM of the internal standard (C17D33:0) before injecting onto the 
RP-LC column using gradient #1.  Five PFAMs (C18:1, C18:0, C20:0, C22:0 and C22:1) 
plus the internal standards (C17D33:0 and C17:0), which were added during sample 
preparation, were identified in the sample.  (Figure 6-3)  The same PFAMs, except for 
C16:0, were identified using both the SPE column
A
 and the 1 mm i.d. NP column.   
 
Figure 6-3  The sample was purified by loading 2 µL of the lipid extract (reconstituted in 5 mL) 
onto the normal phase column.  The PFAM fraction was collected and reconstituted in 50 µL of 2-
propanol before injecting onto the RP-LC column.  Five PFAMs (C18:1, C18:0, C20:0, C22:0 and 
C22:1) plus the internal standards (C17D33:0 and C17:0), which were added during sample 
preparation, were identified in the sample.  Except for C16:0 the same PFAMs were identified 
using both of the sample preparation methods.  
 
                                               
A
 Unpublished manuscript – Kroniser, K.M. and M.E. Johnson, Liquid Chromatography 
Mass Spectrometry Analysis of Primary Fatty Acid Amides in Bovine Omentum. 
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The method on the 4.6 mm i.d. NP-LC column was verified by analyzing the 
PFAM content in omentum tissue and then 200 μL of the sample was injected onto the 
NP column.  The PFAM fraction was collected and reconstituted in 100 µL of 2-propanol 
containing 16 μM of C17D33:0 before injecting onto the RP-LC column using 
gradient #1.  Two PFAMs (C22:0 and C22:1) plus the internal standards (C17D33:0 and 
C17:0), which were added during sample preparation, were identified in the sample 
(Figure 6-4).  The peak at 30 min was an impurity.  The concentration of PFAMs varied 
greatly from trial to trial, even when the recovery of the internal standard was the same.  
This led to the hypothesis that the PFAM content was not consistent over the entire 
bovine omentum sample; therefore, this data cannot be directly compared to the results 
from the SPE method.   
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Figure 6- 4  The sample was purified by loading 200 µL of the lipid extract onto the normal phase 
column.  The PFAM fraction was collected and reconstituted in 100 µL of 2-propanol before 
injecting onto the RP-LC column.  Two PFAMs (C22:0 and C22:1) plus the internal standards 
(C17D33:0 and C17:0), which were added during sample preparation, were identified in the 
sample.   
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A lipid extraction was done after spiking 30 nmol of C16:0, C17:0, C18:0, C20:0, 
and C22:0 into the 1 g bovine omentum tissue samples.  In this case, the blank was an 
unspiked sample of tissue.  Some solvent remained in the samples after dry-down but 
before reconstituting in 1 mL because the only method of drying down was blowing 
nitrogen over the sample.  The final lipid extract sample (200 μL) was loaded onto the 
NP-LC column.  Two fractions were collected from the NP-LC column and combined 
during dry down before reconstituting in 150 μL of 16 μM C17D33:0 in methanol.  20 μL 
of the solution was injected onto the RP-LC column using gradient method #2 for 
analysis.  The results from two extractions injected separately on the NP-LC column and 
then run in triplicate on the RP-LC column are summarized in Figure 6-5 and Table 6-6.  
See Appendix A for calculation procedures.  These numbers were better than previous 
experiments, but the error was still significant.  A series of experiments where the mass 
load on the normal phase column was varied by loaded the same spiked lipid extract at 
different volumes (100, 150, 175, and 200 μL) onto the column was done.  No trends 
were noticed.   
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Figure 6- 5  Percent recovery of each individual PFAM (C16:0, C18:0, C20:0, and C22:0) when 
collected off of the NP-LC column and then further separated with the RP-LC column using 
gradient #2.  30 nmol of each PFAM including C17:0 was spiked into the omentum tissue.  Two 
injections were done on the NP column and three injections were done on the RP column.  Error 
bars are the 95 % confidence limit.  The asterisks show when the data was statistically different 
from 100 %. 
 
 
PFAM C16:0 C18:0 C20:0
 
C22:0 
Extraction 1 36 % 45 % 107 % 13 % 
Extraction 2 132 % 127 % 187 % 64 % 
Extraction 1 error 31 % 52 % 141 % 74 % 
Extraction 2 error 7 % 7 % 9 % 7 % 
Extraction 1 95 % C.L. 78 % 130 % 350 % 183 % 
Extraction 2 95 % C.L. 18 % 18 % 22 % 16 % 
Table 6- 6  Percent recovery of 30 nmol of each PFAM spike from two extractions loaded on to 
the NP-LC column and analyzed with gradient #2 on the RP-LC column and APCI-MS.  The 
values were calculated using a basic calibration curve.   
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In an attempt to determine whether incomplete dry-down of the extract was a 
source of variability, two new methods were tested for post-extraction processing.  One 
method was to put the centrifuge tubes containing the lipid extract into a vacuum 
desiccator for about an hour with the pump running in order to completely dry the 
samples.  The other method was to add magnesium sulfate in excess to the lipid extract 
after removing the top layer.  The sample was centrifuged at 1500 g for 30 min to 
separate out the magnesium sulfate.  The liquid was pored through a filter into a clean 
centrifuge tube and dried down under nitrogen.  The samples still needed to be dried 
under vacuum in order to remove all the solvents.   
In order to test both of these dry down methods, 60 nmol of each PFAM was 
spiked into approximately 0.5 g of bovine omentum tissue before extraction.  In these 
cases, the blank was an unspiked sample of tissue.  The samples were reconstituted into 
2 mL of 80:20 heptane:2-propanol.  200 μL of the final lipid extract sample was loaded 
onto the NP-LC column.  Two fractions were collected from the NP-LC column and 
combined during dry down before reconstituting in 150 μL of 16 μM C17D33:0 in 
methanol.  The PFAM solution (20 μL) was injected onto the RP-LC column using 
gradient method #2 for analysis.  The results from two extractions injected separately on 
the NP-LC column and then run in triplicate on the RP-LC column are summarized in 
Figure 6-6 and Table 6-7 for the vacuum dry down and Figure 6-7 and Table 6-8 for the 
desiccant/vacuum dry down.  See Appendix A for calculation procedures using the basic 
calibration method.  The percent recovery using the magnesium sulfate as a desiccant did 
not significantly reduce the dry down time, but the percent recoveries are noticeably 
lower.  The student t test shows that there was less uncertainty in the calculated values 
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shown in table 6-7 when the lipid extract mass was completely dried before reconstituting 
as opposed to some solvent remaining in the lipid extract (data shown in table 6-6).  
Overall, the percent recoveries were higher when the sample was dried under vacuum 
after drying under nitrogen.  Because the remaining solvent would not have been the 
same for each sample, the solvent could have affected the concentration of the PFAMs 
and/or the retention times on the NP-LC column.     
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Figure 6- 6  Percent recovery of 60 nmol of each PFAM spike from three extractions loaded on to 
the NP-LC column and analyzed with gradient #2 on the RP-LC column and APCI-MS.  The 
samples were dried down using by blowing nitrogen over the sample and then pulling a vacuum.  
Two injections were done on the NP column and three injections were done on the RP column.  
Error bars are the 95 % confidence limit.  The asterisks show when the data was statistically 
different from 100 %. 
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PFAM C16:0 C18:0 C20:0
 
C22:0 
Extraction 1 81% 102% 59% 76% 
Extraction 2 95% 122% 68% 76% 
Extraction 3 85% 101% 44% 59% 
Extraction 1 error 15% 18% 10% 29% 
Extraction 2 error 20% 23% 23% 8% 
Extraction 3 error 10% 17% 19% 8% 
Extraction 1 95 % C.L. 38% 45% 26% 73% 
Extraction 2 95 % C.L. 51% 57% 58% 20% 
Extraction 3 95 % C.L. 25% 42% 48% 20% 
Table 6- 7  Percent recovery of 60 nmol of each PFAM spike from three extractions loaded on to 
the NP-LC column and analyzed with gradient #2 on the RP-LC column and APCI-MS.  The 
samples were dried down using by blowing nitrogen over the sample and then pulling a vacuum.  
The values were calculated using a basic calibration curve.   
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Figure 6- 7  Percent recovery of 60 nmol of each PFAM spike from three extractions loaded on to 
the NP-LC column and analyzed with gradient #2 on the RP-LC column and APCI-MS.  The 
samples were dried down using desiccant and then a vacuum.  Two injections were done on the 
NP column and three injections were done on the RP column.  Error bars are the 95 % 
confidence limit.  The asterisks show when the data was statistically different from 100 %. 
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PFAM C16:0 C18:0 C20:0
 
C22:0 
Extraction 1 68% 18% 54% 40% 
Extraction 2 67% 33% 144% 78% 
Extraction 3 60% 55% 174% 91% 
Extraction 1 error 17% 11% 16% 11% 
Extraction 2 error 15% 8% 25% 21% 
Extraction 3 error 6% 7% 18% 11% 
Extraction 1 95 % C.L. 42% 27% 39% 28% 
Extraction 2 95 % C.L. 37% 20% 63% 51% 
Extraction 3 95 % C.L. 15% 17% 44% 28% 
Table 6- 8  Percent recovery of 60 nmol of each PFAM spike from three extractions loaded on to 
the NP-LC column and analyzed with gradient #2 on the RP-LC column and APCI-MS.  The 
samples were dried down after a desiccant was used to remove the water from the sample using 
by blowing nitrogen over the sample and then pulling a vacuum.  The values were calculated 
using a basic calibration curve.   
 
 
6.8  Conclusions 
 
The PFAMs were extracted from the tissue sample with the other neutral lipids 
using Sultana’s method [15, 18].  After the sample is reconstituted, it could be loaded 
onto either SPE silica based column and then an amine based column or a normal phase 
LC column.  In both cases, the PFAM fraction was collected, dried down, and 
reconstituted before loading a portion onto the RP-LC column.   
Replacing the SPE purification method with a NP gradient followed by fraction 
collection improves the reproducibility of the method.  Because the gradient can be 
measured when problems occur, time spent on problem solving due to day-to-day 
variation in retention time is eliminated.  The NP-LC separation can be monitored using 
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ESI-MS, unlike the SPE method where only fractions can be analyzed (either by TLC or 
by MS).  Secondly, the same column was used for each extraction, rather than the two 
freshly hand packed columns needed to complete the SPE method, reducing run to run 
variations.  One of the limitations of the NP-LC method was that because the separation 
has been analyzed using ESI-MS, the elution pattern was only known for the lipid classes 
that ionize.  Furthermore, the method is only set up to monitor for one example in each 
lipid class with the exception of the PFAMs.  By following the trends of chromatography, 
the PFAM fraction was assumed to only have PFAMs and maybe some MAGs.  When 
using TLC to monitor the separation, all of the lipids in a given class are detected, but the 
method does not differentiate between contamination and lipids.   
There were several sources of error including experimenter and instrument.  All 
of the glassware had to be silanized, so any piece of glassware not fully silanized would 
have contributed to sample loss during sample preparation.  All of the samples were 
homogenized by hand.  Two sources of experimenter error would be if the tissue was not 
fully homogenized or if one of the solvent volumes were incorrectly measured.  The first 
internal standard (C17:0) should have corrected for any of these mistakes during sample 
preparation.  From running replicates of the standard mix solutions, it was determined 
that the instrument response was not the same from one injection to the next.  Initially, a 
second internal standard (C17D33:0) was added to the extract before injection.  However, 
further experiments showed that using a shorter gradient and a basic calibration curve 
(i.e. without the second internal standard) was actually more reproducible than the longer 
gradient and the response factor calculation method.  The concentration of PFAMs varied 
greatly from one bovine omentum tissue sample to the next.  Because the percent 
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recovery of the internal standard was similar, it was hypothesized that the concentration 
of PFAMs was not homogenous throughout the entire omentum making the tissue sample 
the greater source of error.  In order to reduce variations between samples within the 
same experiment, several grams of tissue were blended together before homogenizing 
one gram portions separately.   
Two different gradients were developed.  The gradient #1 was 45 min long while 
gradient #2 was 20 min long.  Gradient #1 was used for identify which PFAMs were 
present in the tissue sample.  This gradient separated all of the even saturated PFAMs 
from C12:0 through C22:0 and partially separated a series of PFAMs with one degree of 
unsaturation and the same carbon chain length.  Unfortunately, this method varied over 
20 % from one injection to the next.  The instrument error was reduced to less than 5 % 
by using the gradient #2.  Gradient #2 did not separate the PFAMs with one degree of 
unsaturation and the same carbon chain length, but could be used to quantitate a few 
saturated PFAMs spiked into the tissue sample.  Additionally, two different calculation 
methods were compared:  basic calibration method and response factor method.  The 
response factor method was set up to correct for instrument variations, but the results 
were more accurate when a short calibration curve was used with the basic calibration 
method.  The drawback to this method was that the PFAM concentration in the tissue had 
to be estimated before setting up the calibration curve.  Gradient #1 was used for 
qualitative results and gradient #2 was used for quantitative results.   
Figure 6-8 shows a schematic breakdown of the method.  Starting from the end of 
the method, it has been determined that there was approximately 5 % error between 
injections of standard mixtures on the RP-LC/APCI-MS using gradient #2.  When the 
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PFAM fraction was loaded onto the NP-LC column, collected, and then analyzed by 
RP-LC/APCI-MS using gradient #2, the error increased to approximately 15 % except for 
C22:0.  By comparing the variation between the percent recovery of the internal standard 
(C17:0) between samples versus the absolute percent recovery of the spiked PFAMs, it 
was determined that most of the error was from the variation in the PFAM concentration 
in the bovine omentum tissue.  For example, looking at the data depicted in Figure 6-6, 
the error (when comparing sample to sample variation) in the C17:0 recovery was 6 % 
and the error for the other PFAMs except for C22:0 was less than 10 %.  Therefore only 
approximations can be given for the PFAM concentrations in the bovine omentum tissue 
using this method.   
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Figure 6- 8  Schematic breakdown of the offline 2D-LC method for the analysis of PFAMs in 
bovine omentum tissue.   
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Although these experiments show that an off line 2D-LC method has been 
developed, further modifications need to be made to this method in order to develop a 
comprehensive 2D-LC method for quantitative lipid analysis.  The biggest problem is the 
length of the RP-LC gradient.  Ideally, the NP-LC separation should be slow enough so 
that three to four fractions of each peak can be injected onto the RP-LC column.  With 
the current NP-LC method, the PFAMs elute in approximately 2.5 min, which would 
only allow for one injection onto the RP-LC column.  If the total fraction (250 μL) was 
directly loaded onto the RP-LC column, the additional solvent would affect the 
separation.  The RP-LC method was developed with a 20 μL injection volume.  
Additionally, the off line 2D-LC method focused on PFAM analysis; therefore only the 
PFAM lipid class was collected from the NP-LC column and further separated by RP-LC.  
Future experiments would evaluate the effectiveness of separating the lipids in the other 
“polar” neutral lipid classes by RP-LC.  The RP-LC gradient may need to change as the 
polarity of the lipid eluting from the NP-LC column changes.   
Erin Divitio will do the method development needed to turn this off line 2D-LC 
method into a comprehensive 2D-LC method.  Divitio has already started developing a 
shorter gradient using a 6460 Agilent Technologies (Santa Clara, CA) rapid resolution 
LC and triple quadrupole MS.  There are several advantages of using this instrument over 
the Waters 2695 LC pump and ZMD MS.  The LC pumps have a higher pressure limit; 
therefore RP columns with smaller particle sizes and/or gradients with faster flow rates 
can be used for the separation of the PFAMs by chain length and degree of unsaturation.  
Preliminary experiments show that a partial series of the C18:1 isomers can be separated 
using a RP column (2.1 x 50 mm; 1.8 μm particles) and isocratic conditions (80:20 
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methanol:water with 0.3 % formic acid) in under 10 min.  In theory, using a triple 
quadrupole MS instead of the single quadrupole should reduce the background noise 
allowing for lower detection limits.  The method for the single quadrupole MS monitors 
for the [M+H]
+
 mass to charge signal corresponding to the PFAMs of interest.  The triple 
quadrupole method can be set up to scan for the [M+H]
+
 mass to charge signal, and then 
further fragment the ion.  The fragmentation pattern obtained from the MS/MS would 
identify if each peak was a PFAM or an impurity.   
Future work might include evaluating NP capillary columns for the first 
dimension.  This method would be needed if the RP method cannot be shortened so that 
several injections can be done on the RP column for every peak eluting from the NP 
column.  By switching to a longer column with a smaller i.d., the NP separation will be 
lengthened.  The sample loop collecting the fractions for the RP column could then be 
reduced and the number of samples loaded onto the RP column could be increased.  
Depending on the separation parameters, this should allow for longer analysis times in 
the second dimension compared to using the 4.6 mm i.d. NP column.  It is important that 
the NP and RP gradients be modified at the same time so that optimizing one dimension 
does not interfere with the separation in the other dimension.   
Currently, this method can be used to screen tissues for PFAMs.  The carbon 
chain length and degree of unsaturation can be determined, but the bond position cannot 
be positively identified.  An approximation of the quantity of each PFAM can be made.  
However, the amount of uncertainty in these values will be a problem when comparing 
the quantity of PFAMs in various tissues.  Since only a few different tissues have been 
screened for PFAMs [15], several different tissues will be screened for PFAMs before 
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focusing on determining the concentration of PFAMs.  Knowing where the PFAMs are 
stored and synthesized in vivo will allowed for more focused analytical methods to be 
developed for the quantification of the PFAM content.   
The second phase of experiments will involve developing the method, so that 
other lipid classes can be monitored.  This will be important for when studying the 
metabolic pathways.  Although, some studies have been done to determine the biological 
pathway, having a method that is able to monitor all the lipid classes involved at the same 
time will help confirm the proposed cycles.   
In conclusion the current method is good for screening biological tissues for 
PFAMs.  After it has been determined which biological tissues contain the most PFAMs, 
the comprehensive 2D/LC method can be developed to focus on the lipids present in 
these tissues.  The ultimate goal would be to have a method to separate and detect all the 
different variations and isomers of the neutral lipids; however, it is only necessary to 
optimize the separation for the neutral lipids that are naturally found in the tissues of 
interest.   
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